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The global prevalence of infertility is on the rise, and so is male factor infertility. Out of the 
approximately 72.4 million infertile couples worldwide, male factor is responsible for 50%. It 
has been reported that sperm quality is on the decline, even in healthy men. Several 
aetiologies have been identified, and this includes disease-related male infertility, such as 
diabetes mellitus (DM). DM is a chronic non-communicable disease, marked by increased 
hyperglycaemia which occurs as a result of lack in insulin secretion or due to the insensitivity 
of the target tissue to the metabolic effect of insulin. It has been reported that 422 million 
people are affected with DM globally, of which ≤10% is type 1 diabetic and ≤90% is type 2. 
Studies have shown that although most autoimmune diseases usually affect a higher 
percentage of women, type 1 diabetes is more prevalent in boys and men. The consequential 
detrimental effects of DM on male fertility have been reported in both experimental animals 
and diabetic men. This includes, decreased sperm motility, reduced normal sperm 
morphology, increased fragmented spermatozoa and many more defects. In the course of 
unravelling the pathways through which DM affect male fertility, studies have elucidated the 
role of endocrine dysfunction, formation of reactive oxygen species (ROS) and the subsequent 
development of oxidative stress (OS). However, other possible related pathways such as the 
involvement of glycated proteins, are yet to be explored. Since there are evidences that DM 
is detrimental to male fertility, it is important to firstly understand the underlying 
pathophysiology and then develop and explore strategies to combat this disease and its 
associated male reproductive complications.  
Many natural and artificial agents have been proposed to have antioxidant properties due to 
their potential in reducing oxidation. Antioxidants work either by scavenging ROS or by 
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preventing its formation. Rooibos (Aspalathus linearis), honeybush (Cyclopia intermedia) and 
sutherlandia (Lessertia frutescens) are plants endemic to Southern Africa. Herbal teas are 
derived from the leaves and stems of these plants. These infusions have been shown to be 
caffeine-free. Studies have also reported that the infusions from these plants contain 
bioactive chemical compounds with therapeutic benefits. Additionally, studies have shown 
their beneficial role in preventing the development of diseases and some have shown their 
ameliorative effects. However, their role in male reproduction is little understood as this 
represents the first study to report the effects of honeybush and sutherlandia on male 
reproductive function. Based on the expressed gaps in knowledge, the study was divided into 
two main parts, with each having several objectives.  
For the first part, thirty adult male rats were randomly divided into three groups of ten, which 
included a vehicle and two streptozotocin (STZ) groups receiving either 30mg/kg (STZ30) or 
60mg/kg (STZ60) intraperitoneally. For the second part, ninety animals were divided into nine 
groups of ten without bias. The groups included a control (water only), vehicle (STZ control, 
citrate buffer + water), rooibos (2% fermented rooibos), honeybush (4% fermented 
honeybush), sutherlandia (0.2% unfermented sutherlandia), diabetic control (STZ45mg/kg + 
water), diabetic + rooibos (STZ45mg/kg + 2% rooibos), diabetic + honeybush (STZ45mg/kg + 
4% honeybush), and diabetic + sutherlandia (STZ45mg/kg + 0.2% sutherlandia) group. Animals 
in the diabetic infusion treated groups were pre-treated with the respective infusion one 
week before DM induction. Animals were monitored closely throughout the treatment period 
and were sacrificed seven weeks after DM induction. Blood, testes and epididymides were 




The results of the first part of this study showed the negative effects of DM on male 
reproductive function, as diabetic animals presented with a decrease in spermatozoa with 
normal morphology and an increased number of spermatozoa with a higher deformity index. 
Histological and histomorphometrical analysis of the testis showed alteration in the 
seminiferous tubules’ cellular association in diabetic animals. Additionally, the first section 
further sheds some light on the involvement/expression of advanced glycation end products 
(AGE), its receptor (RAGE), mitogen-activated protein kinases and the activation of apoptosis 
in diabetes, which may contribute to the impairment seen in male fertility. Briefly, in DM, 
there is altered antioxidant enzyme activity (↓Catalase) which may result in OS. The 
development of OS can on the one hand instigate the breakdown of polyunsaturated fatty 
acids (PUFA), which can be measured by the levels of malondialdehyde (MDA) and also 
indirectly increase AGE formation. The peroxidation of PUFAs attracts more ROS formation, 
which can activate apoptotic induction, resulting in impaired sperm function. AGEs work by 
binding to their receptor (RAGE). The AGE-RAGE complex initiates the activation of the 
MAPKs, which may induce apoptosis by increasing the cleavage of PARP, hence resulting in 
nDNA damage. All these effects collectively result in reduced male fertility.  
To properly understand the role of the infusions (rooibos, honeybush and sutherlandia) on 
male reproduction of both healthy and diabetic animals, the second part of the study was 
divided into four sub-studies. 
Subsection one of the second part of the study investigated whether treatment with rooibos, 
honeybush and sutherlandia will impact sperm functional parameters positively or otherwise, 
in healthy rats. Animals treated with the respective infusions presented with a percentage 




morphology. Paradoxically, they presented with increased sperm concentrations. Hence, 
rooibos, honeybush and sutherlandia may enhance sperm concentration, which represents 
the sperm quantity. However, they may impair sperm quality (sperm motility and 
morphology), when consumed by healthy animals. 
Subsection two of the second part of the study investigated the testicular oxidative stress and 
apoptosis status in diabetic rats following treatment with rooibos, honeybush and 
sutherlandia infusions. This section highlighted the negative impact of DM on sperm 
functional parameters through increased lipid peroxidation and reduced antioxidant activity. 
The infusion treatment groups displayed increased antioxidant enzyme activity, which may 
be partly responsible for the observed improvement in sperm motility and morphology of 
diabetic animals receiving rooibos (DRF) and diabetic animals receiving sutherlandia (DSL). 
Additionally, the current study have shown the increased expression of apoptotic biomarkers 
in the diabetic control (DC) animals, which were not alleviated by the infusions. This suggests 
that these infusions play a role in alleviating diabetes-induced sperm function impairment 
through suppression of OS, but their role in apoptosis is still unclear. 
Subsection three of the second part of the study investigated the role of rooibos, honeybush 
and sutherlandia on insulin signalling in the testes of diabetic rats. All diabetic groups 
presented with a significant increase in blood glucose levels after diabetes induction. 
However, the diabetic animals treated with the infusions showed only a mild decrease in 
fasting blood glucose. The diabetic control animals showed a decrease in testis protein 
expression of IRS-1, PkB/Akt and GLUT4. Diabetic animals treated with rooibos (DRF) and 
honeybush (DHB) displayed an upregulation in IRS-1, while diabetic animals treated with 




decrease in PkB/Akt, DHB and DSL animals displayed upregulation compared to control. All 
diabetic animals showed increased phosphorylated ERK1/2 and reduced total ERK1/2 when 
compared to control and vehicle. Additionally, diabetic control animals presented with a non-
significant decrease in plasma testosterone concentration compared to control, while DRF 
and DSL showed a significant decrease and DHB showed upregulation. This suggests that (i) 
the activation of IRS, PkB/Akt, ERK and GLUT translocation is important in testicular insulin 
signalling (ii) rooibos, honeybush and sutherlandia may play a role in testicular insulin 
signalling, however, through different pathways (iii) honeybush may mildly enhance 
testosterone production in diabetes. 
Lastly, the fourth subsection of the second part of the study investigated the descriptive 
histological evaluation of the testis and cauda epididymis after treating with rooibos, 
honeybush and sutherlandia in both healthy and diabetic rats. The infusion control groups 
(RF, HB and SL) showed normal seminiferous tubule cellular association, presence of 
spermatozoa in the epididymal lumen and normal overall architecture. Both the testicular 
and epididymal morphology were altered in DM, but these disruptions were mildly alleviated 
by rooibos, honeybush and sutherlandia. 
It appears, from appreciating the results of the entire study, that diabetes does have 
detrimental effects on male reproduction, both at the tissue and cellular levels. The cellular 
impact may be exerted through protein glycation, development of OS and apoptosis 
induction. The use of rooibos, honeybush and sutherlandia, when healthy, should be taken 
moderately and with caution, as too much may be detrimental and may impair sperm 
functional parameters. However, in disease conditions such as diabetes, these infusions may 




(i) Rooibos and sutherlandia may mildly improve sperm quality (motility and 
morphology), 
(ii) Rooibos, honeybush and sutherlandia may mildly reduce hyperglycaemia by 
enhancing insulin signalling, 
(iii) Honeybush may enhance testosterone production, 
(iv) Rooibos, honeybush and sutherlandia may mildly improve the histomorphological 







Die wêreldwye voorkoms van onvrugbaarheid, en in spesifiek manlike-faktor-
onvrugbaarheid, is besig om toe te neem. Die manlike faktor is verantwoordelik vir 50% van 
alle gevalle van onvrugbaarheid in die ongeveer 72,4 miljoen onvrugbare paartjies 
wêreldwyd. Gepaardgaande hiermee word daar berig dat spermkwaliteit aan die afneem is, 
selfs in gesonde mans. Verskeie etiologieë is geïdentifiseer, en dit sluit in siekteverwante 
manlike onvrugbaarheid soos diabetes mellitus (DM). DM is ŉ chroniese nie-oordraagbare 
siekte, gekenmerk deur hiperglukemie, wat voorkom as gevolg van ŉ gebrek aan 
insulienafskeiding of weens die ongevoeligheid van die teikenweefsel vir die metaboliese 
effek van insulien. Daar is berig dat 422 miljoen mense wêreldwyd deur DM geaffekteer word, 
waarvan ≤10% tipe 1-diabete en ≤90% tipe 2-diabete is. Studies het getoon dat hoewel die 
meeste outo-immuun siektes gewoonlik ŉ hoër persentasie vroue aantas, tipe 1-diabetes 
meer algemeen voorkom in seuns en mans. Die gevolglike nadelige gevolge van DM op 
manlike vrugbaarheid is in sowel eksperimentele diere as in diabetiese mans aangemeld. Dit 
sluit in verlaagde spermmotiliteit, verminderde normale spermorfologie, verhoging in 
spermatosoa met DNS-fragmentasie en nog vele meer defekte. In die proses om die roetes 
waardeur DM ŉ invloed op manlike vrugbaarheid het te ontrafel, het studies die rol van 
endokriene disfunksie, die vorming van reaktiewe suurstofspesies (RSS) en die 
daaropvolgende ontwikkeling van oksidatiewe spanning (OS) toegelig. Ander moontlike 
verwante roetes, soos die betrokkenheid van geglikeerde proteïene, moet egter nog 
ondersoek word. Aangesien daar bewyse is dat DM nadelig is vir manlike vrugbaarheid, is dit 




en te ondersoek om hierdie siekte en die gepaardgaande komplikasies vir manlike 
voortplanting te bestry.  
Daar word voorgehou dat baie natuurlike en kunsmatige middels antioksidant-eienskappe het 
as gevolg van hul potensiaal om oksidasie te verminder. Antioksidante werk óf deur RSS op te 
vang óf deur die vorming daarvan te voorkom. Rooibos (Aspalathus linearis), heuningbos 
(Cyclopia intermedia) en sutherlandia (Lessertia frutescens) is plante wat inheems is aan 
Suider-Afrika. Kruietee word gemaak van die blare en stamme van hierdie plante. Daar is 
bewys dat hierdie infusies kafeïenvry is. Studies berig ook dat die infusies van hierdie plante 
bioaktiewe chemiese verbindings met terapeutiese voordele bevat. Daarbenewens het 
studies getoon dat hulle ŉ voordelige rol speel in die voorkoming van die ontwikkeling van 
siektes, en sommige het verbeterende effekte getoon. Hulle rol in manlike voortplanting word 
egter nog nie goed verstaan nie, en hierdie is die eerste studie wat die gevolge van 
heuningbos en sutherlandia op manlike voortplantingsfunksie aantoon. Op grond van die 
gemelde kennisleemtes is die studie in twee hoofafdelings verdeel, elk met verskeie 
doelstellings.  
Vir die eerste deel is dertig volwasse manlike rotte lukraak in drie groepe van tien elk verdeel, 
wat ŉ draer en twee streptosotosien (STS) groepe insluit wat óf 30 mg/kg (STS30) óf 60 mg/kg 
(STS60) intraperitoneaal ontvang het. Vir die tweede deel is negentig diere sonder 
vooroordeel in nege groepe van tien elk verdeel. Die groepe het ŉ kontrole- (slegs water), 
draer- (STS-kontrole, sitraatbuffer + water), rooibos- (2% gefermenteerde rooibos), 
heuningbos- (4% gefermenteerde heuningbos), sutherlandia- (0,2% ongefermenteerde 
sutherlandia), diabeteskontrole- (STS45 mg/kg + water), diabetes + rooibos- (STS45 mg/kg + 




sutherlandia- (STS45 mg/kg + 0,2% sutherlandia) groep ingesluit. Diere in groepe wat 
behandel is met ŉ diabetiese infusie is ŉ week voor die DM-induksie met die onderskeie 
infusies behandel. Diere is noukeurig gemonitorgedurende die behandelingsperiode en is 
sewe weke ná DM-induksie geoffer. Bloed, testes en epididimisse is ingewin vir verdere 
ontleding. 
Die uitslae van die eerste deel van hierdie studie het die negatiewe gevolge van DM op 
manlike voortplantingsfunksie getoon, aangesien daar ŉ afname in spermatosoa met normale 
morfologie en ŉ verhoogde aantal spermatosoa met ŉ hoër deformiteitsindeks in diere met 
diabetes voorgekom het. Histologiese en histomorfometriese analise van die testis het 
veranderinge in die sellulêre assosiasie van die seminale tubules in diabetiese diere getoon. 
Daarbenewens lig die eerste afdeling die betrokkenheid/uitdrukking van gevorderde glikasie-
eindprodukte (AGE), sy reseptor (RAGE), mitogeen-geaktiveerde proteïenkinases (MGPK) en 
die aktivering van apoptose in diabetes, wat kan bydra tot die afwykings gesien in manlike 
vrugbaarheid, toe. Kortliks, in DM is daar ŉ veranderde antioksidant-ensiemaktiwiteit (↓ 
Katalase) wat kan lei tot OS. Die ontwikkeling van OS kan enersyds die afbreek van poli-
onversadigde vetsure (POVS) aanhelp, wat gemeet kan word aan die vlakke van 
malondialdehied (MDA), en andersyds ook die vorming van AGE indirek verhoog. Die 
peroksidasie van POVS lok meer RSS-vorming, wat apoptotiese induksie kan aktiveer, wat lei 
tot beskadigde spermfunksie. AGE's werk deur te bind aan hul reseptor (RAGE). Die AGE-
RAGE-kompleks inisieer die aktivering van die MGPK’s, wat apoptose kan veroorsaak deur die 
splitsing van PARP te verhoog, wat gevolglik lei tot nDNA-skade. Al hierdie effekte lei 




Om die rol van die infusies (rooibos, heuningbos en sutherlandia) op manlike voortplanting 
van beide gesonde en diabetiese diere behoorlik te verstaan, is die tweede deel van die studie 
in vier substudies verdeel. 
Onderafdeling een van die tweede deel van die studie het ondersoek of behandeling met 
rooibos, heuningbos en sutherlandia sperm se funksionele parameters in gesonde rotte 
positief of andersins sal beïnvloed. Diere wat met die onderskeie infusies behandel is, het met 
ŉ persentasie toename in superoksieddismutase-aktiwiteit gepresenteer, maar het ŉ verlaging 
in spermmotiliteit en normale morfologie getoon. Paradoksaal genoeg het hulle verhoogde 
spermkonsentrasies gehad. Rooibos, heuningbos en sutherlandia kan dus moontlik 
spermkonsentrasie, wat die hoeveelheid sperma verteenwoordig, verhoog. Die gebruik 
hiervan kan egter moontlik die spermkwaliteit (spermmotiliteit en morfologie) van gesonde 
diere benadeel. 
Onderafdeling twee van die tweede deel van die studie het die testikulêre OS en apoptose 
status in diabetiese rotte ondersoek na behandeling met rooibos, heuningbos en 
sutherlandia-infusies. Hierdie afdeling het die negatiewe impak van DM, as gevolg van 
verhoogde lipiedperoksidasie en verlaagde antioksidant aktiwiteit, op die funksionele 
parameters van sperms beklemtoon. Die infusiebehandelingsgroepe het ŉ verhoogde 
antioksidant-ensiemaktiwiteit getoon, wat moontlik deels verantwoordelik kan wees vir die 
waargenome verbetering in spermbeweeglikheid en -morfologie van diabetiese diere wat 
rooibos (DRF) ontvang, en diabetiese diere wat sutherlandia (DSL) ontvang. Daarbenewens 
het die huidige studie die toenemende uitdrukking van apoptotiese biomerkers in die 




hierdie infusies ŉ rol speel in die verligting van die verswakking van diabetes-geïnduseerde 
spermfunksies deur onderdrukking van OS, maar hulle rol in apoptose is nog onduidelik. 
Onderafdeling drie van die tweede deel van die studie het die rol van rooibos, heuningbos en 
sutherlandia op insulienseingewing in die testes van diabetiese rotte ondersoek. Al die 
diabetesgroepe het ŉ beduidende toename in bloedglukosevlakke gehad ná die induksie van 
diabetes. Die diabetesdiere wat met die infusies behandel is, het egter slegs ŉ effense afname 
in die vastende bloedglukose getoon. Die DK diere het ŉ afname in testisproteïenuitdrukking 
van IRS-1, PkB/Akt en GLUT4 getoon. Diabetiese diere wat met rooibos (DRF) en heuningbos 
(DHB) behandel is, het ŉ opregulering in IRS-1 getoon, terwyl diabetiese diere wat met 
sutherlandia (DSL) behandel is, verbetering in IRS-2 getoon het. Alhoewel DRF-diere ŉ afname 
in PkB/Akt getoon het, het DHB- en DSL-diere opregulering getoon in vergelyking met 
kontrole. Alle diabetiese diere het verhoogde gefosforileerde ERK1/2 en verlaagde totale 
ERK1/2 getoon in vergelyking met die kontrole- en draerdiere. Daarbenewens het DK-diere ŉ 
nie-noemenswaardige afname in plasma-testosteroonkonsentrasie in vergeleke met kontrole 
getoon, terwyl DRF en DSL ŉ beduidende afname en DHB opregulering getoon het. Dit dui 
daarop dat (i) die aktivering van IRS, PkB/Akt, ERK en GLUT translokasie belangrik is in 
testikulêre insulienseingewing (ii) rooibos, heuningbos en sutherlandia moontlik ŉ rol kan 
speel in testikulêre insulienseingewing deur verskillende roetes en (iii) heuningbos moontlik 
testosteroonproduksie in diabetes effens kan verhoog. 
Laastens het die vierde onderafdeling van die tweede deel van die studie die beskrywende 
histologiese evaluering van die testis en cauda epididimis ondersoek na behandeling met 
rooibos, heuningbos en sutherlandia in beide gesonde en diabetiese rotte. Die infusie-




teenwoordigheid van spermatosoa in die epididimale lumen en normale algehele argitektuur 
getoon. Beide die testikulêre en epididimale morfologie was veranderd in DM, maar hierdie 
ontwrigtings is effens verlig deur rooibos, heuningbos en sutherlandia. 
Met inagname van die resultate van die hele studie blyk dit dat diabetes wel ŉ nadelige 
uitwerking op manlike voortplanting het, beide op die weefsel- en sellulêre vlak. Die sellulêre 
impak kan uitgeoefen word deur proteïenglikasie, ontwikkeling van OS en induksie van 
apoptose. Rooibos, heuningbos en sutherlandia moet matig en met omsigtigheid deur 
gesonde persone geneem word, aangesien te veel daarvan nadelig kan wees en die 
funksionele parameters van spermatosoa kan benadeel. In siektetoestande soos diabetes kan 
hierdie infusies egter voordelig wees, aangesien:  
(i) Rooibos en sutherlandia die spermkwaliteit (beweeglikheid en morfologie) effens 
kan verbeter, 
(ii) Rooibos, heuningbos en sutherlandia hiperglukemie effens verlaag deur insulien 
seingewing te verbeter, 
(iii) Heuningbos testosteroonproduksie moontlik kan verhoog, 
(iv) Rooibos, heuningbos en sutherlandia moontlik die histomorfologiese argitektuur 
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Introduction and problem statement 
1.1 Introduction and Rationale 
Infertility, which is described as a disease of the reproductive system has become an integral 
part of global health, as fertility, measured by the number of children per woman declined by 
±44% (from 4.5 to 2.5 children per woman) between 1970 and 2015 (United Nations, 
Department of Economic and Social Affairs, 2017). Jacky et al. estimated that globally, 
infertility is prevalent among 72.4 million women of infertile couples, serving as a 
representative of infertile couples (Jacky et al., 2007). Because of the difference in culture and 
belief systems, studies in the past neglected the role of male factor in infertility. However, 
contrary to the previous beliefs, that infertility majorly stems from the female partner of 
infertile couples, it is now evident that infertility is equally attributable to both male and 
female. Recent studies have reported that male factor is exclusively responsible for 30% of 
infertility cases, and another 20% is associated to both partners (Agarwal et al., 2015). The 
prevalence of male infertility is on the rise (Collet et al., 1988; Lunenfeld and Van Steirteghem, 
2004; Agarwal et al., 2015; Datta et al., 2016), as it was recently estimated that 1 in every 10 
men between ages 16 and 74 years have experienced infertility (Datta et al., 2016). This report 
suggests that more men are becoming infertile during their reproductive years. Several 





DM is a metabolic disorder that affects 422 million people globally as of 2014. It has been 
ranked as the 7th highest cause of death in humans (World Health Organization, 2014). 
Hyperglycaemia is a known effect of uncontrolled DM that can consequently lead to 
damageing of various systems and tissues (Vanstone et al., 2015). Diverse pathogenic 
processes are included in the development of DM. This ranges from the autoimmune 
destruction of the pancreatic β-cells with resulting insulin insufficiency, to abnormalities that 
causes resistance to insulin action (Burén et al., 2002). The fundamental effect of insulin loss 
or insulin ineffectiveness on glucose homeostasis is the inefficient uptake and usage of 
glucose by glucose dependent cells, resulting in hyperglycaemia (World Health Organization, 
2014). The numerous cases of DM fall into two broad categories, which are classified as either 
Type I DM or Type II DM. In both types of DM, metabolism of carbohydrates, lipids and protein 
are affected. 
DM may influence male reproductive function at multiple levels. This occurs as a result of its 
effects on the endocrine control of the hypothalamic-pituitary-gonadal (HPG) axis (Sexton and 
Jarow, 1997) ), or because of the inequality between ROS production and antioxidant defence 
mechanisms subsequently leading to OS (Du Plessis et al., 2010, 2015). Apoptosis induction 
(Said et al., 2004; Zhao et al., 2011), and the alteration in the modulation of glucose 
transporters have also been implicated (Lampiao and du Plessis, 2010). Baccetti et al. showed 
that the gonadotropins released in response to GnRH were lower in diabetic men. This was 
accompanied by a decrease in sperm motility and a higher percentage of sperm immaturity 
(Baccetti et al., 2002). These findings indicate that DM may affect male reproduction by 
interfering with the hypothalamic-pituitary-testicular axis. DM has been shown to increase 
testicular oxidative damage, which occurs when reactive oxygen species (ROS) exceeds the 




cascades of reactions, which subsequently lead to sperm DNA damage, mitochondrial DNA 
fragmentation, altered sperm parameters and ultimately, male infertility (Mangoli et al., 
2013). Kanter et al. showed that after DM induction in rats, there was an increase in testicular 
malondialdehyde (MDA) levels with reduced antioxidant enzyme activities (glutathione 
peroxidase (GPx) and superoxide dismutase (SOD). Which subsequently resulted in severe 
testicular damage as evidenced by disrupted seminiferous tubule structure. Also observed 
was the increased number of spermatozoa with fragmented DNA following apoptosis 
activation (Kanter, Aktas and Erboga, 2012).  
Additionally, Jiang et al. reported that streptozotocin (STZ)-induced diabetic rats displayed an 
increase in testicular tunnel positive cells, Bax/Bcl2 ratio and oxidative damage (Jiang et al., 
2013). In the same vein, Roessner et al. reported increased cleaved caspase 3 in the ejaculate 
of diabetic men (Roessner et al., 2012). These findings show that DM may affect male 
reproduction via apoptotic signalling. Furthermore, increased ROS production has also been 
implicated in the generation of advanced glycation end products (AGEs). AGEs are products 
of non-enzymatic reactions between sugars and the amino groups of proteins, lipids and DNA 
under hyperglycaemic conditions. AGEs can alter the normal functioning of macromolecules 
by generating ROS independently, or by activating the receptors for advanced glycated end 
products (RAGE), which leads to a further increase in ROS production by these mutated 
proteins. RAGE is a multi-ligand member of the immunoglobulin family which interact with 
specific ligands. Binding of RAGE to its ligands leads specifically to altered gene expression. 
The role of AGE-RAGE activation in the induction of apoptosis has been widely evaluated. 
Many of these studies were performed on various cell types such as neuronal and endothelial 
cells (Chen et al., 2010; Ramasamy et al., 2005), as well as periodontal ligament fibroblasts (Li 




kinase (MAPK) signalling and the nuclear factor kappa B (NF-κB) pathway, thereby leading to 
elevated production of ROS and upregulation of intercellular adhesion molecule-1 (ICAM-1), 
vascular cell adhesion molecule-1 (VCAM-1), and monocyte chemoattractant protein-1 (MCP-
1) (Hoefen and Berk, 2002). Interestingly, AGEs have been suggested to play a role in 
instigating harm and is believed to act as a mediator of damage to the reproductive system 
of diabetic men (Mallidis et al., 2009). 
Seeing that DM may inflict damage on male fertility at various levels, it is pertinent to counter-
act this action by exploring every possible strategy to combat DM and its associated male 
reproductive complications.  
Many natural and artificial agents have been proposed to have antioxidant properties due to 
their ability in inhibiting oxidation. Antioxidants work either by scavenging ROS or by 
preventing the formation of ROS (Lampiao, 2013).  
Rooibos (Aspalathus linearis), honeybush (Cyclopia intermedia) and sutherlandia (Lessertia 
frutescens) are plants endemic to the Southern Africa (Morton, 1983; McGaw, Steenkamp 
and Eloff, 2007; Joubert et al., 2008, 2011; van Wyk and Albrecht, 2008; Schloms and Swart, 
2014). Herbal teas derived from their leaves and stems have been shown to be caffeine-free. 
Studies have also shown that the infusions from these plants contain high bioactive chemical 
compounds with therapeutic benefits.  
1.2 Statement of problem 
A large amount of data is available on the effects of DM on sperm function. However, the 
mechanism through which the effects are exerted is less clearly understood. To gain further 




aimed to shed some light with regards to the pathway by which OS induced AGE formation is 
correlated with apoptosis and the resultant effect of the association.  
Additionally, rooibos, honeybush and sutherlandia have been shown to have antioxidant 
properties and several studies have shown their beneficial role in diverse disease states. 
Regarding male reproduction, very few studies have investigated the role of rooibos tea and 
this represent the first study to determine the effects of honeybush and sutherlandia on male 
reproductive function. Thus, this study also aimed to investigate the individual effect(s) of 
these infusions on male reproductive function and to determine their possible ameliorative 
role in DM-impaired male reproductive function. 
1.3 Aims and objectives  
As highlighted in the statement of problem, this study was divided into two, having different 
independent aims.  
1.3.1 Aim 1 
The first aim was to investigate the mechanism and correlation between apoptotic pathway 
activation, accumulation of AGEs and the expression of the receptor for AGEs (RAGE) in the 
streptozotocin (STZ) rat models of pre-diabetes and diabetes, as well as the independent and 
collective impact on male reproductive function. 
Objectives  
I. To establish an in vivo rat model of pre-diabetes and diabetes, 




III. To investigate the apoptotic pathway activation, accumulation of AGEs and 
expression of receptor for AGEs in the testis of pre-diabetic and diabetic rats and 
their respective impact on male reproductive function. 
 
1.3.2 Aim 2 
The second aim of this study was to determine the effects of rooibos, honeybush and 
sutherlandia on diabetes induced male reproductive impairment in Wistar rats. 
Objectives  
I. To establish an in vivo model of streptozotocin induced diabetes, 
II. To determine the effects of rooibos, honeybush and sutherlandia on sperm 
functional parameters, 
III. To determine the effects of rooibos, honeybush and sutherlandia on the 
antioxidant status of diabetic rats and the plausible ameliorative effects on the 
impaired male reproductive functions in DM rats. 
1.4 Study Layout 
To give a background to the study, chapter 1 briefly introduces the study by highlighting the 
rationale, statement of the problem, aims and objectives and the study layout. Chapter 2 
explains the general overview of the literature regarding diabetes mellitus, male infertility, 
rooibos, honeybush and sutherlandia. Chapter 2 is accompanied by two addenda (2A and 2B), 
focusing on the mechanisms through which diabetes impact male fertility and the resultant 
outcomes. This is followed by a comprehensive basic materials and methods section (Chapter 




manuscripts in preparation (prepared according to journal guidelines). Both Chapters 4 and 5 
addresses aim 1, while another three chapters (Chapters 6-8) focused on the role of rooibos, 
honeybush and sutherlandia on male reproductive function, either independently or their 
role in diabetes impaired male reproductive function. Chapter 9 describes the qualitative 
histological evaluation of the testis and cauda epididymis. The final chapter (Chapter 10) 
include the conclusion and recommendation for future studies. 
Addendum 2A and Chapter 4 are presented as published papers. Addenda 2B and Chapters 5 
and 7 are shown as submitted for publication, while Chapters 6, 8 and 9 are displayed as 
manuscripts in preparation. Hence, repetition may occur in the introductory section of each 
chapter. In addition, applicable references are included in each chapter. 
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2.1 Introduction  
This chapter entails a broad overview of the literature regarding, diabetes mellitus (DM), male 
infertility, mechanisms through which DM impact male fertility, rooibos, honeybush, 
sutherlandia and their potential impact on general health, including male reproductive health. 
The mechanisms/relationship between DM and male infertility are discussed in addendum 2A 
as published, while the mechanistic role of AGE/RAGE pathway in the investigation of male 
infertility is elucidated in addendum 2B as submitted for publication. 
 
2.2 Diabetes mellitus  
DM is a chronic disease that result from the inability of the pancreas to produce enough 
insulin or from the incapability of the body to effectively use the produced insulin. DM has 
become an important public health problem, because its prevalence is on the rise and has 
recently been included as one of the four prioritized non-communicable diseases that 
requires immediate attention (World Health Organization, 2014). It can be said that the global 
prevalence of DM has escalated since the 1980s, as it was reported to affect 108 million 
people in 1980, 177 million in 2002, 346 million in 2004 and 422 million in 2014 (World Heallth 




prevalence relative to age-standard has tripled since 1980. It was reported that DM and DM-
related complications caused 3.7 million deaths in 2012, of which 43% are people younger 
than 70 years (World Health Organization, 2014). This increase in DM prevalence has led to a 
substantial loss to both health systems and national economies.  
Diverse pathogenic processes are involved in DM development. This includes the 
autoimmune destruction of the pancreatic β-cells with resultant deficient insulin synthesis 
and secretion and other disorders that lead to insulin resistance. The basis for metabolic 
abnormalities seen in DM is the deficient action of insulin on target tissues (American 
Diabetes Association, 1970). Symptoms of DM include, hyperglycaemia, polydipsia, polyuria, 
polyphagia, reduced body weight, impaired growth, vulnerability to infections, fatigue and 
blurred vision (American Diabetes Association, 1970; World Health Organization, 2014). DM 






Figure 1: The rise in the global prevalence of diabetes mellitus from 1980-2014.  
Adapted from (World Health Organization, 2014). 
 
 
Figure 2: Showing regional distribution of diabetes prevalence (1980 vs. 2014). 
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2.3 Type 1 DM 
2.3.1 Prevalence 
Out of the 422 million people affected by DM globally in 2014, ≤10% is attributed to type I 
DM. About 85% of this population are diagnosed before the age of 20 and ≥15% of the cases 
are ascribed to adults (≥30years). The WHO through the DIAMOND project estimated that 
4.5% of the world’s population as at 2000 between age ranges 0-14 have type I DM following 
an estimation from 50 different countries. However, a >350-fold difference was seen in the 
incidence of type I DM after inclusion of another 50 countries and that it increases with age 
in most populations with the highest occurrence observed in 10–14 year olds (Karvonen et 
al., 2000; Maahs, David M; West, Nancy A; Lawrence, Jean M; Mayer-Davis, 2010). Although, 
most autoimmune diseases usually affect a higher percentage of women, type 1 DM is more 
prevalent in boys and men (Östman et al., 2008). 
 
2.3.2 Pathogenesis of type 1 DM 
Type 1 DM is instigated by injury or cellular-controlled autoimmune destruction of the 
pancreatic β-cells. Heredity, race or ethnicity, age and gender are some of the associated risk 
factors that play a role in ascertaining the susceptibility of the insulin producing cells to 
abrasion. It may develop swiftly over a period of a few days or weeks, following this sequence: 
(1) decreased insulin, (2) elevated usage of fats for energy, and (3) degradation of the body's 
proteins and amino acid oxidation due to insulin deprivation (Caso and McNurlan, 2010)  
Studies have shown the importance of genetic susceptibility in the development of type 1 DM 
(Lambert et al., 2004; Pociot et al., 2010; Redondo, Steck and Pugliese, 2018). The genes for 




components. This is because they provide both vulnerability towards and protection against 
the development of type 1 DM. These genes are located within the major histocompatibility 
complex (MHC) HLA class II region on chromosome 6p21 and they accounts for 45-50% 
susceptibility for the disease (Buzzetti, Quattrocchi and Nisticò, 1998). These same genes 
protect against developing type 1 DM. Therefore, it can be said that type 1 DM is not just a 
disease instigated by the autoimmune destruction of the pancreatic β-cells, it is a 
heterogeneous and polygenic disease (Lernmark and Ott, 1998). 
 
2.4 Type 2 DM 
2.4.1 Prevalence 
The prevalence and incidence of type 2 DM is rapidly increasing throughout the world and it 
accounts for 90–95% of those with DM. Type 2 DM was known to be an adult or old age 
disease, but in the last few decades, its prevalence has increased among youth, which predicts 
for higher estimate of occurrence in the future. Nijpels in 2016 predicted a 71.5% increase in 
the prevalence of type 2 DM amidst age 20-79 by 2035, including 6% increase in Africa, 7.1% 
in Europe, 11.3% in Middle East, 12.3% in North America and Caribbean, 8.2% in South and 
Central America, 9.4% in South East Asia and 8.4% in the Western Pacific (Nijpels, 2016).  
2.4.2 Pathogenesis of type 2 DM 
It occurs because of decreased perceptivity of target tissues to the metabolic effects of 
insulin. Type 2 DM is also described as a ‘‘modern day disease’’ because it is caused by lifestyle 
factors, such as, diet and obesity. Ethnicity, environmental exposure and socio-economic 
factors are also evident risk factors. In comparison to type 1 DM, it is correlated with elevated 




the pancreatic β-cells for reduced sensitivity of responsive tissues to the metabolic effects of 
insulin. The diminished insulin sensitivity debilitates carbohydrate usage and storage, 
increasing blood glucose and spurring a compensatory increase in insulin secretion. 
Since the basis for abnormalities in carbohydrate, fat, and protein metabolism in DM is the 
insufficient action of insulin on the target tissues, it is important to know what insulin is, what 
it does and how it works. 
 
2.5 Insulin  
Insulin, synthesized and secreted by the pancreatic β-cell, is a fundamental peptide hormone 
with physiological importance in the regulation of carbohydrates, fats and protein 
metabolism (D.Melloul, S.Marshak and E.Cerasi, 2002). Insulin is secreted in its inactive form, 
preproinsulin. The proteolytic cleavage of insulin precursor produces proinsulin and as a 
compensatory response to an increase in blood glucose or amino acid concentration, 
proinsulin is secreted and proteolytically converted to active insulin (Rains and Jain, 2011). 
Active insulin consist of two polypeptide chains connected by disulphide bridges (D.Melloul, 
S.Marshak and E.Cerasi, 2002). The function of insulin is to regulate glucose, lipid and protein 
homeostasis. Insulin controls glucose metabolism by stimulating glucose transport into the 
muscle and adipose cells and concurrently reducing gluconeogenesis and glycogenolysis by 
the liver. While lipid homeostasis is achieved by increasing lipid synthesis in the liver and 





2.5.1 Insulin signalling in health 
Insulin receptors, such as insulin-like growth factor 1-receptor (IGF1-R) and insulin receptor 
related-receptor (IRR), are tetrameric proteins having four functional subunits (2α and 2β 
subunits). These receptors can form functional complexes with insulin, such that the 
inhibitory mutation in one receptor subunit can inhibit the activity of the others (Butler and 
LeRoith, 2001). When there is an increase in blood glucose, insulin is released and it binds the 
α-subunit of insulin receptor. This leads to the suppression of β subunit kinase activity and 
subsequent stimulation of tyrosine auto-phosphorylation of the β subunit (Alan and Kahn, 
2001; Bloch-Damti and Bashan, 2005). Hence, the insulin receptor is 
activated/phosphorylated. The activation of the receptor leads to the phosphorylation of 
insulin receptor substrates (IRS 1-4), although only IRS 1/2 are important in glucose transport 
(Kriauciunas, Myers and Kahn, 2000). Activated IRS proteins acts as binding sites for molecules 
that contains src-homology-2 (SH-2) domains such as phosphoinositide-3-kinase (PI3K), 
growth factor receptor-bound protein-2 (GRB-2)/ Son-of-sevenless proteins (SOS) and 
phosphotyrosine phosphatase (SHP2). Binding of these molecules to IRS1/2 form a complex 
that mediate the down-stream signalling.  
It has been shown that PI3K is the major signal mediator of the metabolic (catabolic and 
anabolic) and mitogenic actions of insulin. PI3K is composed of a regulatory p85 subunit and 
a p110 catalytic subunit. Binding of the p85 subunit to IRS enhances the catalytic action of 
p110 which then allows the phosphorylation of its substrate, Phosphatidylinositol 4,5-
bisphosphate (PtdIns(4,5)P2) to Phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) 
(Bloch-Damti and Bashan, 2005). PtdIns(3,4,5)P3 recruits serine kinases, protein kinase-B 
(PKB/Akt), protein kinase-C (PKC) and phospho-inositide-dependent kinase -1 (PDK-1) 




translocation of glucose transporter 4 (GLUT 4) from the intracellular vesicles (storage pools) 
to the plasma membrane, (ii) phosphorylation of glycogen synthase kinase-3 (GSK-3) to 
synthesize glycogen and (iii) upregulation of fatty acid synthase gene to induce lipogenesis.  
Additionally, insulin can activate the mitogen activated protein kinases (MAPK), especially the 
ERKs through the binding of GRB-2 and SOS to IRS1/2. Activation of ERK induces cell 
proliferation and differentiation gene expression. GRB-2, SOS and SHP-2 binds IRS1/2 to 
activate membrane bound Ras. The phosphorylation of Ras stimulates a stepwise activation 
of kinase signalling of Raf, MEK and ERK. ERK is then translocated into the nucleus where it 
stimulates the phosphorylation of transcription factors to initiate gene expression needed for 
cell proliferation and differentiation (Alan and Kahn, 2001)  
Another pathway through which insulin enhances glucose uptake is by stimulating the 
tyrosine phosphorylation of the Cb1 proto-oncogene. Cb1 functions by binding to CAP. CAP is 
an adaptor protein that contains SH3 domains and Sorbin homology (SoHo) domain. Binding 
of Cb1 to CAP, forms a complex called Cb1-CAP. The interaction of the SoHo domain of the 
complex with protein flotillin, stimulates the phosphorylation of Cb1-CAP complex and its 
translocation to the lipid raft domains on the plasma membrane (Baumann et al., 2000). The 
presence of the Cb1 complex on the lipid raft results in the recruitment of adapter protein 
CrkII, which leads to the formation of complex signalling that aid the activation of G protein, 
TC10. Once TC10 is activated, it acts as a second signal (in addition to the signalling of PI3K) 
in recruiting GLUT4 from the intracellular pools to the plasma membrane (Baumann et al., 
2000). 
However, when the blood glucose levels is uncontrolled due to lack in secretion or 




DM. In recent years, the views that DM has inconsequential effects on male reproductive 
functions have been questioned by conclusive data from various studies (Zhao et al., 2011; 
Roessner et al., 2012)  
 
2.6 Infertility: male infertility 
The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and 
the WHO describes infertility as the reproductive system disease marked by the failure to 
achieve a clinical pregnancy after 1year or more of consistent unprotected sexual intercourse 
(Zegers-Hochschild et al., 2009). Infertility has become an integral part of reproductive health 
as it is estimated to affect about 60-80 million couples of reproductive age, of which 56% 
seeks health care (Jacky et al., 2007). Male infertility on the other hand, describes a male’s 
inability to cause fertilization in a fertile female over a period of 12 months of consistent and 
unprotected intercourse. It is estimated that about half (50%) of all the infertility cases is 
attributed to the problem of the male with 20-30% exclusively attributed to the problem of 
the male and another 20-30% are due to a combination of male and female anomalies (Sharlip 
et al., 2002). A recent study revealed that 1 in every 10 men between the age of 16 and 74 
have experienced infertility (Datta et al., 2016), and that the cause of infertility due to the 
male factor ranged from 20-70% across different groups. This include 50% in North America 
(Agarwal et al., 2015), 60-70% in the Middle East (Collet et al., 1988), 20-40% in Sub-Saharan 
Africa (Lunenfeld and Van Steirteghem, 2004) and 37% in Asia (Elussein et al., 2008). 
Several studies have highlighted the negative impact of DM on male fertility. This include 
endocrine function dysregulation, testicular dysfunction, disruption of spermatogenesis, 




et al., 2010; Chen et al., 2016). The adverse effects of DM on male fertility and the mechanism 
through which the effect are exerted are broadly discussed in addenda 2A and 2B as published 
and submitted respectively.  
Since it has been shown that DM affects 422 million people globally (World Health 
Organization, 2014), including men in their reproductive age (Nijpels, 2016), it is therefore 
important to explore every possible strategy to combat DM and its associated male 
reproductive complications.  
Many natural and artificial substances have been proposed to have antioxidant properties 
due to their ability in scavenging free radicals (ROS) or their ability to prevent the formation 
of ROS (Lampiao, 2006), in diseases such as DM. 
 
2.7 Rooibos  
Rooibos is a low-tannin, caffeine free beverage (Morton, 1983). It was first discovered in the 
Cederberg Mountains of the Western Cape region of South Africa (Joubert et al., 2008; 
McGaw et al., 2007). Rooibos is a remarkable polymorphic straight plant with differing 
ecology, morphology, geographical distribution and chemical contents (Hawkins et al., 2011; 
Van Wyk & Gorelik, 2017). It has a rigid, densely clustered shoot system with varying 
aspalathin content (leaves>stems>dried shoots), even, between plants from the same 
plantation (Joubert and Schulz, 2006) (Figure 3). 
There are varieties of wild types of rooibos tea that are all considered part of the Aspalathus 
linearis species complex. These various forms were first made known by the Conservator of 




rocky region of Cederberg mountain with less aroma). (ii) Vaal type (it is pale and greyish 
green, grows in Cederberg and the Olifants River, with undesirable honey aroma). (iii) Rooi-
bruin type (reddish-brown in colour, grows on the sand flats in the northern region of 
Clanwilliam division, it is slightly coarse and has mild flavour). (iv) Cederberg type (grows in 
the northern part of Cederberg) and lastly, the Rooi type. (v) The Rooi type originated from 
the wild forms found mainly in the northern part of the Cederberg Mountains. Although all 
forms of rooibos tea were previously commercially available only Rooi Tea is obtainable 
today, which is generally known as the rooibos tea (Van Wyk and Gorelik, 2017). 
Rooibos is traditionally produced in two ways, which include the fermented and the 
unfermented products (Figure 4A, B). The fermented tea is achieved by oxidation that result 
in the distinctive reddish-brown leaf colour with woody-fynbos-floral honey flavour (Koch et 
al., 2012). The unfermented type is also called the green rooibos. Hot water extracts prepared 
from both fermented and green rooibos are used as food and/or cosmetic ingredients due to 
the presence of high aspalathin content, especially in the unfermented. Fermented rooibos 
aspalathin content is 2% while that of green rooibos is 8% (de Beer et al., 2017; Joubert & de 
Beer, 2012), this is because the amount of aspalathin decreases during fermentation. 
However, fermented rooibos is more preferred in food because of the flavour and it is 






     








Figure 4: Different types of processed rooibos (Medical News Today 
www.medicalnewstoday.com/articles/323637.php) 





2.7.1 Fermentation/degradation process of Rooibos 
The red-brown colour formation of rooibos during fermentation has been linked largely to 
the degradation of aspalathin, a process known to be a non-enzymatic oxidative breakdown. 
After shredding, bruising and wetting of the plant material in heaps, the fermentation process 
begins. In brief, aspalathin is oxidized to O-quinone. This O-quinone rearranges to quinine 
methide, which allows fast conversion of isolated single eriodictyols into a stable equilibrium. 
Quinine methide undergo further oxidation to give (S)-eriodictyol-6-C-β-D-glucopyranoside 
(A), (S)-eriodictyol-8-C-β-D-glucopyranoside (B), (R)-eriodictyol-6-C-β-D-glucopyranoside (C) 
and (R)-eriodictyol-8-C-β-D-glucopyranoside (D) (Krafczyk and Glomb, 2008). Further 
oxidation of A+C results in the formation of isoorientin and orientin while oxidative 
breakdown of B+D results in the formation of isoorientin (Figure 5). During this process, the 
oxidative coupling intermediates produced are known to be colourless dimers (Bramati, 
Aquilano and Pietta, 2003). However, Heinrich et al., reported the presence of two additional 
coloured dimers with dibenzofuran skeleton ( (S)-and (R)-3-(7,9-dihydroxy-2,3-dioxo-6-β-D-
glucopyranosyl- 3,4-dihydrodibenzo[b,d]furan-4a(2H)-yl) propionic acid) during the 






Figure 5: Fermentation process of rooibos.  







2.7.2 Chemical composition of Rooibos 
The recognized health promoting advantages of rooibos are partly attributed to its phenolic 
composition. The phenolic constituents of rooibos comprises of the dihydrochalcones 
(nothofagin, aspalathin, C-5-hexosyl derivative of aspalathin), cyclic dihydrochalcone 
(aspalalinin), phenylpropenoids (phenypyruvic acid-2-0-glucoside), flavones (orientin, 
isoorientin, vitexin, isovitexin, luteolin, luteolin-7-0-glucoside, chyrysoeriol) and the flavonols 
(quercetin, isoquercetin, hyperoside, rutin, quercetin-3-0-ribinobioside), flavanones ((S)-
Eriodictyol-6-C-glucosidee), (R)-Eriodictyol-6-C-glucosidee), (S)-Eriodictyol-8-C-glucosidee 
and (R)-Eriodictyol-8-C-glucosidee) (Figure 6) (Beelders et al., 2012).  
 
 





2.7.3 Benefits of Rooibos  
Several studies have investigated and elucidated the antioxidant activities of the flavonoid 
contents of rooibos on different systems (Awoniyi et al., 2012; Pheiffer, de Beer, et al., 2013; 
Hong, Lee and Kim, 2014) and cells (Schloms and Swart, 2014; Moosa et al., 2018; Shabalala 
et al., 2019). Pheiffer et al. reported that treatment of 3T3-L1 adipocytes with fermented 
rooibos inhibited intracellular lipid build-up. It was further stated that the inhibition of 
adipogenesis was accompanied by reduced mRNA expression of peroxisome proliferator-
activated receptor gamma (PPARy), peroxisome proliferator-activated receptor alpha 
(PPARα), sterol regulatory binding factor (SREBF1) and fatty acid synthetase (FASN). This 
collectively suggest its likely potency to prevent obesity. 
Additionally, the effects of major rooibos flavonoids such as, dihydrochalcones (aspalathin 
and nothofagin) and the flavones (orientin and vitexin) were examined on the adrenal 
steroidogenic enzymes (3β-hydroxysteroid dehydrogenase (3βHSD2), cytochrome P450 
(cP450), P450 17α hydroxylase/17,20-lyase (CYP17A1), P450 21-hydroxylase (CYP21A2) and 
P450 11β-hydroxylase (CYP11B1). It was concluded that flavonoids of interest inhibited 
3βHSD2 and CYP11B1 thereby causing structural changes of the enzymes. This suggest that 
flavonoids influence the activity of adrenal steroidogenic enzymes by causing structural 
plasticity (Schloms and Swart, 2014). Furthermore, Hong et al. reported the antioxidant effect 
of rooibos on immobilization induced OS in rat brain (Hong, Lee and Kim, 2014). 
Several in vivo studies have reported the anti-diabetic effect of rooibos (Son et al., 2013; 
Dludla et al., 2018; Layman et al., 2019). Some authors showed that aspalathin treatment in 
diabetic vervet monkeys improves glucose tolerance and also decreases low-density 




percentage of oxidized CoQ10 and circulating oxidized low-density lipoproteins were 
observed. This collectively suggest that rooibos can ameliorate OS and impaired glucose 
metabolism (Orlando et al., 2019). Additionally, rooibos was able to repair the impaired 
insulin signalling by activating 5´-adenosine monophosphate-activated protein kinase (AMPK) 
pathway and also improve lowered mitochondria respiration rate in induced hepatic insulin 
resistance (Mazibuko-Mbeje et al., 2019). In addition to the antioxidant, anti-diabetic and 
anti-inflammatory effects of rooibos, studies have further highlighted its long-term beneficial 
effect on long-term spatial memory in adult male rats (Pyrzanowska et al., 2019). 
However, despite the numerous available data on rooibos and its health benefits, few studies 
have investigated its effect on male reproductive function. This includes a study that reported 
improvement in sperm motility, sperm concentration and sperm viability after treatment with 
rooibos (Opuwari and Monsees, 2014). Additionally, Ros-Santaella and Pintus reported that 
the in vitro treatment of boar semen with rooibos protected the sperm acrosome structure 
accompanied by improved sperm velocity (Ros-Santaella and Pintus, 2017).  
Despite the enormous health benefits of rooibos, studies have highlighted some adverse 
effects when the consumption is excessive. It was shown that lengthened exposure to rooibos 
induces acrosome reaction in rats, which can subsequently lead to impaired reproduction 
(Opuwari and Monsees, 2014). 
 
2.8 Honeybush  
Honeybush is native to the Southeast and Southwest coastal areas of South Africa and it forms 




a traditional tea since the 19th century (Joubert et al., 2011; Schloms and Swart, 2014). 
Honeybush is a short woody perennial plant with the life span of 15 years (North et al., 2017). 
About 23 different species of honeybush have been identified, however, only five species are 
commercially available. This includes, Cyclopia intermedia, Cyclopia genistoides, Cyclopia 
maculata, Cyclopia sessiliflora and Cyclopia subternata. A mature honeybush plant has the 
flowers, leaves, stem and seeds. The flowers are bright yellow, fluorescent and sweetly 
scented, having a characteristic sweet honey flavour. The leaves are in trifoliolate with 
differing shapes and sizes relative to specie variability. In general, the leaves are thin, needle-
like and elongated. Honeybush have golden yellow woody stem and grows to about 1-3 m in 
height (Figure 7). The seeds are formed in small pods that turns brown when ripe. Honeybush 
tea is made from the flowers, leaves and twigs and it is mostly preferable in the fermented 
form, however, the unfermented product is also commercially available (Joubert et al., 2011).  
 
2.8.1 Chemical composition of Honeybush 
Honeybush tea does not only have a pleasant taste and scent, it also contains phytochemicals 
especially polyphenols and some volatile organic compounds that are beneficial to health 
(Joubert et al., 2008). Le Roux et al. found 183 volatile organic compounds in honeybush 
(C.subternata) which included compounds that are believed to be responsible for the sweet 
aroma after fermentation. The odour-active compounds found in honeybush are (E)-β-
Damascenone, (R/S)-linalool, (E)-β-damascone, geraniol, (E)-β-ionone, (7E)-megastigma-
5,7,9-trien-4-one, (6E,8Z)-megastigma-4,6,8-trien-3-one, (6E,8E)-megastigma-4,6,8-trien-3-
one, (7E)-megastigma-5,7,9-trien-4-one, 10-epi-γ-eudesmol, epi-α-muurolol, and epi-α-




The known health benefits of honeybush are ascribed to its phytochemicals, which includes 
the flavanones (eriodictyol, hesperetin, isokuranetin, naringenin, chrysoeriol), inositols 
(pinitol), flavones (luteolin), flavonols (kaempferol), phenolic acid (tyrosol and derivatives), 
xanthones (isomangiferin, mangiferin), coumestans (flemichapparin, medicagol, 
sophoracoumestan) and isoflavonols (afrormosin, calycosin, formononetin, fujikinetin, 




Figure 7: Different species of honeybush. 






Figure 8: The chemical composition of honeybush tea. 
 
 
2.8.2 Benefits of Honeybush  
The C. maculata and C. subternata specie of honeybush have been reported to inhibit 
adipogenesis (Dudhia et al., 2013) and stimulate lipolysis (Pheiffer, Dudhia, et al., 2013). 
Studies have highlighted the in vitro (Moreira, Carlos and Vilegas, 2001; Leiro et al., 2003; 
Marnewick et al., 2005; Hubbe and Joubert, 2010) and in vivo (Sánchez et al., 2000; 
Marnewick et al., 2003) antioxidant activity of honeybush.  
Marnewick et al. reported that honeybush increases the activities of cytosolic glutathione S-
transferase alpha and microsomal glucuronosyl transferase with a significant elevated ratio 
of oxidized glutathione (GSSG) and reduced glutathione (GSH). This suggest that honeybush 
may modulate metabolizing enzymes and OS (Marnewick et al., 2003). Additionally, 




keratinocytes by stimulating the activities of antioxidant enzymes, inhibiting phosphorylation 
of mitogen-activated protein kinase (MAPK) and suppressing the expression of inflammatory 
cytokines (Im et al., 2016; Magcwebeba et al., 2016). This shows that honeybush exhibit 
antioxidant and anti-inflammatory properties that can be used as a skin anti-photoageing 
agent. Cyclopia intermedia specie of honeybush was shown to display chemoprotective 
properties against fumonisin B1 induced cancer in rat liver (Marnewick et al., 2009) and anti-
wrinkle effects in hairless mice (Im et al., 2014). Additionally, honeybush has been reported 
to have antidiabetic effects (Miura et al., 2001; Muruganandan et al., 2002; ICHIKI et al., 2011) 
and phytoestrogenic activity (Verhoog, Joubert and Louw, 2007; Louw, Joubert and Visser, 
2013). Unfortunately, to the best of our knowledge, no studies reported the effect of 
honeybush on male reproduction. Hence, this is the first study investigating the effect of 
honeybush on male reproductive function. 
 
2.9 Sutherlandia  
Sutherlandia is a plant with diverse species that are widely spread across specific geographic 
regions of Southern Africa. It is indigenous to the northern, eastern and western Cape areas 
of South Africa, southern areas of Namibia and south eastern regions of Botswana and 
Lesotho (van Wyk and Albrecht, 2008). Lessertia frutescens is an erect short-lived perennial 
plant with varying heights range of <0.2-2.5m. The stems are smooth having numerous leaves. 
The leaves are shortly attached to the stalk with ≤8 pairs of opposite leaflets. The leaflets have 
an oval to oblonglated shape, depending on the specie. The flowers are oblong in shape and 




Six species of sutherlandia were previously identified, namely Lessertia frutescens, 
Sutherlandia humilis, Sutherlandia microphylla, Sutherlandia montana, Sutherlandia speciose 
and Sutherlandia tomentosa. However, in 1998, a group of authors suggested that the classes 
of sutheralndia sub species should be reduced to two, as some of the sub species have similar 
characteristics after analysing the plant with enzyme electrophoresis (Moshe et al., 1998). 
The suggested two classes are Sutherlandia tomentosa and Lessertia frutescens, as all the 
remaining sub species are now regarded as S. frutescens. 
Sutherlandia is used traditionally to treat varying ailments (fever, wounds, stress, internal 
cancer and diabetes) among diverse cultural groups in the regions of southern Africa. In the 
old days, traditional medicine practitioners prepares the infusion from the leaves, flowers, 
stems and roots for diverse diseases (Figure 9). That is, the different type of diseases 
presented are treated with infusions from the separate part of the plant. However, in recent 
years, sutherlandia is available in various forms, including capsules and tablets, syrups and 






    
Figure 9: Image of Lessertia frutescens (van Wyk and Albrecht, 2008). 
 
 
2.9.1 Chemical composition of Sutherlandia 
Sutherlandia has a variety of phytochemicals (Figure 10), which are known to have health 
benefits. The chemical composition includes free amino acids (asparagine, proline and 
arginine) (Moshe et al., 1998; van Wyk and Albrecht, 2008), non-protein amino acids (ƴ-
aminobutyric acid (GABA), and L-carvanine) (Ortega, 2003), flavonoids (sutherlandin A, 
sutherlandin B, sutherlandin C, and sutherlandin D) (Avula et al., 2010), cycloartanol 
glycosides (sutherlandioside A, sutherlandioside B, sutherlandioside C, sutherlandioside D) 
(Avula et al., 2010), and triterpenol saponins (cycloartane-type triterpene glycoside) (van Wyk 






Figure 10: The chemical composition of sutherlandia. 
 
 
2.9.2 Benefits of Sutherlandia 
Based on the array of pharmacological products present in sutherlandia, studies have 
highlighted its role in cancer (Tai et al., 2004; Grandi, Roselli and Vernay, 2005), Human 
immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) (Harnett, 
Oosthuizen and Van De Venter, 2005; Mills et al., 2005; Wilson et al., 2015), diabetes (Sia, 
2004; Chadwick et al., 2007), inflammation (Lei et al., 2015; Vasaikar et al., 2018) stress 
(Chuang et al., 2015; Sergeant et al., 2017) and oxidative stress (Fernandes et al., 2004; 
Tobwala et al., 2014). 
Although the mechanism through which sutherlandia exert it effect is still unclear, a group of 




sutherlandia (Grandi, Roselli and Vernay, 2005). Some in vitro studies reported the anti-
proliferative and pro-apoptotic effects of sutherlandia on several human tumour cell lines (Tai 
et al., 2004; Skerman, Joubert and Cronjé, 2011; Van Der Walt, Zakeri and Cronjé, 2016). This 
suggest that Lessertia frutescens extracts may be used in anti-cancer therapy, although 
further investigation is required to ascertain its effects (Chinkwo, 2005). Additionally, the 
inhibitory effect of sutherlandia on HIV target enzymes were reported in in vitro studies 
(Harnett, Oosthuizen and Van De Venter, 2005; Bessong et al., 2006), hence, displaying a 
prospective pathway to treating HIV. Studies have also shown improved CD4 counts and 
reduced viral loads in AIDS patients who used sutherlandia tonic (Johnson et al., 2007). 
The anti-diabetic effect of sutherlandia have been described in experimental studies. Some in 
vivo studies showed that pinitol, a component of sutherlandia exerted an insulin-like effect in 
diabetic mice and thus reduces blood glucose levels (Bates, Jones and Bailey, 2000; Ojewole, 
2004). Additionally, Chadwick et al. reported that sutherlandia increases glucose uptake in 
peripheral tissues and also reduces intestinal glucose uptake in rats fed with diabetogenic diet 
(Chadwick et al., 2007).  
Although studies have shown the relatively safe usage of sutherlandia, the toxicity of 
canavanine has been implicated in lupus erythematosus syndrome (Capasso et al., 2000). 
Additionally, the cross-links of proteins after long exposure to sutherlandia was reported and 
that it can result in autoimmunity (Prete, 1985) and teratogenicity. Ngcobo et al. showed that 
the in vitro chronic treatment of normal T lymphocyte cells with sutherlandia was toxic 
(Ngcobo et al., 2012), hence , too much of sutherlandia may be bad. It was also reported by 
Adrienne et al. that the concurrent use of sutherlandia with an antiretroviral protease 




sutherlandia may reduce the anti-HIV efficacy of atazanavir (Müller, Skinner and Kanfer, 
2013). Up-to-date, the effect of sutherlandia has not been reported on male reproductive 
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Infertility is prevalent in about 10%-25% of couples in their reproductive age, analogous to 
60-80 million infertile couples globally. Of these infertility cases, 10%-30% are exclusively 
attributed to a problem of the male. Several diseases have been implicated as contributors to 
deteriorating male fertility and diabetes mellitus (DM) is included. DM, a chronic non-
communicable disease, is one of the most appreciable health threats, as it affects 9% (422 
million) of the world’s population as of 2014. It is characterised by hyperglycaemia, which can 
result from the inability of the pancreatic β-cells to secrete insulin or from the target tissue 
becoming insensitive to insulin. DM has been reported to influence male reproductive 
function through diverse pathways and mechanisms. The adverse effects of reactive oxygen 
species and successive development of oxidative stress that occur due to DM have been 
investigated and implicated by several studies. The products of non-enzymatic glycosylation 
are reported to be widely distributed in the reproductive tract of diabetic men. Additionally, 
DM has been implicated to impair the processes of male sexual acts. Data reported in this 
review were extracted from PubMed, Google Scholar, Science Direct and Scopus with 
diabetes and male infertility as the key search words.  
In light of the aforementioned, the aim of this review is to provide brief background 






2A.1  Introduction 
Diabetes mellitus (DM) is an embodiment of diverse metabolic disorders marked by chronic 
hyperglycaemia that can result from lack in insulin synthesis and secretion or reduced 
sensitivity of tissues to insulin [1]. In present-day societies, DM represents one of the most 
noticeable health perils and its prevalence is increasing swiftly. In 2014, the World Health 
Organization (WHO) reported that 422 million people have DM, connoting a 60% global 
increase relative to 2002 [2]. The WHO previously projected that the number will rise to about 
300 million by 2025 [1]. Our calculation, however, showed that the projected value of DM for 
2025 has already been surpassed by 28.9% in 2014. In recent years, the views that DM has 
inconsequential effects on male reproductive function have been questioned by conclusive 
data from various studies. 
Male infertility describes a male’s inefficiency to cause fertilization in a fertile female over a 
period of 12 month of consistent and unprotected intercourse [3]. It is estimated that 56% of 
infertile couples of childbearing age seek medical help [4]. Amidst these couples, 10%-30% of 
infertility cases are attributed exclusively to a problem of the male and another 15%-30% of 
cases showed significant anomalies in both partners [5]. Studies on prevalence of infertility in 
DM male partners of infertile couples revealed diminished sperm motility and increased 
abnormal sperm morphology [6-7]. Additionally, the increased production of highly potent 
free radicals and subsequent production of advanced glycation end products (AGEs) as well 
as an upsurge in the expression of receptor for AGE (RAGE) have been reported in DM [8,9]. 
These molecules are likewise implicated amongst other pathology of diabetic neuropathy 
(DN) [10]. With the data available, there is no uncertainty that DM is responsible for various 




The aim of this review is to provide an abrupt background on DM and introduce its 
relationship to male infertility. It will as well make specific reference of the possible 
mechanisms via which DM elicits its impact on the male reproductive system. Data reported 
in this review were extracted from PubMed, Google Scholar, Science Direct and Scopus with 
diabetes and male infertility as the key search words.  
 
2A.2  Overview of diabetes mellitus 
DM prevalence has increased substantially in the last three decades, and has been ranked to 
be the 7th cause of death in the human race [2]. Hyperglycaemia is a known effect of 
uncontrolled DM and consequently can lead to damage to various systems and tissues, 
especially the nerves and blood vessels [12]. Diverse pathogenic processes are included in the 
development of DM ranging from pancreatic β-cells autoimmune destruction with insulin 
insufficiency to abnormalities that causes resistance to insulin action [13]. The fundamental 
effect of insulin loss or insulin ineffectiveness on glucose homeostasis is the inefficient uptake 
and usage of glucose by glucose-dependent cells, resulting in hyperglycaemia. 
In the healthy state, the presence of insulin causes the stimulation of the glucose transporters 
(GLUTs), allowing glucose to bind to the extracellular portion of these transporters, which 
results in the translocation of the protein, thus having rapid glucose diffusion into the cell [14-
15]. In DM, due to decreased insulin, there is dysregulation of the processes of glucose 
metabolism and utilization that concurrently alters the stimulatory effect of insulin on glucose 
transporter translocation. 
The numerous cases of DM fall into two broad categories that are classified as Type Ⅰand 




2A.2.1   Type Ⅰ DM 
Out of 422 million people affected by DM globally, ≤10% is attributed to Type ⅠDM. About 
85% of this population are diagnosed before the age of 20 and ≥15% of the cases are ascribed 
to adults (≥ 30 years old). It is instigated by injury or cellular-controlled autoimmune 
destruction of the pancreatic β-cells. Heredity, race or ethnicity, age and gender are some of 
the associated risk factors that play a role in ascertaining the susceptibility of the insulin 
producing cells to abrasion. It may develop swiftly over a period of a few days or weeks, 
following this sequence: (1) decreased insulin; (2) elevated usage of fats for energy and for 
formation of cholesterol by the liver; (3) reduction of the body’s proteins [16]. 
 
2A.2.2  Type Ⅱ DM 
The prevalence and incidence of Type II DM is rapidly increasing throughout the world and it 
accounts for 90%-95% of those with DM. Type II DM was known to be an adult or old age 
disease. But in the last few decades, its prevalence has increased among youth, which predicts 
for higher estimate of occurrence in the future. It occurs as a result of decreased perceptivity 
of target tissues to the metabolic effects of insulin. Type Ⅱ DM is also described as a 
‘contemporary disease’ because it is caused by lifestyle factors, such as diet and obesity. 
Ethnicity, environmental exposure and socio-economic factors are also evident risk factors. 
In comparison to Type Ⅰ DM, it is correlated with elevated plasma insulin concentrations 
(hyperinsulinemia). This occurs as compensatory feedback by the pancreatic β-cells for 
reduced sensitivity of marked tissues to the metabolic effects of insulin. The diminished 
insulin sensitivity debilitates carbohydrate usage and storage, increasing blood glucose and 




It was predicted in 2016 that there would be a 71.5% prevalence increase of Type Ⅱ DM 
amidst age 20-79 by 2035, including 6.0% in Africa, 7.1% in Europe, 11.3% in Middle East, 
12.3% in North America and Caribbean, 8.2% in South and Central America, 9.4% in South 
East Asia and 8.4% in Western Pacific [17]. Considering the above futuristic prevalence 
evaluation, DM will affect more men ahead of and amid their reproductive years.  
 
2A.3  Impact of diabetes on male fertility 
Diabetes has been substantiated to have adverse effects on both male and female 
reproductive function [16,18] and its impacts can be seen in increased prevalence of infertility 
[6,19-21]. About 90% of diabetics experience upheaval in sexual function, including a 
decrease in libido, impotence and infertility [22]. Furthermore, diabetic men are vulnerable 
to different sexual problems, though progressive physical disorders and deteriorative 
psychological response are contributors [23]. Several studies have investigated and reported 
different pathologies commonly experienced by diabetic men and have also highlighted the 
subsequent reproductive defects. Some of the extracted findings highlighting the impacts of 
DM on male reproductive functions in human and animal models were represented in Table 
2A.1. Selected mechanisms through which DM impact male reproductive function were 








Table 2A.1: Findings highlighting the impact of DM on male reproductive functions in human 
and animal models. 
STZ=streptozotocin.↑= increase, ↓= decrease. 
Ref Author Year Numbers Type Model DM Results 
[24] Mallidis et al. 2007 52 In vivo Human TypeⅠ/Type
Ⅱ 
↓Sperm count 
[25] Agbaje et al. 2007 56 In vivo Human Type Ⅰ ↓Semen volume, ↑sperm 
nDNA fragmentation, 
↑deletion of mtDNA 
[18] American Society 2009 12 In vivo Human Type Ⅰ ↓nDNA damage 






[27] Sudhindra et al. 2014 103 In vivo Human Type I  ↓motility, ↓semen 
volume, ↑DNA damage 
[28] Murray et al. 1985 91 In vivo Rats Type Ⅰ ↑Testosterone, ↓LH, 
Altered Sertoli cells, 
↑abnormal morphology 
[29] Maresch et al. 2017 26 In vivo Mice Type I ↓Normal morphology, 
↓seminiferous tubule 
diameter , ↑ 
spermatogenic disruption 
[30] Ballester et al. 2004 44 In vivo Rats Type Ⅰ, STZ ↓Testosterone, ↓Leydig 
cells, ↓FSH, ↓LH 
[31] Shrilatha et al. 2007 24 In vivo Mice Type Ⅰ, STZ ↑nDNA damage, ↓sperm 
count 
[32] Vikram et al. 2008 45 In vivo Rats Type Ⅰ, STZ ↓Testosterone, ↑Lipid 
peroxidation 
[33] Jelodar et al. 2009 16 In vivo Rats Type I, Alloxan ↓ Leydig cells, ↓Sertoli 
cells, ↓seminiferous 
tubule diameter 
[34] Soudamani et al. 2009 36 In vivo Rats Type Ⅰ, STZ ↓Motility 
[35] Navarro-Casado et 
al. 
2010 86 In vivo Rats Type Ⅰ, STZ ↓Testosterone, ↓motility 






Figure 2A.1 Mechanisms through which DM affects male reproductive functions. 
↑= increase, ↓= decrease 
 
 
2A.3.1  DM effects on spermatogenesis: role of endocrine disorder 
Under normal circumstances, the hypothalamus releases gonadotropin-releasing hormone, 
thereby stimulating the anterior pituitary to secrete luteinizing hormone (LH) and follicle-
stimulating hormone (FSH). LH stimulates the Leydig cells to secrete testosterone and 
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dihydrotestosterone, while FSH stimulates the Sertoli cells of seminiferous tubules to assist 
the process of spermatogenesis.  
Unarguably, spermatozoa are capable of using glycolysis and/or oxidative phosphorylation in 
generating energy. They are as well structured to be capable of using external hexoses 
(glucose, fructose and mannose), and smaller substrates (lactate, citrate amino acids and 
lipids) for energy production [30]. Though spermatozoa are known to secret their insulin, they 
are however sensitive to hormonal fluctuations [37]. Therefore, deficiency of insulin or 
insensitivity to insulin in DM alters the endocrine pathway (negative feedback mechanism), 
resulting in impaired male reproductive function. 
Animal studies on induced hyperglycaemia revealed some adverse effects on male 
reproductive function relative to altered endocrine control (Table 2A. 1). Additionally, 
decreased Sertoli cell vacuolization [26], decreased sperm production [29,33,38-40], 
decreased fertility [33,41], alteration of epididymis morphology and density [39], decreased 
LH, FSH and testosterone serum levels [42,43], decreased number of Leydig and Sertoli cells 
and decreased number of spermatogonia [33] were observed in induced DM. The effects of 
DM on spermatogenesis have not only been shown in animal models, but have also been 
shown in men (Table 2A. 1). 
Furthermore, Ballester et al [30] reported a reduction in Leydig cell number and impaired cell 
function in streptozocin (STZ) induced mice model of DM. The decreased Leydig cell number 
linked to the decrease in serum LH, which in part explained the stimulatory effects of LH on 
Leydig cells. This also indicated that the Leydig cells production involving insulin and insulin-
like growth factor 1 signal mechanisms is mediated by LH [44,45]. While the impaired cell 




expression of GLUT-3 receptors, androgen receptors and insulin-like growth factor 1 
receptors [36]. These findings are supported by several other animal studies that investigated 
the effect of DM on male fertility [35,39,46,47]. In addition, DM alters spermatogenesis 
through an FSH-related mechanism. Insulin deficiency present in Type Ⅰ DM does not appear 
to affect spermatogenesis through a direct effect on the epithelium of seminiferous tubules, 
but instead by an alteration in serum FSH levels [30,48]. Decreased FSH is followed by a 
reduction in tubular FSH receptors in STZ induced Type Ⅰ DM, thus causing a diminished 
response of the epithelium of the seminiferous tubules to FSH stimulation. Therefore, DM 
alters spermatogenesis by disrupting the modulating effect of insulin on the regulation of 
serum FSH levels [30,48]. 
Likewise, glucose has been shown to be important for spermatogenesis and the acrosome 
reaction (AR). This was evidenced when a medium deprived of glucose inhibited the 
spontaneous AR, which was swiftly restored after the subsequent addition of glucose [49]. 
These substrates are conveyed into the cell by GLUTs [50].  
GLUTs are specific transporters that catalyse the passive diffusion of glucose into the 
mammalian cells along a concentration gradient. The GLUT family consists of 14 members 
and can be divided into three groups based on their sequence similarities [51]. 
GLUT8 belongs to the class 3 transporters and is expressed predominantly in the testis 
[52,53]. Research on GLUT8 expression in human spermatozoa revealed its presence in the 
acrosome and mid-piece region of mature spermatozoa [54]. It was also found in the 
acrosome and mid-piece region of mouse mature spermatozoa [55]. While some researches 
detected GLUT8 in differentiating spermatocytes of the stage 1 type, but not in mature 




for spermatogenesis and motility. The disruption of GLUT8 activity caused by decreased 
insulin resulted in reduced sperm motility and impaired fertilization [56]. This can as well be 
a result of lower gonadotropin response to gonadotropin releasing hormone in diabetics [44]. 
 
2A.3.2 DM effect on sperm parameters: role of oxidative stress (OS) and AGEs 
Studies have shown that DM induces subtle molecular changes that are essential for sperm 
quality and function. In a study carried out on 52 diabetic men, semen analysis revealed a 
significant decrease in sperm motility, including the number of rapid progressive cells [57]. 
Furthermore, in a comparative study on sperm cryopreservation, semen samples collected 
from diabetic men showed a significant decrease in sperm parameters when compared to 
groups of men with autoimmune disorders, kidney diseases, ulcerative colitis and heart 
diseases [58]. Another study on prevalence of infertility carried out by Delfino et al. [7], 
revealed a significant alteration in sperm kinetic properties and sperm morphology of male 
diabetic partners. A few more studies also revealed a significant decrease in semen volume, 
sperm motility and morphology in the semen of diabetic men [25,59]. All these outcomes are 
associated to the development of OS. 
Effect of DM on male reproductive function can also be explained through the impact of OS, 
caused by the inequality between reactive oxygen species (ROS) production and antioxidant 
defence mechanisms [60]. The main origins of ROS in the male reproductive system are 
known to be the immature spermatozoa and leukocytes [60,61]. Additionally, mechanisms 
that involve repeated mild changes in cellular metabolism may result in tissue damage within 
a brief occurrence of hyperglycaemia. An enormous bulk of data give priority to certain 




e.g. elevated glycolysis, glucose autoxidation, increased polyol pathway flux, increased AGE 
formation, activation of protein kinase C isoforms and increased hexosamine pathway flux 
[62,63]. It has been shown that excessive production of O2- by mitochondria in 
hyperglycaemia is the trigger that propels these pathways. Excessive production of O2- 
momentously inhibits glyceraldehyde-3-phosphate dehydrogenase activity, which in turn 
activates all the pathways of hyperglycaemic damage by diverting upstream glycolytic 
metabolites to these pathways [62]. Furthermore, when the highly potent ROS exceeds the 
seminal antioxidant defence ability, many cascades of reactions will occur, which can lead to 
sperm DNA damage and mitochondrial DNA fragmentation, then altered sperm parameters 
and subsequently male infertility. 
In OS, there is excessive production of NO-, which is detrimental to sperm motility. NO- may 
react with O2- or H2O2 to form ONOO- or OH-, which will cause oxidation of sperm membrane 
lipids and thiol proteins [45]. It can also cause a decreased ATP levels, thereby affecting the 
kinematics of spermatozoa. 
The high polyunsaturated fatty acids contents in the sperm plasma membrane are susceptible 
to ROS, its invasion thereof, leads to lipid peroxidation [64]. Lipid peroxidation occurs in three 
stages including, initiation, propagation, and termination. During initiation, free radicals react 
with fatty acid chains to form the lipid peroxyl radical. Peroxyl radicals in turn react with fatty 
acids to produce free radicals and the reaction is thus propagated. In termination, the two 
radicals react with each other which lead to lipid break down [64]. Furthermore, oxidation of 
sugar by OH- has been shown to be the main cause of DNA strand breaks. Oxidative damage 
can further cause base degradation, DNA fragmentation, and cross-linking of proteins. The 




Apoptosis, also regarded as programmed cell death, can be instigated by ROS-induced 
oxidative damage. High levels of ROS alter integrity of mitochondrial membrane [65-68], 
resulting in mitochondria DNA (mtDNA) damage and subsequently affects sperm functions 
negatively. 
Elevated ROS production has also been implicated in the generation of AGEs. AGEs are 
products of non-enzymatic reaction between sugar and the amino groups of proteins, lipids 
and DNA under hyperglycaemic conditions [69,70]. AGEs can alter the normal functioning of 
macromolecules directly, by generating ROS independently, or indirectly, by activating the 
receptors for advanced glycated end products (RAGE) [71]. AGEs may play a key role in 
instigating harm and further act as mediator of damage to reproductive system of diabetic 
men [72]. 
RAGE is a ligand binding receptor that increases cellular dysfunction in inflammatory disorders 
such as DM. RAGE is expressed at low levels in normal tissues. However, in diseased 
conditions such as DM, its increased expression leads to tissue damage [73,74]. 
Immunohistochemistry on the testes, epididymis and spermatozoa of 21 diabetic men 
revealed the wide distribution of RAGE in their reproductive tracts as compared to non-
diabetics [24]. An increased prevalence of immunoreactive cells was revealed in the 
seminiferous epithelium in the testes of diabetic men and sections of the epididymis 
displayed various degrees of RAGE immunoreactivity. Increased RAGE expression was also 
found in the spermatozoa acrosomal cap of these men, as determination of the specific 
location of RAGE was examined during different stages of the AR [72]. It therefore suggests a 




Furthermore, it has been shown that seminal plasma has important antioxidant systems that 
can supply the spermatozoa with a defensive environment against OS [45]. However, it was 
demonstrated that diabetic men have significantly lower seminal total antioxidant capacity 
(TAC) levels compared to their non-diabetic counterparts. This was supported by another 
study that showed that seminal TAC has an effect on male fertility and that increased ROS 
levels leads to low TAC levels [75]. The reduced TAC level in DM is consistent with higher 
malonaldehyde levels, which suggests a possible role for AGEs in instigating lipid peroxidation 
levels. 
 
2A.3.3   Diabetic neuropathy 
DN is one of the most prevalent complications of DM. It has been reported to affect about 
50% of patients with TypeⅠand TypeⅡ DM. It can be categorized into autonomic neuropathy 
and peripheral neuropathy because of its effect on either autonomic or peripheral nervous 
systems. Both neuropathies results from microvascular dysfunction which can affect the 
autonomic nervous system (ANS), leading to autonomic neuropathy and can as well impair 
peripheral nerves causing peripheral neuropathy. Various pathogenic pathways involved in 
the development of DN and subsequent damage of the male reproductive function were 
summarized in Figure 2A.2. Since the ANS is involved in the regulation of sexual response 
cycle, impairment thereof by DN can result in reduced sexual response, erectile dysfunction 





Figure 2A.2: Pathogenic pathways of DN leading to male reproductive function impairment. 
NAD=nicotinamide adenine dinucleotide; NADH= reduced nicotinamide adenine 


































2A.3.3.1  Reduced sexual response 
Male sexual response is a result of physical or psychological stimulation which leads to 
vasodilation and subsequent increased blood flow into the penis. Low libido has been 
reported to be associated with DM and that it worsens with progressive diabetic state [77]. 
The reduced sexual response/libido can be related to the physical and psychological 
susceptibility to deterioration in DM. For instance, Fairburn et al. [77] reported an absence of 
pumping sensation that usually follow ejaculation in over a third of diabetic subjects in their 
study, with these patients describing semen flowing from their erect or drooping penis’ either 
at or prior to orgasm. 
 
2A.3.3.2 ED 
ED is rampant in millions of men, and has been reported to be more prevalent amongst 
diabetic men. However, ED’s prevalence depends on variant factors, such as the population 
reviewed, as well as the definition and methods used [78]. For instance, it was reported that 
41.3% of adult men (above 18 years old) in France have ED, 33.2% in Brazil and 41.8% in 
China[79]; 18.0%-48.0% among middle-aged men in Germany [80] and about 50.0% of ageing 
diabetic men (aged 56-85) have ED in the United States [81]. 
Usually, neurotransmitters, especially NO are released either from the penile nerve endings 
or from endothelium during normal sexual activity, which triggers the relaxation of the 
cavernosa arteries and the surrounding smooth muscles. This in turn, promotes an increase 
in penile arterial blood flow, thereby causing an erection. However, diabetic men have 
impairment in both endothelium dependent smooth muscles and autonomic mechanism that 
mediate the relaxation of corpora cavernosa [37]. In addition, endothelial dysfunction reflects 




2A.3.3.3  Retrograde ejaculation 
The emptying of semen in the prostatic urethra results in various reflex actions controlled by 
sensory nerves from the prostatic urethra. This excites centres in the sacral and lumbar 
regions of the spinal cord, which then transmits impulses to autonomic and somatic 
pathways, thereby causing ejaculation. However, in DM, retrograde ejaculation occurs due to 
ANS impairment and subsequent loss of constriction by the external urethral sphincter and 
loss of other reflex actions involved in ejaculation. Retrograde ejaculation can be defined as 
the retro-influx of semen into the bladder rather than emptying into the anterior urethra [84]. 
This can result in the subject experiencing the pumping sensation associated with ejaculation 
without semen emerging from the penis. Urine collected immediately after ejaculation in 
these men appears cloudy and the diagnosis of retrograde ejaculation can be confirmed by 
the numerous spermatozoa in a post-orgasmic urine sample. 
 
2A.4 Treatment of male infertility caused by DM 
Once an individual has been identified as having fertility related issues due to diabetic 
complications, treatment should be aimed at treating the disease through amelioration of the 
underlying cause and subsequently treating the consequences. 
 
2A.4.1  Treatment of DM 






2A.4.1.1 Treating Type Ⅰ DM 
Effective treatment of Type Ⅰ DM requires administration of sufficient exogenous insulin to 
maintain glucose metabolisms and to prevent hyperglycaemia. Insulin present in several 
forms, such as short acting insulin and protein derivative precipitated insulin. The half-life of 
short acting insulin is 3-8hr, while that of the protein derivatives is 10-48hr [16]. However, 
treatment should be given with an individualized pattern. 
 
2A.4.1.2 Treating Type Ⅱ DM 
Management of Type Ⅱ DM can be accomplished through a strict adherence to healthy 
lifestyle, diet control, exercise, weight loss and the use of suitable medication in an attempt 
to reverse insulin resistance. Examples of prescribed drugs for Type Ⅱ DM are metformin and 
thiazolidinediones. Metformin works by improving the sensitivity of the body tissues to 
insulin. Thiazolidinediones make the body’s tissues more sensitive to insulin, while 
sulfonylureas and meglitinides stimulate the pancreas to secret more insulin. 
 
2A.4.2  Treating the consequences 
2A.4.2.1 Antioxidant therapy 
Antioxidants operate by arresting the oxidative chain reaction, removing, or reducing the 
formation of ROS [85]. Hughes et al. [86] reported a significant protection of a media 
containing ascorbic acid (600 μmol/L), alpha-tocopherol (30 and 60 μmol/L), and urate (400 
μmol/L) from sperm DNA damage by the non-enzymatic antioxidants during an in vitro 
fertilization (IVF) procedure. Studies on antioxidant treatment of OS related male infertility 








Infertility can be reduced in diabetic men with ED or retrograde ejaculation through intra 
cytoplasmic sperm injection (ICSI) or IVF. 
Spermatozoa of diabetic men with ED can be obtained via testicular biopsy. Since ICSI-IVF 
requires at least one sperm, the sperm retrieved can be injected into the female gamete for 
fertilization. The fertilized embryo can then be transferred inside the uterus. 
In addition, ICSI-IVF can as well be applied to treatment of diabetic men with retrograde 
ejaculation. This can be achieved by recovering the spermatozoa from the post ejaculatory 
urine of these men. Nakolettos et al. [54] advised that retrograde ejaculation resistant to long 
term medication can be managed using the ART, following an outcome of 51.2% fertilization 
rate amongst their study subjects. 
2A.4.2.3 Treating diabetic neuropathy 
The aim of manageing reduced sexual response, ED and retrograde ejaculation is to help 
reduce infertility and also aid the affected enjoy their sexual activities irrespective of the limits 
set by the diseased factors. The treatment can be focused on physical, psychological and 
surgical treatment as well as medication. Physical treatment improves the subject’s general 
state of health by changing any reversible physical activity contributing to the sexual problem. 
Psychological treatment is that primary and secondary psychological reactions contributing 
to the problem should be tackled. Surgical treatment means surgical management of ED 




procedure to correct retrograde ejaculation can be done by reconstructing the bladder vesical 
sphincter [91]. Medication refers to drugs commonly used to manage ED that are Avanafil 
(Stendra), Sildenafil (Viagra), Tadalafil (Cialis) and Vardenafil (Levitra, Staxyn). All these work 
by relaxing the smooth muscles and boosting vasodilation, thereby making it easier to achieve 
and maintain erection. 
 
2A.4.3  Conclusion 
DM has been implicated in the impairment of male fertility. Studies have revealed the 
different mechanisms involved in this pathology. The mechanisms include endocrine disorder, 
alteration in GLUT8 activity, OS development, AGEs formation and occurrence of DN. It is 
important that endocrinologists and physicians educate their patients on the possible impact 
of DM on male fertility, while reproductive endocrinologists should carefully consider the 
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Advanced glycation end products (AGEs) are products of cascades of non-enzymatic 
glycosylation. They are formed over a period of hours to days, depending on the protein 
lifetime. AGEs acts by independently producing reactive oxygen species (ROS) or by binding 
to their receptors. Binding of AGE to the receptor for advanced glycation end products (RAGE) 
has been shown to play a role in physiological processes, including lung homeostasis, bone 
metabolism, neuronal systems and the immune system. When in excess, they take part in the 
pathogenesis of diseases such as diabetes mellitus, cardiovascular diseases, 
neurodegenerative diseases, and etcetera.  
The cause of male infertility is considered unexplained in many cases, suggesting that there 
are gaps in the mechanistic knowledge of sperm production and function, especially, 
pathways involved in the physiochemical protein regulation of spermatogenesis. It is 
therefore important to consider areas of research highlighting protein modification and 
identification and their implication for male fertility.  
Keywords: Advanced glycation end products, Receptor for advanced glycation end products, 




2B.1 Introduction  
Male infertility describes a male’s inability to impregnate a fertile female over a period of 12 
months of consistent and unprotected intercourse [1]. It has been estimated that 20-30% of 
infertility cases is solely attributed to male factor and another 20% associated with problems 
from both partners [2], cumulatively, it accounts for 50% of the total cases [3,4].  
Various studies have attempted to elucidate the impact of molecular alterations, in terms of 
genetic and epigenetic modifications, on male fertility [5,6]. It has been shown that genetic 
modification, including chromosomal abnormalities and single-gene mutation, explains for 
about 10-15% of infertility cases [7]. Chromosomal abnormalities comprise of both the 
numerical and structural variations of chromosomes. The numerical chromosomal variation 
such as Klinefelter syndrome has been reported to be the most persistent karyotype 
abnormality in infertile men [8]. On the other hand, the structural modification of the Y 
chromosome, including translocation between the Y chromosome and autosomal 
chromosome, deletions, and inversion of the Y chromosome is prevalent in oligozoospermic 
patients [9]. Furthermore, the changes caused by molecular modifications of DNA or histones 
rather than changes in the DNA sequence resulting in the phenotype alteration have been 
reported to impact male fertility [10–13]. These findings collectively serve as a gateway to 
further investigations on the implication(s) of expressed modified proteins either during 
spermatogenesis or fertilization. 
2B.1.1 Brief Evidence of Protein Build-up in the Male Reproductive System 
Proteins are large biomolecules that are involved in several physiological processes. Michael 
and Michael (1983) reported that the Sertoli cells synthesize and secrete a protein referred 




serum ceruloplasmin [14]. Ceruloplasmin is a protease, oxidase sensitive serum protein, 
which is also essential for copper transport protein. It has further been suggested to be a 
protein required for germ cell viability [14]. 
Additionally, it has been shown that the Sertoli cells secrete a protein called testicular 
transferrin, which allows for iron transport and helps in the development of germ cells. It was 
reported to be regulated by follicle-stimulating hormone (FSH), insulin, testosterone and 
Vitamin A [15]. Furthermore, the importance of aquaporin (s) in the transport of water and 
solutes across cell membranes has been elucidated. Aquaporin proteins (AQPs) are integral 
transmembrane proteins, functioning as selective water, glycerol, urea and non-electrolytes 
channels [16–24]. Thirteen subunits of AQPs have been identified in mammalian cells and are 
categorized into three groups based on sequence similarity and substrate selectivity. The first 
group (AQP0, AQP1, AQP2, AQP4, AQP5, AQP6 and AQP8) are water-selective channels having 
high permeability to water. They are also known as orthodox AQPs. Aquaglyceroporins (AQP3, 
AQP7, AQP9 and AQP10) are the second subunit of AQPs, having high permeability not only 
to water but also to glycerol, urea and other small non-electrolytes. Superaquaporins (AQP11 
and AQP12) are also water-selective channels but differ from both orthodox and 
aquaglyceroporins in localization. Superaquaporins are found in the membrane of 
intracellular organelles and are therefore involved in regulating volume, vesicle homeostasis 
and water transport intracellularly [25]. However, the male reproductive tract including the 
testes, epididymides and efferent ducts contains various AQPs except for AQP6 and AQP12. 
The most abundant AQPs in the epididymides are AQP1 and in the efferent ducts, AQP9. They 
have been shown to play a crucial role in the dynamics of luminal fluid secretion and 
reabsorption during sperm transport and maturation. Additionally, AQP3, AQP7, AQP8 and 




spermatids to spermatozoa during spermiogenesis. They also help in regulating osmolality 
during sperm transit [26].  
Furthermore, the AQPs present in the male reproductive tract (epididymides and efferent 
ducts) have been shown to be regulated by estrogen. That estrogen controls water 
reabsorption in the epididymides and efferent ducts via AQP1 and AQP9 [27]. While 
Bernardino et al. showed that estrogen modulates glycerol permeability in the Sertoli cells 
through the regulation of AQP9 [28]. This suggests that AQPs are essential for normal male 
reproductive function and alteration in their expression or function may result in subfertility 
or infertility [26]. 
Thus, this is indicative that proteins are involved in the physiological processes of 
spermatogenesis and fertilization. Seeing that the organs and cellular components involved 
in male reproduction are loaded with proteins, it is pertinent to further investigate the 
implication of protein modification due to physiological or pathophysiological stress in male 
fertility.  
2B.1.2 Why Advanced Glycation End Products? 
Under both normal and abnormal conditions, proteins undergo enzymatic and non-enzymatic 
glycosylation. Glycosylation is a form of post-translational and co-translational modification, 
which are mostly involved in the production of amino acids, RNA and DNA [29]. During 
enzymatic glycosylation, the carbonyl group of reducing sugars covalently attach to proteins 
and lipids, aiding folding and physiochemical stability of glycoproteins. However, when 
proteins and lipids attach to reducing sugars covalently, but non-enzymatically, glycation 
occurs. In 1985, Ahmed et al. reported the presence of a trace product during a glycation 




compound observed was said to be NƐ-carboxymethylysine (CML) representing the first 
advanced glycation end product (AGEs) discovered [30]. After a 15-day period, 40% CML 
formation was observed following incubation at physiological pH and temperature. The rate 
of formation, however, was intensified with increased phosphate buffer concentration in the 
incubation mixture. This suggests that AGE formation surges with increased exposure to 
sugar. The role of AGEs have been widely investigated in several pathologies, including 
neurodegenerative diseases, chronic inflammatory diseases, diabetes mellitus (DM) and DM 
related disorders. However, its role in infertility, specifically, male infertility, is less 
understood. It is worth noting that most studies that reported the impact of AGEs on male 
fertility investigated DM (type 1 and type 2 DM) related infertility. This is because AGEs are 
shown to increase under hyperglycaemic conditions and reducing sugars are important key 
players in their formation. Mallidis et al. reported a significantly higher percentage of 
spermatozoa with nuclear DNA fragmentation and elevated levels of AGEs in the testis, 
epididymis and sperm of diabetic men [31], while Agbaje et al. showed increased nuclear and 
mitochondrial DNA damage in the spermatozoa of diabetic men [32]. DM and/ or disease 
related male infertility is not the only factor involved in sperm function decline. In their very 
detailed systematic review, Levine et al. [33], reported a significant (50-60%) decrease in 
sperm count across different populations including North America, South America, Europe, 
Australasia, Asia and Africa over a period of 4.6 decades [33].  
Unfortunately, in many cases, the cause of infertility is not identified and hence considered 
unexplained [34]. This suggests that there are gaps in the mechanistic knowledge of sperm 
production and function. Especially, pathways involved in the physiochemical/protein 
regulation of spermatogenesis. It is therefore appropriate to consider areas of research 




Hence, this review aimed to evaluate the existing literature on the impacts of protein 
modification, especially the AGEs on male reproduction and to briefly highlight their role in 
certain pathologies.  
 
2B.2 Overview/ formation of Advanced Glycation End Products 
AGEs are products of non-enzymatic glycosylation of endogenous and exogenous proteins. 
Various routes of formation have been identified (Figure 2B.1). Firstly, AGEs can be formed 
during a conventional Millard reaction through glycoxidation. Briefly, the electrophilic 
carbonyl group of reducing sugars react with the free amino acids [35] to form unstable Schiff 
bases. The Schiff bases undergo a reversible rearrangement, thereby producing to a greater 
extent stable Amadori products. Amadori products are glycated proteins. Hence, when 
glycated proteins undergo oxidative cleavage (glycoxidation), they give rise to glycated 
protein products. While the Schiff bases are undergoing rearrangement, some highly reactive 
molecules called the α-dicarbonyl compounds (α-oxoaldehyde), including, glyoxal (GO), 
methylglyoxal (MGO) and 3-deoxyglucosone (3-DG) are formed [36,37]. These compounds 
are regarded as AGE precursors as they can further undergo auto-oxidative, oxidative or non-
oxidative degradation to form AGEs. Hence, α-dicarbonyls are important in the formation of 
AGEs. Briefly, GO is formed from the oxidative cleavage of glucose [38]. Or, from the 
breakdown of glycated proteins, monosaccharide autoxidation [39], and lipid peroxidation 
[40]. While MGO is formed by both enzymatic and non-enzymatic degradation of triose 
phosphates, the breakdown of acetone, and the catabolism of threonine [41]. 3-DG, on the 
other hand, is formed by the degradation of glycated proteins [42] and from the 




Secondly, AGEs can be indirectly formed from the autoxidation of monosaccharides. Glucose 
can be oxidized under physiological conditions in the presence of transition metals, which 
reduces molecular oxygen to form α-dicarbonyls (GO specifically), hydrogen peroxide (H2O2) 
and free radical intermediates. The α-dicarbonyls formed binds to the lysine groups of amino 
acids to form AGEs [38]. Thirdly, AGEs can also be formed from lipid peroxidation. The cell 
plasma membrane contains polyunsaturated fatty acids (PUFA), which are vulnerable to free 
radicals. Attack of PUFA by ROS results in the formation of lipid and peroxyl radicals. Due to 
the highly reactive nature of the peroxyl molecules, lipids further undergo oxidation, thereby 
forming lipid hydroperoxides (4-hydroxy-trans-2-nonenal, acrolein), α-oxoaldehydes, such as 
GO, MGO, and 3-deoxyglucusone and H2O2 [44,45]. The α-oxoaldehydes formed can further 
undergo auto-oxidative, oxidative or non-oxidative degradation to form AGEs [46]. The role 








Figure 1: Identified route of AGEs formation.  
CML=N-carboxymethyllysine, CEL=N-carboxyethyllysine, GOLD=glyoxal lysine dimer, 
MOLD=methylglyoxal lysine dimer, DOLD=deoxyglucosone-lysine dimer, ROS=reactive 





2B.2.1 Classification of Advanced Glycation End Products 
The categorization of AGEs is partly based on examining the level of protein modification, 
aggregation state of glycated proteins and the fructosamine content. These characteristics 
are measured by fluorescence and colorimetric. For instance, modifications on arginine and 
lysine side chains result in protein cross-link [47]. Cross-linkers are molecules with two or 
more reactive ends, capable of chemically attaching to specific functional groups (amines, 
sulfhydryls) on proteins or other particles. Therefore, depending on the presenting features 
of AGEs, they are classified into three groups: (i) Non cross-linking AGEs (CML, N-
carboxyethyllysine (CEL) and pyrraline), (ii) Non-fluorescent cross-linking AGEs such as 
imidazolium derivatives, (glyoxal lysine dimer (GOLD), methylglyoxal lysine dimer (MOLD), 
alkyl-formyl-glycosyl pyrrole and argininelysine imidazole), and (iii) Fluorescent cross-linking 
AGEs (crossline and pentosidine) [35].  
CML is a heterogeneous non-fluorescent protein compound formed by the oxidative glycation 
of its precursor GO. Since its discovery, it has been the most studied biomarker of AGEs, 
including food sources. Various studies have elucidated the accumulation of CML in different 
systems, both in health and disease [48–55]. GO, and free CML have been reported to be 
involved in serotonin release. Serotonin is known for its role in wellbeing and happiness. 
However, it also regulates feeding and satiety when present in small quantities [56]. 
Imidazolium derivative cross-links (MOLD and GLOD) are formed by reactions between MGO 
and GO derivatives and lysine residues. Hiroko et al. reported an increase in the levels of 
MOLD and GOLD in the sera of non-diabetic uremic patients. This suggests that, even in the 
absence of hyperglycaemia, an increase in the production of dicarbonyls caused by OS can in-




produced from the reaction between ϵ-one in lysine and D-glucose in vitro. It has been 
identified to be the first protein cross-link, having fluorescent features similar to the in vivo 
products. Crossline levels have further been reported to increase with age in the lenses of 
diabetic rats [58]. 
2B.2.2 Sources of Advanced Glycation End Products 
AGEs have both endogenous and exogenous sources; endogenous as in biological systems 
(skin collagen, neonate urine, human lens, etc.) and exogenous as in food. AGEs are present 
in food such as meat, fish, cereal-derived products, coffee, soups, sauces, dairy products, 
cooked fruit and vegetables [59–61]. An increase in the production of AGEs has been 
documented in thermally treated products, especially after cooking at high temperatures 
(frying, roasting, and toasting). Hull et al. reported a higher concentration of CML in heat-
cooked foods compared to non-to low thermally treated foods [62]. Uribari et al. reported 
the moderate formation of AGEs after cooking at low temperatures (boiling, steaming and 
stewing) [63]. This increase in AGE formation during food processing may lead to a decrease 
in nutritional value and can further generate toxic compounds [63]. 
 
2B.2.3 Elimination/ Excretion of Advanced Glycation End Products 
AGEs are part of human life from birth to death. Hence, it is essential that there is a coping 
strategy by which biological systems regulate their formation and accumulation. AGEs can be 
removed from tissues through extracellular proteolysis, degradative glyoxalase enzymes and 
tissue macrophages (lysosomes and proteasomes). Lysosomal degradation is a process 
whereby macromolecules are internalized from the extracellular space through endocytosis. 




degradation of the macromolecules. Proteasomes, on the other hand, are important in 
regulating the degradation of proteins [44]. In brief, AGEs are engulfed by the cell-surface 
receptor, mediated by endocytosis. They are then broken down intracellularly to release 
second-generation AGEs [49]. These second generation AGEs are subsequently filtered and 
excreted by the kidney. 
However, an imbalance between the rate of formation and excretion of AGEs may lead to 
accumulation. These raised concentrations are implicated in the pathology of several diseases 
as multiple pathways have been identified through which AGEs can affect biological systems. 
 
2B.2.4 Mechanism of Action of AGEs 
AGEs are often the root cause of various pathologies and can affect tissues and organs 
through several mechanistic pathways. Firstly, as they change protein structures, it leads to a 
functional modification. Secondly, because of the molecular protein cross-linking that occurs 
during AGE formation, it affects the tissues. Thirdly, it can result in increased free radical 
formation due to the accumulation of damaged proteins and the subsequent imbalance in 
molecular homeostasis. Fourthly, AGE accumulation can acutely activate signalling pathways 
due to heightened binding to their receptors, that is, the receptor for advanced glycated end 
products (RAGE), or even other cell membrane receptors. Several other AGE receptors have 
also been identified, but with RAGE being the most well-known and widely studied. These 
other receptors include AGE-R1/oligosaccharyl transferase-48 (OST-48), AGE-R2/80K-H, AGE-
R3/galectin-3 and macrophage scavenger receptors (SR-A, SR-B: CD36, SR-BI, SR-E: LOX-1, 




RAGE is a multi-ligand receptor that is composed of three extracellular domains, one V and 
two C-type areas. The V-type has ligand binding properties, and the two C-types are 
immunoglobulin domains [69]. In addition to the activation of RAGE by AGE, RAGE can also 
be stimulated by the expression of other ligands including amphoterins, S100-calgranulins, 
amyloid fibrils, β-amyloid, β-integrin MAC-1 and HMGB-1 [70]. Furthermore, the binding of 
AGE to RAGE has been suggested to trigger the activation of mitogen-activated protein 
kinases (MAPK), extracellular signal-regulated kinases (ERK 1/2), phosphatidyl-inositol 3 
kinase (PI3K), p21Ras, stress-activated protein kinase/c-Jun-N-terminal kinase and nuclear 
factor kappa B (NF-κB) pathways. Activation of these pathways ultimately lead to elevated 
ROS production, and the upregulation of intercellular adhesion molecule-1 (ICAM-1), vascular 
cell adhesion molecule-1 (VCAM-1), and monocyte chemoattractant protein-1 (MCP-1)[71]. 
Increased expression of RAGE has been correlated to elevated accumulation of AGEs, and 
subsequent enhancement of tissue damage as well as the development and progression of 
diseases. The spectrum of diseases include DM and DM related pathologies (nephropathy, 
retinopathy, and neuropathy), neurodegenerative diseases (Parkinson’s disease, Alzheimer’s 
disease), arthritis, periodontitis, ovarian ageing and male infertility. Interestingly, AGE-RAGE 
activation is not only involved in the aetiology of diseases, but it also participates in some 
physiological processes including embryogenesis, ageing, lung homeostasis, bone 
metabolism, neuronal systems and the immune system. 
 
2B.3 Physiological role of AGE-RAGE 
Christiane et al. reported the expression of RAGE-mRNA on day 4 in the early blastocyst in the 




embryoblast during blastocyst formation. Another group of authors discovered RAGE-mRNA 
in embryonic cortical neurons in rats, and it was shown to be associated with neurite 
outgrowth [73]. RAGE expression during embryogenesis has been largely linked with fetal 
lung development in rats, as it helps in the proliferation of type 1 alveolar epithelial cells. 
Reynolds et al. reported a systematic increase in the expression of RAGE from embryonic day 
13.5 to birth (18.5) in type 1 alveolar epithelial cells in mouse lungs [74]. Interestingly, RAGE 
expression was down regulated in the malignant tumour of the lungs, which further validate 
its physiological role in the development of fetal lungs. 
In bovine tissues, RAGE was expressed in the pulmonary endothelium, alveolar macrophages, 
leiomyocytes, visceral pleural surface, bronchial and vascular smooth muscle [75]. In RAGE 
knockout mice, Al-Robaiy et al. reported upregulation of dynamic lung compliance and a 
reduction in maximum expiratory air flow, which subsequently affected cell coupling [76]. 
Additionally, the role of RAGE in the enhancement of cell to matrix adhesion has been shown, 
as inhibition of RAGE decreases alveolar epithelial cells adhesion to the basement membrane 
[77].  
In RAGE knockout mice, bone biomechanical strength and mineral compactness were 
increased, which led to a reduction in the number of osteoclasts formed. It was suggested 
that the lack of RAGE deteriorate osteoclast function as a gene involved in osteoblast 
differentiation was downregulated [78–80].  
RAGE expression has been identified on various immune cells, including neutrophils, 
monocytes/macrophages, lymphocytes and dendritic cells [75]. Kislinger et al. reported a 
reduced inflammatory response subsequent to RAGE blockade [81]. Brisslert et al. showed 




(sRAGE). Also observed was the increase in the number of CD19+ B cells in the spleen and a 
reduced rate of CD19+ B cells in the bone marrow. Splenocytes showed higher IgG production 
with elevated levels of interleukin-6, interleukin-10, and interferon-γ in response to 
lipopolysaccharide stimulation. It was concluded that since the administration of sRAGE in 
healthy mice led to rearrangements in cellular composition in the bone marrow and spleen, 
this indicates that RAGE may play a role in adaptive immunity [82]. 
 
2B.4. Pathophysiological role of AGE-RAGE 
Increased expression of RAGE has been correlated to elevated accumulation of AGEs, and 
subsequent enhancement of tissue damage as well as the development and progression of 
diseases. The spectrum of diseases Include DM and DM related pathologies (nephropathy, 
retinopathy, and neuropathy), neurodegenerative diseases (Parkinson’s disease, Alzheimer’s 
disease), arthritis, periodontitis, ovarian ageing and male infertility. 
 
2B.4.1 AGEs and Diabetes Mellitus 
Studies have shown the importance of AGEs in the pathogenesis of diabetic complications 
[83]. In DM, AGEs are formed more rapidly, which can be up to a 14-fold increase [84]. 
Intracellular reducing sugars and their derivatives have been shown to participate in glycation 
at a much faster rate than glucose [84]. The detrimental effect of AGEs arises from the 
modification of protein structures and function and the cross-linking of modified proteins.  
In DM, increased concentrations of reducing sugars lead to elevation of downstream 




Increase in AGEs leads to elevated RAGE with subsequent ROS production. In brief, AGE-RAGE 
interaction stimulates NADPH-oxidase activity, leading to activation of Nf-κB and ultimately 
result in increased expression of iNOS and ONOO- [87]. AGEs have been implicated in several 
DM-related complications, including diabetic retinopathy, diabetic atherosclerosis, diabetic 
cataract, diabetic nephropathy, diabetic embryopathy, and diabetic neuropathy. Please refer 
to the manuscripts of Ahmed [35] and Yamagishi [49] for a comprehensive review on these 
complications. 
 
2B.4.2 AGEs and Male Infertility 
The hypothesis that AGEs is one of the underlying causative factors of infertility has provided 
a new facet to researching this pathology on different levels, including its role in disease 
induced male reproductive function impairment. As previously explained, the formation of 
AGEs depends on the quantity of proteins available for glycoxidation, the level of oxidants, 
and primarily, the presence of reducing sugars which is increase in hyperglycaemia. Hence 
the rate of AGE production increases with long term hyperglycaemia. Based on this rationale, 
the majority of studies that investigated AGEs, explored whether its formation is increased in 
male infertility and if it is, where is it located. Very few studies have highlighted its mechanism 
per se, hence, the pathway by which AGEs impact male fertility is still less understood. 
However, to achieve the key aim of this review, a comprehensive literature search was 
performed on the two foremost research databases, that is, Scopus and PubMed. The main 
keywords “advanced glycation end products” was used in combination with “sperm”, “semen”, 
“fertility” and “male infertility” and the initial search produced 18, 12, 9, and 13 studies 




articles and those not related to the topic, while further limiting the studies to the English 
language and date of publication (1 January 1986 and 31 May 2019), a total of only 13 studies 
remained and thus form the basis of the remainder of this review (Table 1). 
 
 
Table 1: Studies illustrating the effects of AGEs on male fertility 
Ref no Authors Year Model Main findings 
94 Bagheri et al. 2016 Infertile men with 
Varicocele 
↑S100A12 (RAGE 
ligand) in semen of 
infertile men 
↓sperm motility 
87 Chen et al. 2016 Leydig cells treated 
with AGEs (in vitro) 
AGEs induce ROS 
production, apoptosis 
and activates HIF-1α 
and HO-1 





89 Chen et al. 2019 Rodents (Mice and Rat 
Models) 
AGEs diet induced 
histopathological 







93 Charalampidou et al. 2017 Normo-oligo-
zoospermic men 
↓soluble RAGE in 
seminal plasma 
49 Karimi et al. 2010 Diabetic men ↑AGEs in seminal 
plasma 
↑lipid peroxidation 







29 Mallidis et al. 2007 Diabetic men ↑in spermatozoa 
displaying RAGE 
↑ RAGE in seminal 
plasma 
50 Mallidis et al. 2010 Diabetic men AGE accumulates in 
the reproductive tract 
of diabetic men 
100 Neil et al. 2010 Diabetic mouse ↑formation of CML 
↑sperm DNA 
fragmentation 
46 Nevin et al. 2018 Spermatozoa + GO 
Sperm + MGO (in vitro) 
↑DNA damage 
98 Oborna et al. 2011 Normozoospermic 
male partners from 
Infertile relationship 
AGE-RAGE negatively 
impact male fertility 
through oxidative 
stress (OS) 
90 Tóthová et al. 2013 OS- induced Rats ↑AGEs 
↑MDA levels 
 
Table 1: Studies illustrating the impacting effects of AGEs on male fertility. AGEs=advanced 
glycation end products, MDA=malondialdehyde, CML=N=carboxylmethyllysine 
MGO=methylgloxal, GO=glyoxal, RAGE=receptor for advanced glycation end products, 
nDNA=nuclear deoxyribonucleic acid, MAPK=mitogen activated protein kinase, HIF-1α= 






Mallidis et al. reported the presence of CML in the epithelium of seminiferous tubule, nuclei 
of spermatogonia and spermatocytes. CML was also found in the caput epididymis, 
cytoplasmic droplets, sperm acrosomal cap, mid-piece and tail. The quantity of this AGE was 
significantly increased in the spermatozoa of diabetic men [52]. Bearing in mind the identified 
damaging effects of AGEs in other systems, the presence, localization, and quantity of CML 
suggest that they may play a role in male infertility, especially, DM related male infertility. 
This group of authors also reported in a different manuscript, elevated seminal plasma 
concentrations of RAGE and an increase in the number of spermatozoa displaying RAGE in 
diabetic men. RAGE was also expressed throughout the testis and caput epididymis of both 
diabetic and non-diabetic men but was higher in diabetic men [31]. Karimi et al. likewise 
reported an increase in the expression of RAGE in the spermatozoa of diabetic men and went 
on to show a positive correlation between RAGE levels and nDNA fragmentation [88].In a 
different manuscript, Karimi et al. also reported elevated total AGEs in the seminal plasma of 
diabetic men with spermatozoa showing increased lipid peroxidation [51]. It is known that 
men with DM display increased OS parameters accompanied by elevated sperm nDNA 
fragmentation [32]. Considering the interplay between AGE formation, RAGE expression and 
ROS production it is plausible that an increase in the accumulation of AGEs and RAGE can 
cause an upsurge in ROS which can lead to lipid peroxidation and eventually sperm damage.  
Additionally, after treating murine Leydig TM3 cells with AGEs for 48 hours, Ying et al. 
reported increased ROS production, apoptosis induction and activation of HIF-1α and HO-1 
[89]. HIF-1α is a protein required for apoptosis regulation in physiological systems. The testis 
is a relatively hypoxic organ [90], hence, HIF-1α is required for the control of primary 
transcriptional responses to hypoxic stress, plays an adaptive role and also regulate apoptosis. 




that weakened expression of HIF-1α exacerbated OS injury by AGEs [89]. This suggests that 
HIF-1α protein regulate the apoptotic effect of AGEs. However, when proteins are altered, 
testicular damage and ultimately male infertility ensue. 
In a recent study conducted by Min et al. (2019), histopathological damage was observed in 
the testes and epididymides of mice fed with an AGE rich diet. This was accompanied by a 
decrease in normal sperm morphology and epididymal sperm reserve [91]. There was a 
concomitant increase in the level of RAGE, accompanied by elevated MDA levels. 
Conclusively, dietary AGE may promote testicular dysfunction through the OS pathway. 
Furthermore, Clare et al. reported that GO (CML precursor), induced a significant increase in 
CML levels in spermatozoa with a resultant increase in DNA damage. It was further reported 
that AGEs were located in all regions of the sperm, but motility and hyaluronidase activity 
were not negatively affected [48]. Considering the reported damaging effects of elevated 
levels of AGE on DNA integrity, without an effect on motility and hyaluronidase activity, 
suggests that sperm may preserve some fertilizing capacity under adverse conditions or that 
the in vitro assay did not mimic in vivo processes. 
Tothova et al. reported a significant increase in the formation of AGEs after administration of 
exogenous testosterone to rat testes [92]. In this model, elevated AGE levels were 
accompanied by increased MDA levels. It was suggested that since AGEs, a biomarker of 
carbonyl stress, were increased, the signalling of testicular oxidative damage was also 
increased. This may lead to a decrease in total antioxidant capacity and further impairment 
of sperm function [93,94]. 
A report from one of the few studies that investigated the role of soluble RAGE (sRAGE, a 




comparison to what is known in DM. Charalampidou et al. reported increased serum sRAGE 
in fertile men compared to infertile men [95]. However, it was interesting to see that there 
was a significant decrease in sRAGE levels in the seminal plasma of both fertile and infertile 
groups compared to the levels in sera. It was therefore suggested that these reduced levels 
of sRAGE in seminal plasma may be due to the increased clearance of AGE-sRAGE complexes 
[95]. However, they suggested that further research is required to enumerate the role and 
mechanism of sRAGE in male infertility and why it was increased in the sera of fertile men. 
Furthermore, Vahid et al. [96] investigated the link between S100A12 (RAGE ligand) and 
infertility and also examined the amount of S100A12 in the semen of infertile men who 
suffered from varicocele [96]. S100A12 (EN-RAGE) is a member of the S100 multigene family 
of calcium-binding proteins involved in Ca2+-dependent synchronization of a variety of 
intracellular activities, including protection against oxidative cellular damage, protein 
breakdown and inflammation. They are primarily secreted by activated neutrophils in humans 
[97]. Increase in the number of WBC in semen have been associated with male reproductive 
tract infections and/or inflammation. During inflammation, the WBC are activated with 
subsequent release of an array of products including ROS, inflammatory molecules such as 
S100 proteins and cytokines [98]. 
The authors, therefore, argue that the significant increase in S100A12 in the semen of infertile 
men may be as a result of neutrophil accumulation in the lower part of the genital tract, which 
may further be correlated with the reduction in sperm motility observed [96].  
Additionally, Hakimi et al. [99] reported the increased levels of other pro-inflammatory 




increased expression of RAGE in any part of the male reproductive tract can be bad as several 
ligands such as AGEs and S100A12, can bind to inflict damage. 
A randomized controlled trial that investigated the effect of lycopene (an antioxidant) on 
sRAGE levels in the blood and seminal plasma of normozoospermic male partners of infertile 
couples showed that lycopene reduced sRAGE in seminal plasma. The decrease in the seminal 
sRAGE levels may be a result of lycopene suppression of oxidative stressors [100]. The 
improvement in fertility reported by this group of authors following antioxidant 
administration can serve as further evidence that AGE-RAGE negatively impacts male fertility 
through OS. 
Additionally, Yuping et al. reported the suppression of the AGE-RAGE /p38 MAPK pathway in 
streptozotocin (STZ) induced DM after iridoid glycoside from C. officinalis (IGCO) treatment, 
a traditional Chinese medicine. It was shown that the IGCO reduced ROS and MDA levels, 
restored SOD and CAT activities, and decreased spermatogenic cell apoptosis [101], which 
cumulatively reduced the formation of AGEs, RAGE and phosphorylated p38 MAPK levels. This 
suggests that AGE-RAGE can impair male fertility through the p38 MAPK pathway.  
Neil et al. [102], in their quest to build on human studies that explored the role of AGEs in 
male infertility, and to also establish a model of DM that is similar to human findings, 
investigated the formation and accompanying adverse effects of CML in two different DM 
animal models (heterozygous Ins2Akita and the STZ induced DM mice). It was shown that both 
the control and Ins2Akita mice presented with identical immunohistochemical localization of 
CML in the testis. Though, the degree of the staining was noticeably higher in the Ins2Akita 
mice. Additionally, a speckled-like structure appearance was observed throughout the 




interstitium. Furthermore, the nuclei of spermatogonia and differentiating spermatogenic 
cells exhibited little immunoreactivity for CML with the most prominent stain found in the 
lumen border of the tubules, especially the phase where elongating and mature spermatids 
were present [102].  
The formation of CML in the STZ treated mice was significantly increased when compared to 
the control and Ins2Akita groups. Additionally, the round spermatids (especially the area 
related to the developing acrosome) exhibited immunoreactivity for CML. In relation to what 
was observed in the testis, the efferent ducts and the caput (head) epididymis were 
immunoreactive for CML. Furthermore, the sperm head of both diabetic groups had 
prominent immunofluorescent bands for CML and RAGE. This was accompanied by a 
significant increase in the percentage of sperm with single DNA strand breaks with a more 
elevated alteration in the Ins2Akita mice [102]. Cumulatively, these results mirror what is 
observed in human studies, which further support the detrimental effects of AGEs in DM 
related male infertility. 
 
2B.4.3  AGEs and other Fertility Related Effects 
Seeing that about 20% of infertility cases are attributed to both male and female, it is 
important to make brief mention of the involvement of AGEs and RAGE in female infertility. 
Studies have shown that from this 20%, ovarian ageing is the most frequent cause for female 
partners. 
During fetal life, the ovaries have approximately 6 million oocytes surrounded by somatic 
granulosa cells. The primordial follicles are slowly depleted by atresia, such that about 1 




about 1000 follicles are lost each month during reproductive life [103–106]. The decrease in 
the ovarian follicle pool due to senescence is proportional to the reduction of ovarian function 
and a decline in the ability to fall pregnant [105].  
Mette et al. reported the presence of AGE and RAGE in granulosa-lutein cells as well as ovarian 
monocytes in cells isolated from aspirates of ovarian follicles from women who underwent 
assisted reproduction treatment (ART) [107]. It was suggested that the reduction in ovarian 
function that comes with ageing may be caused by the structural long-lived extracellular 
matrix AGEs [107]. 
Additionally, AGEs has been reported to be present in the granulosa, theca and luteinized 
cells of healthy women. However, in women with polycystic ovarian syndrome (PCOS), AGEs 
are expressed in the granulosa, theca interna and the ovarian endothelial cells with increased 
accumulation compared to healthy counterparts [108]. Interestingly, there was a mild RAGE 
expression in the ovaries of healthy women and this activated the NF-Kβ (p50/65) in the 
cytoplasm of the theca interna and granulosa cells [108]. However, increased RAGE 
expression was observed in the ovaries of women with PCOS. This appears to further 
stimulate the activation of NF-Kβ (p65) in the cytoplasm of the theca interna and granulosa 
cells. Women with PCOS have been shown to have endothelial dysfunction which have been 
previously related to insulin resistance [109], androgen levels and inflammation [110,111], 
but the presence of increased AGEs in the endothelial cells of PCOS ovaries may be a plausible 
mechanism through which this dysfunction occurs. 
Embryogenesis, which refers to the formation and development of human embryo, involves 
both the male and female gamete. Therefore, it is appropriate to consider the involvement 




AGE accumulation has been reported to affect embryonal development adversely and to as 
well endanger the development and achievement of pregnancy by ART. 
Jinno et al. [112] investigated the role of AGEs during in vitro fertilization (IVF) and 
intracytoplasmic sperm injection (ICSI) and their consequence in achieving pregnancy. Toxic 
AGE (TAGE), pentosidine and CML were measured in both follicular fluid (FF) and serum of 
ART patients. It was reported that increase in TAGE, pentosidine and CML in FF and TAGE in 
serum significantly decreases the level of estradiol as well as the number of follicles larger 
than 12mm in diameter, retrieved oocytes, fertilized oocytes and embryos. Furthermore, it 
was interesting to note that the correlation between the degree of TAGE, pentosidine, CML 
accumulation and the resultant negative effect on achieving pregnancy was an independent 
determinant despite normal fertility parameters (reproductive age and normal day-3 FSH). It 
was thus concluded that an increase in serum TAGE is an indicator of ovarian dysfunction 
[112]. 
Additionally, a study investigated the influence of reproductive age on the accumulation of 
AGE, sRAGE and VEGF in the plasma and FF of women undergoing ART. The increase was 
subsequently correlated to pregnancy outcomes. A negative correlation was found between 
the age of the participant and the number of oocytes retrieved [113]. This suggests that the 
sRAGE secreted in older women (>35 years) is more involved in binding to AGEs which are 
increased with age. Studies have reported that the increase in FF concentration of VEGF may 
decrease the pregnancy rate in ART [114,115].  
Furthermore, Lin et al. [116] reported the negative effect of AGEs on embryonic development 
from the pronuclear to the blastocyst stage. Embryos from flushed fallopian tubes of rats after 




concentrations over time. It was shown that GO, in a concentration-dependent manner, 
repressed cleavage of embryos at every stage (2n-cell, 4n-cell, morula and blastocyst). The 
blastocyst yield was significantly reduced and morphological changes, such as fragmentation, 
were observed after treatment with GO at higher concentrations. Additionally, BSA-AGEs also 
suppressed the cleavage of embryos at every stage in a concentration-dependent manner. It 
was Interesting to note that, N-acetyl-L-cysteine (L-NAC) inhibited both GO and BSA-AGE 
induced embryonic toxicity. Hence, AGE accumulation may influence the pregnancy rate after 
IVF and embryo transfer, which ultimately increase infertility [116]. 
 
2B.5 Conclusion and Recommendation 
In small quantity, AGEs play a physiological role in embryogenesis, ageing, lung homeostasis, 
bone metabolism, neuronal systems and the immune system. However, when the formation 
rate is higher than the elimination rate, pathophysiological activities ensue. As illustrated in 
this manuscript, studies have reported the adverse impacts of these biomolecules on several 
systems and cells, at least in part. The importance of ROS production, activation of cellular 
signalling and subsequent gene or protein modification in response to increased AGEs have 
been highlighted. In the study of male infertility however, the conventional seminal analysis 
in categorizing fertility is becoming inadequate. It is evident that AGE impact male 
reproductive function and subsequently, male fertility, through ROS and/or activation of 
other mechanistic pathways, which at this time is largely unknown.  
Seeing that normal male reproductive function depends on: (I) the balanced physiochemical 
dynamics of proteins involved in the process of spermatogenesis and (ii) the controlled 




RNA and DNA. It is thus essential to investigate the basic molecular protein interaction, which 
may provide more information about infertility as a whole.  
Understanding the role of proteins involved in fertility will provide clinicians with the 
fundamental information to translate research findings from the bench to the bedside. 
Therefore, we recommend that future studies investigating idiopathic infertility and disease-
induced infertility should further elucidate the impacts of protein modification and glycation. 
Additionally, studies investigating its mechanistic role in infertility are required as this will aid 
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Materials and Methods 
 
3.0 Introduction  
Findings from this study are discussed in separate chapters. Included in each chapter is the 
materials and methods used, as they are formatted according to the requirement of different 
journals. However, an in-depth overview of the materials and methods employed in the entire 
study are outlined below.  
3.1 Preparation of streptozotocin and the infusions  
3.1.1 Streptozotocin (STZ) preparation 
 
STZ (S0130-IG) procured from Sigma was prepared by dissolving it in freshly prepared sodium 
citrate buffer at a pH 4.5 to make a 30mg/ml stock of STZ. The volume of STZ injected was 
relative to the bodyweight. 
3.1.2 Infusion preparation  
Rooibos (fermented, 2%), honeybush (fermented, 4%) and sutherlandia (unfermented 4%) 
were prepared according to standard protocols. These concentrations are commonly used for 
tea making purposes. Preparation methods conformed to the experimental established 
protocols for rooibos (Marnewick et al., 2011), honeybush (Toit and Joubert, 1999; 




The plants used in preparing the infusions were processed during the same season. The same 
batch of the individual plant material was used throughout the study. That is, the plant batch 
that was prepared at the start of experiment was used throughout the treatment period. All 
infusions (rooibos, honeybush and sutherlandia) were prepared every other day (48 hours). 
The infusions served as the only drinking fluid for the animal groups receiving the respective 
infusions. 
 
3.1.2.1 Rooibos  
Rooibos infusion was prepared by adding 20g of dried fermented stems and leaves of rooibos 
(Carmien SA PTY LTD, South Africa) in 1litre of tap boiling water to make a 2% concentration 
and a dose of 20mg/ml. The mixture was allowed to steep/rest for 30 minutes and then 
filtered three times using a cheesecloth, number 4 Whatman filter paper and Whatman 
number 1 filter paper (WhatmanTM, Buckinghamshire, UK) respectively. Filtered infusions 
were transferred to a dark bottle plastic container and stored at 4°C.  
3.1.2.2 Honeybush  
Honeybush infusion was prepared by adding 40g of fermented dried stem and leaves of 
honeybush (Afrinaturals, South Africa) in 1litre of boiled tap water to make a concentration 
of 4% at dose 40mg/ml. The mixture steeped for 30 minutes and thereafter filtered with 
cheese cloth and Whatman filter paper (number 4 and 1). The infusion was then transferred 
to a dark bottle plastic container and stored at 4°C. 
3.1.2.3 Sutherlandia  
Sutherlandia was prepared by adding 40g of unfermented dried stem and leaves of 




concentration of 4% at dose 40mg/ml. The mixture was also allowed to steep for 30 minutes 
and then filtered with cheese cloth and Whatman filter paper. The infusion was transferred 
to a dark bottle plastic container and stored at 4°C. The 4% sutherlandia infusion 
concentration was further diluted to 0.2% by adding 2.5ml of 4% in 50ml of tap water, making 
a final dose of 2mg/ml. This is because the initial 4% infusion was bitter and animals refused 
to drink it.  
3.2 Experimental procedures 
3.2.1 Ethics and animal care 
Ethics approval for this project was obtained from the Stellenbosch University Animal Ethics 
Committee (Project numbers: SU-ACUD16-00101 and SU-ACUD17-00016). Animals were 
treated according to the recommendations of the Laboratory Animal Care of the National 
Society of Medical Research and the National Institutes of Health Guide for the Care and Use 
of Laboratory Animals (Committee for the Update of the Guide for the Care and Use of 
Laboratory Animals; National Research Council, 2010). 
Healthy adult male Wistar rats weighing 240-300g at start of experiment were housed 
individually in standard ventilated cages and were exposed to a 12 hour light: 12 hour dark 
cycle at 23°C±2°C in the Animal Housing Unit of the Faculty of Medicine and Health Sciences, 
Stellenbosch University. Animals had free access to food and water throughout the duration 
of the study. During the first week of acclimatization, animals were fed with pellets (standard 
Epol™ rat chow, Table 1) and water only for the control groups. While, the diabetic + infusion 
groups were fed with pellets and given the individual infusion as per the group. After one 




infusions as appropriate. The only source of fluid intake for the infusion control groups and 
the diabetic + infusion groups are the infusions (that is, the infusions serve as the drinking 
water). 
Table 1: The nutritional values of the standard rat chow pellets 
Contents AS(g/kg) -Dm-(g/kg 
Crude protein (min) 200 240 
Moisture (max) 10  
Crudeoils and fats (min) 50 53 
Linoleic acid (min) 12 14 
Crude fiber (max) 40 45 
Crude ash (max) 70 75 
Ca:P ratio 1.1-2.1 1.1-2.1 
Calcium (min) 12 14 
Phosphorus (min) 7.5 8 
Vitamin A (min) 16000 (IU/kg) 16000(IU/kg) 
Vitamin D (min) 2000 (IU/kg) 2000 (IU/kg) 
Vitamin E (min) 100 (mg/kg) 100 (mg/kg) 
 
 
3.2.2 Diabetes induction 
From the STZ solution prepared as described in section 3.1.1, animals were immediately 
injected intra-peritoneally and administered doses at (30mg/kg, 45mg/kg and 60mg/kg body 
weights). Animals were feed fasted overnight before injecting with STZ. The successful 
induction of diabetes was confirmed after one week, with animals showing a justifying blood 
glucose level of ≥14mmol/L, using a Glucoplus™ glucometer (Ayeleso, Brooks and Oguntibeju, 




3.2.3 Treatments  
Animals were treated with tap water, rooibos, honeybush or sutherlandia as appropriate 
(Table 2). They had free access to feed and fluid. However, before performing test such as 
glucose tolerance, animals were feed fasted overnight (16 hours). The body weights, food and 
fluid intake of the animals were measured three times weekly. The diabetic state was 
confirmed throughout the 8 weeks treatment period as glucose levels were measured once a 
week. Intra-peritoneal glucose tolerance test was performed between 48-72 hours before 
sacrifice. 
3.2.4 Study design 
The study was designed relative to the aims, hence, study design is in two parts (Figure 1). 
First part, thirty animals were randomly divided into three groups of vehicle and two STZ 
groups (STZ30 and STZ60). For the second part, ninety animals were divided into nine groups 
without bias. The groups include control, vehicle, rooibos, honeybush, sutherlandia, diabetic 
control (STZ45mg/kg), diabetic + rooibos, diabetic + honeybush, and diabetic +sutherlandia 
(Table 1). Since one of the objectives for aim 2 (second part) includes determining the effect 
of the infusions on male reproductive function, hence the control (tap water only) was 
included. To investigate these infusions in both health and diabetic states, the second part 














Figure 1: Schematic diagram of the overall study design. Green box=Aim 1 or Part 1 of the study while 

































Table 2: Overall abbreviations and treatment groups. 
 




Groups abbreviation Group Full Names Intervention Treatment 
Veh Vehicle Citrate buffer Tap water 
STZ30 Streptozotocin 30mg/kg STZ 30mg/kg Tap water 
STZ60 Streptozotocin 60mg/kg STZ 60mg/kg Tap water 
Control H20 Control  - Tap water 
Veh Vehicle Citrate buffer Tap water 
RF Rooibos  - 2% Rooibos 
HB Honeybush - 4% Honeybush 
SL Sutherlandia  - 0.2% Sutherlandia 
DC Diabetic control STZ 45mg/kg Tap water 
DRF Diabetic+rooibos STZ 45mg/kg Rooibos 
DHB Diabetic+honeybush STZ 45mg/kg Honeybush 


























3.2.5 Intra-Peritoneal Glucose Tolerance Test (IPGTT) 
Animals were feed fasted overnight, a 20% glucose solution was prepared, and a dose of 2g/kg 
body weight (10µl/g) was administered intra-peritoneally. Glucose levels were measured at 
12 different time points (0, 3, 5, 10, 15, 20, 25, 30, 45, 60, 90 and 120 minutes) after 
administering glucose solution.  
3.2.6 Sacrifice and sample collection 
After 8 weeks of treatment, animals were sacrificed by administering an overdose of sodium 
pentobarbital (160mg/kg body weight). Blood was collected and allowed to clot on ice for 15-
30 minutes, after which it will be centrifuged at 3000rpm for 30 minutes at 4°C and serum 
was collected. Serum aliquots were stored at -80°C for further analyses. The testes, 
epididymides and visceral fats were harvested, rinsed and weighed. 
3.3 Experimental analysis 
3.3.1 Sperm parameters 
 
3.3.1.1 Sperm retrieval  
The harvested left epididymis was defatted and placed in a Petri dish that contains a 2ml 
solution of Hams F-12 nutrient media (Sigma Chemicals, St Louis, MO, USA), at 37°C. After 
rinsing, the cauda area of the epididymis was dissected into a separate dish containing 2ml 
Hams and spermatozoa were allowed to swim out. After 30 seconds of sperm retrieval, sperm 
motility was analysed. Sperm solution for concentration, morphology and viability analysis 
were obtained by dissecting the caudal area into smaller pieces after motility was analysed 




3.3.1.2 Sperm motility 
After 30 seconds of retrieval, 2µl of the sperm solution from the edge of sperm cloud was 
infused into a 20µl depth chamber slide (Leja, Netherlands) and placed on a Nikon Eclipse 
E200 microscope with an in-built heating stage (37°C). Sperm motility was measured via 
computer-aided sperm analysis (CASA) using the Sperm Class Analyser (SCA 6.3, Microptic, 
Barcelona, Spain). The sperm kinematic parameters (Figure 3) (curvilinear velocity (VCL), 
average path velocity (VAP), straight-line velocity (VSL), straight-line index (STR), linearity 
index (LIN), sperm oscillation index (WOB), amplitude lateral head (ALH) and beat frequency 
(BCF), total motility and progressive motility were analysed. Motility was analysed at 4x (p-
phBM) phase contrast 1, no filter and CASA settings, 50 frames/sec, minimum area (µm2) 
=300, maximum area (µm2) =1600, drifting (µm/s) =20, static (µm/s) =<50, slow-medium 
(µm/s) =80, rapid (µm/s) =>120, progressive STR=>70, VAP points (pixels) =9, grid distance 
(µm/s) =100, connectivity (pixels) =80, VCL/VAP =VCL.  
 
 




3.3.1.3 Sperm concentration  
After analysing sperm motility at 30 sec, sperm concentration was measured by dissecting the 
caudal epididymis into smaller pieces and left for further 5 minutes for maximum 
spermatozoa swim out. The pieces were removed after 5 minutes and the sperm solution was 
mixed homogenously. Of the 2ml solution, 10µl was diluted in 50µl Hams. From this solution, 
2µl was infused into a chamber slide and analysed via CASA. 
3.3.1.4 Morphology 
Morphology was carried out in accordance to the protocol of the SURRG laboratory. Two 
staining protocols were employed as the manufacturer upgraded the stains to be time 
effective. From the sperm solution retrieved after 5 minutes, 10µl was smeared on a glass 
slide and left to dry at room temperature. First protocol, air-dried slides were fixed for 20 
minutes in a staining tray containing Sperm Blue® fixative (Microptic SL, Barcelona, Spain). 
Fixed slides were then stained for 15-17 minutes with Sperm Blue Stain. Second protocol, the 
new Sperm Blue is made up of both the fixative and stain. Hence, air-dried slides were fixed 
and stained in Sperm Blue for 3 minutes. Stained slides were gently submerged in water for 3 
seconds to eliminate excessive stains and then allowed to air-dry. Dried slides were mounted 
using a mounting medium (DPX) and cover slip. Sperm morphometry was analysed through 
computer-aided sperm morphometry analysis (CASMA) via Sperm Class Analyser (SCA®; 
Microptic, Barcelona, Spain) and a Nikon E-200 microscope with bright field optics at x60 
magnification under a blue filter. The SCA software automatically analyse sperm 
morphometric parameters including, head-arc, width, chord, ecetera. These parameters are 







Figure 4: Sperm morphology as measured by CASA  
 
3.3.2 Histology 
The testis and the epididymis were fixed in 10% formalin solution. The tissues were kept in 
the solution for a minimum of 48hours to allow for complete fixation. The fixated tissues were 
dehydrated with a series of alcohols, cleared with xylene and then infiltrated with paraffin 
wax. Tissues were processed using automated processor (Duplex Processor, Shandon Elliot).  
Processed tissue pieces were embedded in paraffin wax at 60°C using the Leica EG1160 
embedder. Tissue blocks were kept at 20-25°c until sectioning takes place. Tissue blocks were 
trimmed and sectioned using a Leica RM 2125 microtome, to obtain a uniform 5µm sections. 
Sections were placed in a water bath (40-55°C), allowing the tissue to stretch. Tissues were 
then stained with haematoxylin and eosin (H&E) using an autostainer (Leica Auto stainer XL). 
Stained tissue slides were mounted in DPX mounting medium and left to dry for 48 hours to 




The Zenlite histology analyser software was used to measure the seminiferous tubule 
diameter, luminal diameter, epithelial height and luminal area (Figure 5). 
Additionally, for proper visualization of the tissues towards qualitative analysis, testicular 
tissues were stained with alcian blue-periodic acid schiff (AB/PAS). In brief, sectioned tissues 
were deparaffinised and hydrated in distilled water. Sections were stained with alcian blue 
for 15 minutes, rinsed thoroughly in tap water for 2 minutes and further rinsed in distilled 
water for another 2 minutes. Sections were oxidized in 1% periodic acid solution for 10 
minutes and then rinsed in distilled water. Rinsed sections were placed in Schiff’s reagent for 
15 minutes and then wash in lukewarm tap water for 7 minutes 30 second. At this point, 
sections turned dark pink. Sections were counter stained with haematoxylin solution for 30 
seconds, wash in tap water for 3 minutes and then dehydrated and cleared with xylene. 
















Figure 5: Micrograph showing measurement of seminiferous tubule parameters. 
Seminiferous tubule diameter (yellow line); tubular area (blue spine contour), epithelial 





3.3.3 Protein determination  
 
3.3.3.1 Bicinchoninic Acid (BCA) 
BCA assay was used for protein determination for oxidative stress analysis. In brief, Frozen 
testicular tissue were pulverized and thereafter homogenized in cold lysis buffer (Na3PO4, 
0.5% Triton X-100) by bullet blending at speed 9 for 3 minutes with a 1-minute interval in-
between. The solution was centrifuged at 15000rpm (25200rcf/xg) for 20 minutes at 4°C. 
Supernatant were fractioned. Bovine serum Albumin fraction V (BSA) was prepared and was 
used as standards (µl) (0, 20, 40, 60 and 80). BCA Reagent A and B were prepared at ratio 
50:1. Samples were diluted in ionized water (x10). After preparing and vortexing standards 
and samples, 25µl of each solution was loaded appropriately into microplate vials, 200µl of 
Reagent AB was added and the microplate was vortexed for 5 seconds. Thereafter, samples 
were incubated at 37°C for 30 minutes and absorbance was read at 450nm on a plate reader.  
3.3.3.2 Bradford protein determination 
To determine the quantity of proteins in a sample through the Bradford method 0.05-0.07g 
of tissue were pulverized and placed into 700µl lysis buffer. Seven stainless homogenization 
beads (1.6mm, Next Advance Inc., USA) were added into each tube to allow for complete 
homogenization (Bradford, 1976; Marais et al., 2001). The pulverized tissue was bullet 
blended at speed 8 for 3 minutes at 5 minutes interval in-between, at 4°C. The homogenates 
were centrifuged for 20 minutes (15000rpm (25200rcf/xg), 4°C) and the supernatants were 






3.3.4 Oxidative stress parameters 
3.3.4.1 Catalase  
Tissue homogenates were obtained as described for BCA. For the assay, tissue homogenates 
were diluted to 10x in deionized water. From the diluted samples and standards, 5μl were 
loaded in triplicate into UV microplate wells. Catalase assay buffer (170μl) were added into 
each well and lastly, 50μL of H2O2 was added into the wells and analysis was performed 
immediately on a plate reader (Multiskan spectrum) at 240nm every 60 seconds over a 5 
minute period using SkanIt RE for MSS 2.2 (ThermoScientific™ Inc.) software. 
 
3.3.4.2 Superoxide dismutase (SOD) 
Tissue homogenates were obtained as described for BCA. From the diluted standards and 
samples, 10μl were dispensed into the microplate wells in triplicate, followed by adding 170μl 
of diethylenetriaminepentaacetic acid (DETAPAC) and 5µl of SOD assay buffer (50mM Na/K 
Phosphate buffer at PH 7.4). Immediately before reading, SOD activity was activated by 
adding 15μl of freshly prepared 6-hydroxydopamine (6-OHD) into the wells and instantly 
analysed on a plate reader (Multiskan spectrum) at 490nm, 25°C for 5minutes at 1 minute 
interval using SkanIt RE for MSS 2.2 (ThermoScientific™ Inc.) software. 
 
3.3.4.3 TBARS assay 
Frozen testicular tissue samples were homogenized in lysis buffer (0.1M KPi, 1.15% KCl) by 
bullet blending at speed 9 for 3 minutes with a 1-minute interval in-between. To measure the 




pipetted into corresponding 10ml glass tubes, followed by adding 1ml of SDS and 2ml of 
10%TCA-BHT buffer solution. Samples were vortexed, and after resting for 10 minutes, 2ml 
of TBA was added and vortexed again. The standards and samples were covered with marbles 
and incubated in a water bath (1 hour at 100⁰C), where after it was cooled on ice for 15 
minutes. The standards and samples were centrifuged (3000rpm, 15 minutes 4°C) and the 
supernatants retrieved. From the supernatants, 250μl of each standard and sample were 
loaded in triplicate into microplate wells and analysed on a plate reader (Multiskan spectrum) 
at a 532nm wavelength within 30 minutes after centrifugation. 
 
3.3.5 Western blot  
Sample protein concentration was determined using Bradford method as described in section 
3.3.3.2. Tissue lysates were prepared by diluting the sample in Laemmli sample buffer and 
lysis buffer, boiled for 5 minutes and 50ug protein/µl was separated by electrophoresis on a 
12% SDS-PAGE mini-proteon gel or on a 4-20% stain-free precast gel (Criterion TGX, Biorad, 
USA). The running protocol consisted of an initial 10 minutes electrophoresis at 100V and 
200mA followed by 40minutes at 200V and 200mA. The running protocol for the precast gel 
consist of an initial 10 minutes electrophoresis at 100V and 200mA followed by 25-30 minutes 
at 140V and 140mA. Gels were activated using ChemiDoc (BioRad). Thereafter, the proteins 
were transferred onto a milipore Immobilon-P transfer membrane (0.45µm) (Immobilon®-P, 
Merck Millipore Ltd, Germany). Non-specific sites were blocked with 5% fat-free milk in TBS-
tween.  
The following proteins were probed for, AGE (ab23722; Abcam, SA), RAGE (ab361; Abcam, 




p38MAPK (Cell Signalling Technology), C-Jun-N-terminal kinase (JNK) (Cell Signalling 
Technology) and IkBα (Cell Signalling Technology), GLUT4 (Cell Signalling Technology), 
PKB/Akt (Cell Signalling Technology), XIAP (Abcam, SA), ERK1/2 (Cell Signalling Technology), 
IRS1/2 (Cell Signalling Technology), p53 (Cell Signalling Technology), pTEN (Cell Signalling 
Technology), Bad (Cell Signalling Technology). A goat anti- rabbit-horseradish peroxidase-
conjugated antibody (Sigma-Aldrich) or goat anti-mouse-horseradish peroxidase-conjugated 
antibody were used as the secondary antibody appropriately. Proteins were detected and 
visualized using a ChemiDoc (BioRad, USA) and were further normalized (Stain-free blots as 
housekeeping proteins) and analysed with ImageLab 5.0 (ImageLab software, USA). All 
primary antibodies were diluted in TBS-Tween in a 1:1000 ratio while the secondary antibody 
was diluted in TBS-Tween in a 1:4000 ratio. All data points are from independent biological 
repeats (n=4-5). 
 
3.3.6 Hormone analysis 
3.3.6.1 Testosterone 
Testosterone in the plasma was measured using a commercially available ELISA kit 
(Elabscience Biotechnology, Hubei). All reagents were brought to room temperature (18-
25°C) before use. Fifty microliters of each standard and sample were loaded into their 
corresponding wells, and then another 100µl of HRP-labelled testosterone was added to each 
sample well. From Detection A and Detection B, 50µl was added and the solution was 
thoroughly mixed and cover with the plate sealer. The mixture was incubated for 1 hour at 
37°C. The solution from each well was decanted and thoroughly washed with a 350µl of 




dry. This was be repeated x3. After the washing process, 100µl of Substrate A and Substrate 
B was added to each well and mix thoroughly. This was then incubated for 15 minutes at 37°C. 
After a colour change, 50µl of STOP solution was added to each well and the absorbance was 
be measured at 450nm using the pre heated microplate reader. 
 
3.3.6.2 Estradiol 
Estradiol in the plasma was measured using a commercially available ELISA kit (Elabscience 
Biotechnology, Hubei). All steps were as described for testosterone.  
 
3.3.6.3 Insulin  
Serum insulin was measured using a commercially available ELISA kit (Elabscience 
Biotechnology, Hubei). All reagents were brought to room temperature (18-25°C) before use. 
One hundred microliters of standard and samples were added to each well and incubated for 
90 minutes at 37°C. The liquid was removed without washing and 100µl of biotinylated 
detection antibody was added to each well and allow to incubate for another 60 minutes at 
37°C. After incubation, the solution was aspirated and washed 3 times for 5 minutes. After 
washing, 100µl of HRP conjugate was added and left to incubate for 30 minutes before 
washing for 5 minutes. Ninety microliters of substrate reagent was added and left to incubate 
for 15 minutes, after which 50µl of stop solution was added. The absorbance was determined 






3.4 Statistical analysis 
GraphPad Prism™ software (GraphPad™ Software, Version 5 and 8.2, CA, USA) was used. 
Normal data distribution was measured using the Anderson-Darling and Kolmogorov-Smirnov 
normality tests. When data passed all normality tests, a one-way ANOVA of variance with a 
Tukey’s or Bonferroni’s Post-hoc Tests were performed. Where data were not evenly 
distributed, a Kruskal-Wallis test and a Dunns Post-hoc Test were carried out. A probability 
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Diabetes mellitus (DM) is reported to be involved in male reproductive impairment, and its 
impact is evident in the increased prevalence of infertility. Various studies have reported that 
a single parenteral injection of <40mg/kg Streptozotocin (STZ) is ineffective in ablating 
pancreatic β-cells and creating a rat model to investigate the effect of DM on the male 
reproductive system. This study therefore aims to validate these claims. 
Adult male Wistar rats received either a single intraperitoneal injection of STZ (30mg/kg or 
60mg/kg) or saline (0.9%, Control). Diabetes was confirmed after 72hours if plasma glucose 
levels were ≥14mmol/L. Body weight, glucose level, fluid and food intake were measured 
weekly. Animals were sacrificed after 8 weeks of treatment by an overdose of sodium 
pentobarbital (160mg/kg body weight). The testis and epididymis were harvested and 
weighed prior to preparation for histological evaluation. Epididymal sperm morphology was 
analysed using computer aided sperm analysis (CASA). STZ60 animals presented with 
significantly lower body weights compared to both control and STZ30 groups. Animals in both 
STZ30 and STZ60 groups showed decreased normal sperm morphology compared to control. 
Histological evaluation of the testes showed a decrease in the number of spermatozoa in the 
seminiferous tubules of animals in the STZ30 and STZ60 groups compared to control. A 
complete absence of spermiogenesis was observed in the seminiferous tubules of STZ60 
animals. These findings prove that an STZ concentration of 30mg/kg, which is much lower 
than the reported 40mg/kg, has adverse effects on the male reproductive system via its 













Streptozotocin (STZ) is a chemical compound exhibiting antibiotic and antineoplastic 
properties, and it is produced by the bacterium Streptomyces achromogens (Vavra et al., 
1959). Since the diabetogenic introductory report on STZ in 1963 (Rakieten et al., 1963), 
several work has been done to showcase its mechanism of action and also why it damages 
the pancreatic β-cells. STZ has a dynamic chemical structure that contains deoxy- glucose 
molecules which allows it to identify the GLUT2 receptors that is ample on the plasma 
membrane of pancreatic β- cells (Lenzen, 2008). These molecules are also associated to a 
highly reactive methylnitrosourea group, which is responsible for the cytotoxic effect of STZ.  
Due to STZs high affinity for binding to the glucose receptors present on the pancreatic β-
cells, its ingestion relish the cytotoxic effect upon these cells and lead to dysfunction or cell 
death. This subsequently leads to alteration of insulin levels and blood glucose concentrations 
(Wei et al. 2003), thereby indicating that STZ may be a suitable diabetes inducing agent. To 
further validate its potency, Eleazu et al. (2013) reported that there is a rapid elimination of 
its components by the liver and that any functional impairment observed may be ascribed to 
the hyperglycaemic effect (Eleazu et al. 2013). In lieu of this, STZ can therefore be used to 
induce experimental Type I or Type II diabetes mellitus, either independently, or in 
combination with high fat diet and/or in combo with nicotinamide administration (Skovso, 
2014; Szkudelski, 2012). 
Diabetes mellitus (DM) is a chronic non-communicable disease that is characterized by 
hyperglycaemia, which can result from a lack of insulin secretion by the pancreatic β-cells or 
from target tissues becoming insensitive to insulin. It can be classified into two broad 




lack of insulin secretion; (ii) Type II DM, also called non-insulin-dependent diabetes mellitus 
(NIDDM), is caused by the decrease in sensitivity of the target tissues to the metabolic effects 
of insulin. DM have been shown to affect male reproductive function at multiple levels as a 
result of its effects on the endocrine control of the hypothalamic-pituitary gonadal (HPG) axis, 
spermatogenesis itself or by impairing penile erection and ejaculation (Sexton and Jarow, 
1997). In experimental animals, STZ induced diabetes have been reported to cause decreased 
serum testosterone, decreased serum FSH and decreased serum LH levels as well as a 
decrease in the total number of Leydig cells (Ballester et al., 2004; Murray et al., 1985). 
Another study done on the inhibition of glucose-stimulated insulin secretion in rats’ islets of 
Langerhans by STZ revealed that the main reason for the STZ-induced β-cell death is the 
alkylation of DNA (Szkudelski, 2001). Shrilatha (2007) further reported increased sperm DNA 
damage and decrease in sperm count of STZ induced diabetic animals (Shrilatha, 2007).  
Additionally, Ganda et al., (1976) reported that the use of a single intravenous or 
intraperitoneal dose in adult rats to induce Type I DM is between 40 and 60mg/kg body weight 
(Ganda et al., 1976). Katsumata and Katsumata (1992) supported the above findings and 
further added that a single dose less than 40 mg/kg body weight may be ineffective. 
Furthermore, Vikram et al. (2008) reported a biochemical alteration in rat accessory sex 
organs after administration of STZ at 45mg/kg body weight Also, Navarro-Casado et al. (2010) 
reported a decrease in sperm motility, testicular and epididymal weight, following 
administration of STZ at both 45mg/kg and 60mg/kg to investigate its effects on male 
reproductive function of rats. However, we could not find any study that investigated the 
effects of a lower dose of STZ on male reproductive function in experimental rats. Therefore, 




reproductive function and to compare these outcomes with the effects of a known efficacious 
dose in Wistar rats. 
 
Materials and Methods  
Animals  
Adult male Wistar rats (240-290g) were housed in standard ventilated cages, and were 
exposed to a 12hour light: 12hour dark cycle at 23°C±2°C. Animals had free access to food 
(standard Epol™ rat chow) and water. Ethics approval for this research was obtained from the 
Stellenbosch University Animal Ethics Committee. 
 
Diabetes Induction 
STZ (S0130-IG) was obtained from Sigma and prepared by dissolving it in freshly prepared 
sodium citrate buffer at a pH 4.5 to make a 30mg/ml stock of STZ. The STZ solution was 
immediately injected intraperitoneally and administered at doses of 30mg /kg body weight 
or 60mg/kg body weight. The injection volume was calculated according to the dose required 
and the weight of the animal. 
 
Experimental Design 
Animals were randomly assigned to treatment groups to avoid bias and were acclimatized for 




two treatment groups receiving STZ at either 30mg/kg body weight (STZ30) or 60mg/kg body 
weight (STZ60). Animals in the control group were treated with vehicle (0.9% saline). The 
successful induction of diabetes was confirmed after 72 hours, with animals showing a 
justifying blood glucose level of >14mmol/L, using a Glucoplus™ glucometer (Ayeleso et al., 
2014; Dludla et al., 2014). The diabetic state was confirmed throughout the 8 weeks 
treatment period and glucose levels were measured weekly in all groups. The fluid and food 
intake of the animals were also measured weekly, while the body weights were measured at 
start and end of the experiment. The relative testicular weight is the sum of both testes 
divided by the final body weight of the specific animal multiplied by 100. Values are expressed 
as percentage of body weight. 
 
Experimental Procedure 
Rats were humanely treated at all times and sacrificed after 8 weeks of treatment, by an 
overdose of sodium pentobarbital (160mg/kg body weight). The testis and epididymis were 
harvested, rinsed and weighed. The testis was fixed in 10% formalin solution for histological 
evaluation. The Cauda area of the epididymis was isolated and spermatozoa retrieved, which 
was subsequently used for motility and morphological analysis. 
 
Histology 
The testicular tissues were fixed in a 10% formalin solution. The tissues were kept in the 




dehydrated with series of alcohols, cleared with xylene and infiltrated with paraffin wax. 
Tissues were processed using automated processor (Duplex Processor, Shandon Elliot). 
Processed tissue pieces were embedded in paraffin wax at 60°C using the Leica EG1160 
embedder. Processed tissue blocks were kept at 20-25˚C until sectioning. Sections were 
placed in a water bath (approximately 40˚C), allowing the tissue to stretch. Tissues were 
stained with Haematoxylin and eosin (H & E) using an Auto stainer (Leica Auto stainer XL). 
Stained tissue slides were mounted with DPX mounting medium and left to dry for 48hours; 
allowing for proper visualization. 
 
Histological Evaluations 
Descriptive and quantitative histological evaluations of the testes were carried out. The 
quantitative aspect involves the histomorphometric analysis of the seminiferous tubules 
using the ZENlite histological analyser. This method involves measuring all seminiferous 
tubules seen in a specific field at a given time point. Seminiferous tubules were measured 
randomly at x10 magnification and field area 234.3713mm2, knowing that all seminiferous 
tubules cannot be in the same stage of spermatogenesis at the point of analysis and that 
seminiferous tubules have different sizes at different stages. The following parameters were 
measured; seminiferous tubule (Tubular) diameter (Fig. 1 yellow line); tubular area (Fig.1 blue 
spine contour), epithelial height (Fig.1 red line) and luminal diameter and area (Fig.1 black 
line and green spine contour respectively).  
The descriptive analysis was performed by randomly counting 100 seminiferous tubules 




analysed at field area 58.649mm2 evaluating maximum of 2 tubules per field to avoid bias and 
inaccurate analysis. In each animal the tubules were examined and categorized as normal, 
atrophic, sloughing or undergoing cellular degeneration. Tubules classified as normal are 
characterized by presenting with the complete spermatogenic phases, normal cellular 
organization, typical cellular association and regular interstitial spaces. Atrophy represents 
tubules with very few or absence of germ cells and cellular disorganization, while sloughing is 
characterized by the immature accumulation of cells in the lumen. Cellular degeneration is 
characterized by absence of some or all of the spermatogenic phases as well as degeneration 
















Fig. 1. Micrograph showing measurement of seminiferous tubule parameters. Seminiferous 
tubule diameter (yellow line); tubular area (blue spine contour), epithelial height (red line), 





Evaluation of Sperm Parameters  
Sperm Retrieval 
The Cauda area of the epididymis was extracted inside a separate HAMs solution (2ml) 
forming a sperm solution. 
Motility 
Sperm motility was analysed through computer aided sperm analysis (CASA) using the Sperm 
Class Analyzer (SCA, Microptics, Barcelona, Spain) and Nikon Eclipse E200 microscope. 
Between 500-600 spermatozoa were analysed per animal across five different fields. Total 
motility, progressive, non-progressive and immotile spermatozoa were expressed as a 
percentage. Sperm velocities and kinematic parameters were also analysed and recorded. 
Morphology 
The various sperm mixtures were used to make smears, fixed and then stained with Sperm 
Blue® (Microptic SL, Barcelona, Spain) according to the manufacturer’s guidelines. Sperm 
morphology was analysed using the morphology module of the SCA®; (Microptic, Barcelona, 
Spain). Acrosome, head, mid-piece and tail defects were accurately measured, whilst other 
morphometric variables (head Arc, width, area, linearity, angle, roughness and chord) were 
also analysed in order to determine whether sperm are morphologically normal or abnormal. 
Additionally, the sperm deformity index was evaluated by summing the total number of 
defects divided by the total number of spermatozoa analysed. This index provides a further 







Results are expressed as mean ± SEM. Data were analysed using Shapiro-Wilk test to check 
for normality and even data distribution. Where data showed normal distribution, a oneway 
ANOVA of variance was performed and where global p is significant, a Bonferroni’s post-hoc 
comparison test between the groups was performed. Kruskal-Wallis test was employed when 
data failed normality and Dunn’s post-hoc comparison test was carried out between groups 
if the global p is significant (Graph Pad Prism 5 (GraphPad Software, CA, USA)). A probability 
level of p< 0.05 is considered statistically significant. 
 
Results 
Anthropometry Parameters  
After 8 weeks of treatment, STZ60 animals lost a significant amount of body weight compared 
to control (p<0.001) and STZ30 (p<0.001) as well as their own initial weights (p<0.01), while 
STZ30 animals presented with increased body weight [Table 1]. There was a significant 
increase in the fluid and food intake of STZ60 compared to control (p<0.001) and STZ30 
(p<0.001). STZ30 animals presented with increased fluid and food intake compared to control 
(p=0.09). Additionally, STZ60 presented with a significant increase in glucose levels compared 
to control (p<0.001) and STZ30 (p<0.001) [Table 1], while STZ30 presented with a subtle 
increase in glucose levels compared to control. Furthermore, STZ60 showed a decrease in 





Table 1: Comparison of anthropometry Parameters 
@ p<0.001 vs. control; & p<0.001 vs. STZ30 
 
 
Quantitative histological evaluation 
Following histomorphometric analysis of the seminiferous tubules, there was a significant 
increase of seminiferous tubule diameter of STZ60 compared to control (p<0.05) representing 
121% of control and 117% of STZ30 [Table 2]. 
 
 
Table 2: Quantitative histological parameters of the testes 























Control 264.70±12.55 338.30±19.76 21.46±0.86 28.79±1.34 6.53±0.07 1.40±0.09 0.43±0.01 
STZ30 271.74±7.46 391.26±13.60 24.23±1.32 33.12±1.44 6.95±0.14 1.48±0.08 0.37±0.02 
STZ60 283.70±3.94 234.36±14.92@& 36.40±1.15@& 183.00±9.17@& 23.73±0.65@& 1.36±0.10 0.57±0.02@& 














Control 224.8±8.28 39987.0±2857.00 70.0±11.98 120.1±11.23 11763.0±2132.00 
STZ30 263.1±16.13 55480.0±6605.00 69.3±4.99 138.4±7.02 15613.0±1514.00 




Descriptive histological evaluation 
STZ60 presented with a significant decrease in the number of normal seminiferous tubules 
compared to control (p<0.001) representing 41% of control and STZ30 (p<0.05). STZ30 as well 
presented with a significant decrease in the number of normal seminiferous tubules 
compared to control (p<0.05) representing 21% of control. STZ60 presented with an increased 
number of atrophic tubules compared to control (p<0.001) and STZ30 (p<0.05) [Table 3].  
 
 










Control 94.6±0.92 3.0±1.483 1.8±1.11 0.6±0.60 
STZ30 75.2±3.49* 10.0±5.57 8.8±3.99 6.0±1.30 
STZ60 55.8±6.27@# 24.0±1.70@# 9.0±2.84 11.0±4.56 




Regarding the effect of STZ on male reproductive parameters, STZ60 showed a significant 
decrease in the number of motile spermatozoa compared to control (p<0.05) and also 
displayed a decrease in progressive motility compared to control [Table 4]. Additionally, 
STZ30 presented with a decrease in the number of motile spermatozoa and progressive 
motility compared to control [Table 4]. Thirty seconds post retrieval from the cauda 




and average path velocity (VAP) compared to control and STZ30 [Fig.2]. Additionally, STZ60 
displayed a decrease in oscillation index (WOB) compared to control [Fig. 3]. 
 
 






Control 85.17±7.40 47.79±9.56 
STZ30 78.88±3.62 35.79±10.84 








Figure 2 Sperm velocity parameters for the three groups. VCL= Curvilinear velocity; VSL= 





Figure 3: Sperm kinematic parameters for the three groups. LIN= Linearity index; STR= 











STZ30 and STZ60 exhibited a significant decrease in the number of morphologically normal 
spermatozoa compared to control (p<0.05 and p<0.001 respectively) [Fig. 4 & Fig. 5], while 




Figure 4: The percentage of spermatozoa displaying normal morphology. *p<0.05 vs. control; 
@p<0.001 vs. control, Normal sperm morphology ANOVA p=0.003 (n=3). Sperm is considered 






Figure 5: Stained rat sperm, automatically analysed for morphology. Each image on the left is 
of an actual stained spermatozoon and directly to the right is the subsequent SCA analysis 
with blue overlay showing the head and green overlay the midpiece. Figures a-d are of 
morphologically normal spermatozoa and Figure e-h are of morphologically abnormal 
spermatozoa. Morphology assessment is based on thresholding for head size, head shape 
(arc, width, area, perimeter, linearity, angle, roughness and chord), acrosome size, midpiece 






Figure 6 Sperm deformity index (SDI) for control, STZ30 and STZ60. Sperm deformity index 
measures sperm quality in terms of morphological appearance. *p<0.05 vs. control. Sperm 






STZ has been a known diabetes inducing agent since its discovery in 1963 (Rakieten et al., 
1963) and have been reported to be effective only when administered at concentrations of 
≥40mg/kg (Ganda et al., 1976; Katsumata and Katsumata, 1992). To further validate its 
experimental use, several authors have worked to annul the possible meddling effects of its 
components on male reproductive function (Navarro-Casado et al., 2010). In this study we 
investigated the effects of a lower STZ dose (30mg/kg) on male reproductive function and 
also compare these outcomes with the effects of a known effective STZ dose (60mg/kg). 
Observed was an increase in the intake of fluid and food, as well as the blood glucose levels 
of STZ30, though the elevated blood glucose remained within the normal physiological range 
(as opposed to STZ60 which reached pathophysiological levels) (Oliveira et al.,2015). 
However, there was an increase in body weight of these animals. The elucidated parameters 
are typical characteristics of pre-diabetes (Soewondo and Pramono, 2011), which concur with 
findings, from Rato et al. (2013) and Oliveira et al. (2015). In comparison, STZ60 displayed 
heightened fluid and food intake as well as elevated blood glucose levels. However, these 
animals presented with a decrease in body weight; all of which are pathophysiological 
characteristics of diabetes (Vikram et al., 2008; Navarro-Casado et al., 2010). The decreased 
body weight might be due to the inability to utilize the glucose derived from feeds as a result 
of the ablated pancreatic β-cells and subsequent lack of insulin signalling.  
The testes of STZ30 showed mild abnormal morphology of the seminiferous tubules 
characterized by the presence of immature and irregular accumulation of cells in the lumen. 
Furthermore, an increase in vascular structures was also observed. Likewise this was observed 




cell degeneration was also seldom observed. STZ60 however, presented with severe absence 
of spermatogenic phases as well as persistent cellular degeneration. Furthermore, STZ60 
tubules were greatly disorganized and germ cells were severely dissociated [Fig.7]. Absence 
of spermatogenic phases was also reported by Ricci et al. (2009) following STZ diabetes 
induction, who further reported that the abnormal localization or absence of Occludin in the 
tight junction of Sertoli-Sertoli cells observed in diabetes prevents the formation of the blood-
testis barrier, which is necessary for sustaining spermatogenesis (Lui et al., 2003; Ricci et al., 
2009; Wong et al., 2005). In the same vein, Hess and Nakai (2000) reported that the presence 
of seminiferous tubules with persistent atrophy could indicate infertility. Observed in STZ30 
is the reduced relative testicular weight and increased seminiferous tubules diameter which 
was consistent with increased epithelium width , small lumen, scattered or compressed germ 
cells, presence of vacuoles in the basal region of the tubule and absence of phases II &III of 
spermatogenesis. STZ60 however, exhibited a decrease in testicular weight which is in 
agreement with Ferah (2007) and several other authors that also reported reduction in 
testicular weights of diabetic rats treated with high doses of STZ (Anderson and Thliveris, 
1986, 1987). In addition, we observed the enlargement and increased number of STZ30 and 
STZ60 testicular blood vessels. This is consistent with the findings of Anderson and Thliveris 
(1986) and Amaral et al., (2006) who reported that diabetes is implicated with the increased 






Figure 7 Testicular Sections of Control, STZ30 and STZ60 Rats. Testicular sections with 
different magnification of control rats (a-c) shows normal spermatogenesis and normal cell 
arrangement, STZ30 (d-f), shows enlarged interstitial space (arrow e), increased number of 
blood vessels (d) and tubular disorganization (e, f) while testicular sections of animals treated 
with STZ (60mg/kg body weight) (g -i), presented with further seminiferous tubule 





Regarding the effect of a lower STZ dose on sperm parameters, our results showed a decrease 
in total sperm motility and reduced progressive motility. In comparison to a known effective 
dose, total sperm motility and progressive motility were more negatively affected. A known 
potent STZ dose (≥40mg/kg) has been suggested to adversely affect sperm motility (Mangoli 
et al., 2013; Vignera et al., 2012) due to various physiological alterations such as hormonal 
changes, oxidative stress enhancement and as well as neuropathy development, all caused 
by hyperglycaemia. Additionally, there was a decrease in sperm velocity and kinematic 
parameters of diabetic and prediabetic animals. Interestingly, in a recent study conducted by 
Ayad et al. (2017), sperm kinematic parameters were also reduced after a long ejaculatory 
abstinence period and that short ejaculatory abstinence period of 4hours was associated with 
a substantial increase in human sperm motility and velocity parameters. 
Also observed is the increase in abnormal sperm morphology of STZ30 spermatozoa and a 
more elevated abnormality of STZ60 sperm morphology. This result concurs with the findings 
reported by Murray et al. (1985) and Mangoli et al. (2013). Spermatozoa are known to 
undergo different phases of spermiogenesis (Golgi phase, Cap phase, Acrosome phase, and 
Maturation phase) for normal morphological structure development. However, we observed 
the absence of phases II and III of spermatogenesis in both STZ30 and STZ60, which indicate 
that some tubules did not even undergo spermiogenesis. This result suggests that the absence 
of these phases position the testicular morphological structures formation for abnormalities. 
Moreover, to our utmost knowledge this is the first study reporting the adverse effect of a 
relatively lower STZ dose (30mg/kg) on male reproductive parameters and that the observed 




seen may be associated to the incomplete ablation of the pancreatic β-cells, which might 
allow for partial functioning and secretion of insulin by these cells.  
 
Conclusion  
Based on this present study, we conclude that STZ administration of a lower dose (30mg/kg) 
adversely affects male reproductive parameters via its diabetogenic effect and can therefore 
be used to study the impact of pre-diabetes on male fertility and that damage is more 
prominent in a higher dose. We also recommend that future studies should focus on the 
reason for an increase in testicular blood vessels in diabetes and prediabetes. 
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This study was designed to investigate the possible mechanisms through which diabetes-
induced advanced glycation end products (AGEs) and receptor for AGEs (RAGE) activation can 
affect male reproductive function and to corroborate the interaction of previously established 
independent pathways. 
Male albino Wistar rats (14weeks old) weighing 250-300g received either a single 
intraperitoneal injection of streptozotocin (30mg/kg or 60mg/kg), regarded as STZ30 or STZ60 
respectively or citrate buffer (Control). DM was confirmed if plasma glucose levels were 
≥14mmol/L after one week. Animals were sacrificed after 8 weeks of treatment by an 
overdose of sodium pentobarbital (160mg/kg body weight). The testes and epididymides 
were harvested. The testis was used for biochemical and Western blot analysis, while sperm 
was retrieved from the epididymis and analysed with computer-aided sperm analysis (CASA).  
The blood glucose levels of STZ60 animals were above the cut-off point and hence will be 
regarded as diabetic animals. Diabetic animals presented with a non-significant increase in 
AGE and RAGE expression. Diabetic animals showed a significant increase in the expression 
of cleaved caspase 3 compared to control (p<0.001), which was accompanied by an increase 
in the expression of JNK (p<0.05), PARP (p=0.059) and p38MAPK (p=0.1). Diabetic animals also 
displayed decreased catalase activity accompanied by a non-significant increase in 
malondialdehyde (MDA) levels. Additionally, there was a significant decrease in the 
percentage of progressively motile spermatozoa (p<0.05) in diabetic animals.  
This study has shed some light on the interplay between DM, AGE, RAGE and mitogen-




sperm function and may further contribute to male infertility. However, more studies are 
needed to better understand this complicated process. 
 
Keywords: Advanced glycation end products, Apoptosis, Diabetes-Mellitus, Mitogen-







Diabetes mellitus (DM) is an embodiment of various metabolic pathologies. It represents one 
of the most appreciable health hazards as its prevalence has increased from 177 million to 
422 million in only 12 years (2002-2014). This further connotes a 60% increase (1,2). Infertility, 
a disease of the reproductive system has become an integral part of global health as it is 
estimated to affect 60-80 million couples of which 50% is directly attributed to a male factor 
(3,4). Studies have shown that DM affects male reproductive function adversely. Some of the 
reported effects include a decrease in sperm motility (5,6), alteration in sperm kinematic 
properties, increased abnormal sperm morphology (7,8), decreased seminiferous tubule 
diameter, increased spermatogenic disruption (9–11) and decreased number of Leydig and 
Sertoli cells (9,12).  
Baccetti et al. reported that the gonadotropins released in response to GnRH were lower in 
diabetic men. This was accompanied by a decrease in sperm motility and a higher percentage 
of sperm immaturity (13), which indicates that DM may affect male reproduction by 
interfering with the hypothalamic-pituitary-testicular axis. Additionally, Jiang et al. reported 
that streptozotocin (STZ)-induced diabetic rats displayed an increase in testicular tunnel 
positive cells, Bax/Bcl2 ratio and oxidative damage (14). In the same vein, Roessner et al. 
reported increased cleaved caspase 3 in the ejaculate of diabetic men (15). These findings 
show that DM may affect male reproduction via apoptotic signalling. Furthermore, DM has 
been shown to increase testicular oxidative damage, which occurs when reactive oxygen 
species (ROS) exceeds the seminal antioxidant defence ability (16). Thereby resulting in many 
cascades of reactions, which subsequently lead to sperm DNA damage, mitochondrial DNA 




production has also been implicated in the generation of advanced glycation end products 
(AGEs). AGEs are products of non-enzymatic reactions between sugars and the amino groups 
of proteins, lipids and DNA under hyperglycaemic conditions. AGEs can alter the normal 
functioning of macromolecules by generating ROS independently, or by activating the 
receptors for advanced glycated end products (RAGE), which leads to a further increase in 
ROS production by these mutated proteins. RAGE is a multi-ligand member of the 
immunoglobulin family, which interact with specific ligands. Binding of RAGE to its ligands 
leads specifically to altered gene expression. 
The role of AGE-RAGE activation in the induction of apoptosis has been widely evaluated. 
Many of these studies were performed on various cell types such as neuronal and endothelial 
cells (18,19), as well as periodontal ligament fibroblasts(20). Additionally, the binding of AGE-
RAGE could trigger mitogen-activated protein kinase (MAPK) signalling and the nuclear factor 
kappa B (NF-κB) pathway, thereby leading to elevated production of ROS and upregulation of 
intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and 
monocyte chemoattractant protein-1 (MCP-1) (21). Interestingly, AGEs have been suggested 
to play a role in instigating harm as they are known to produce ROS and subsequently cause 
OS, of which sperm has high susceptibility to the excessive production of ROS. It is believed 
that AGEs may act as a mediator of damage to the reproductive system of diabetic men (22). 
Although there are substantial data available on the effects of DM on sperm function, the 
mechanism through which the effects are exerted is less clearly understood. The present 
study, therefore, aimed to investigate the possibility of AGE-RAGE pathway activation in DM 
related sperm function impairment and to furthermore corroborate the interaction of 




Materials and Methods 
Animals  
Male albino Wistar rats (14weeks old) weighing 250-300g were used in this study. Animals 
were individually housed in standard cages in the Stellenbosch University Animal Unit. Both 
room temperature (23°C±2°C) and light (12 hours light/12 hours dark) were controlled. Ethical 
approval was obtained from the Stellenbosch University Animal Ethics Committee (SU-
ACUD16-00101). Rats were treated according to the recommendations of the Laboratory 
Animal Care of the National Society of Medical Research and the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals (23). Animals were acclimatized for one 
week before treatment commenced and had free access to food (standard Epol™ rat chow, 
Nutritionhub (PTY) LTD, South Africa) and water. 
 
Study Design 
Thirty rats were randomly divided into three groups (n=10), namely, a control group and two 
treatment groups (receiving STZ). STZ (S0130-IG) was obtained from Sigma (South Africa), and 
a stock solution (30mg/ml) was prepared by dissolving it in freshly prepared sodium citrate 
buffer (pH 4.5). Animals were treated with a single intraperitoneal injection of STZ, either 
30mg/kg body weight (STZ30) or 60mg/kg body weight (STZ60), while the control group were 
treated with an equivalent volume (0.5ml) of citrate buffer. The successful induction of 
diabetes was confirmed after one week in animals presenting with a non-fasting blood 
glucose level of ≥14mmol/L, using a Glucoplus™ glucometer. Glucose levels were monitored 




used for the weekly glucose level measurement was collected by pricking the tail vein of the 
restrained animal. Blood glucose levels are the mean of consecutive measurements. 
Experimental Procedures 
After 8 weeks of treatment, animals were sacrificed by administering an overdose of sodium 
pentobarbital (160mg/kg body weight). The testes and epididymides were harvested, 
weighed and rinsed. The left testis was frozen at -80°C until further analysis. 
 
Sperm Motility 
The harvested left epididymis was placed in a Petri dish containing a 2ml solution of Hams F-
12 nutrient media (Sigma Chemicals, St Louis, MO, USA), at 37°C. The mature spermatozoa 
were retrieved into a separate dish containing 2ml Hams by dissecting the caudal area of the 
epididymis and allowing sperm to swim out for 30 seconds. The retrieved spermatozoa (2µl) 
was infused into a chamber slide (20µm, Leja, Netherlands) and placed on a microscope 
(Nikon Eclipse E200) with an in-built heating stage (37°C). Sperm motility was measured via 
computer-aided sperm analysis (CASA) using the Sperm Class Analyser (SCA, Microptic, 






Oxidative Stress Parameters 
Catalase  
Frozen testicular tissue samples were pulverized in liquid nitrogen to prevent thawing and 
prevent enzymatic reactions from taking place. An equal amount (0.05g) of each sample was 
placed in an Eppendorf tube containing 50mg of homogenization beads and 100µl of cold lysis 
buffer (Na3PO4, 0.5% Triton X-100). Samples were homogenized by bullet blending at speed 
9 for 3 minutes with a 1-minute interval in-between. After bullet blending, an additional 400µl 
of lysis buffer was added to allow for total tissue breakdown. Homogenates were centrifuged 
at 15000rpm for 20 minutes at 4°C. The supernatants were transferred to different Eppendorf 
tubes and kept on ice. Tissue homogenates were diluted to 10x in deionized water and 
Bicinchoninic Acid (BCA) assay was used to determine the protein concentration. From the 
diluted samples and standards, 5μl were loaded in triplicate into UV microplate wells. 
Catalase assay buffer (170μl) were added into each well using a multichannel pipette. Finally, 
50μL of H2O2 was added into the wells and analysis was performed immediately on a plate 
reader (Multiskan spectrum) at 240nm every 60 seconds over a 5-minute period using SkanIt 
RE for MSS 2.2 (ThermoScientific™ Inc.) software.  
 
Lipid Peroxidation (Thiobarbituric acid reactive substances (TBARS/MDA) 
Frozen testicular tissue samples were pulverized in liquid nitrogen and 0.05g of each sample 
were placed in an Eppendorf tube containing 0.05g of homogenization beads and 0.5ml of 
cold lysis buffer (0.1M KPi, 1.15% KCl). Samples were homogenized by bullet blending at speed 




analysis (BCA and TBARS assays). In order to measure the MDA levels, 100µl of standards and 
samples were pipetted into corresponding 10ml glass tubes. Subsequently, 1ml of SDS and 
2ml of 10%TCA-BHT buffer solution was added. Samples were vortexed, and after resting for 
10 minutes, 2ml of thiobarbituric acid (TBA) was added and vortexed again. The standards 
and samples were covered with marbles and incubated in a water bath (1 hour at 100⁰C), 
where after it was cooled on ice for 15 minutes. The standards and samples were centrifuged 
(3000rpm, 15 minutes 4°C) and the supernatants retrieved. From the supernatants, 250μl of 
each standard and sample were loaded in triplicate into microplate wells and analysed on a 
plate reader (Multiskan spectrum) within 30 minutes after centrifugation at a wavelength of 
532nm.  
 
Western Blot Analysis  
To determine the quantity of proteins in a sample through the Bradford method 0.05-0.07g 
of tissue were pulverized and placed into 700µl lysis buffer. Seven stainless homogenization 
beads (1.6mm, Next Advance Inc., USA) were added into each tube to allow for complete 
homogenization (25,26). The pulverized tissue was bullet blended at speed 8 for 3 minutes at 
5 minutes interval in-between. The homogenates were centrifuged for 20 minutes 
(15000rpm, 4°C) and the supernatants were removed for further analysis. Tissue lysates were 
prepared by diluting the sample in Laemmli sample buffer and lysis buffer, boiled for 5 
minutes and 50ug protein/µl was separated by electrophoresis on a 12% SDS-PAGE mini-
proteon gel. The running protocol consisted of an initial 10 minutes electrophoresis at 100V 
and 200mA followed by 40 minutes at 200V and 200mA. Gels were activated using ChemiDoc 




membrane (0.45µm) (Immobilon®-P, Merck Millipore Ltd, Germany). Non-specific sites were 
blocked with 5% fat-free milk in TBS-tween.  
AGE was measured using Anti-AGE antibody (ab23722; Abcam, SA) and the expression of 
RAGE was quantified using anti-RAGE antibody (ab361; Abcam, SA). The apoptotic markers 
measured are Caspase 3 (Sigma-Aldrich), Caspase 7 (Abcam, SA), PARP (Cell Signalling 
Technology), p38MAPK (Cell Signalling Technology), C-Jun-N-terminal kinase (JNK) (Cell 
Signalling Technology) and IkBα (Cell Signalling Technology). A goat anti-mouse/rabbit-
horseradish peroxidase-conjugated antibody (Sigma-Aldrich) was used as the secondary 
antibody. Proteins were detected and visualized using a ChemiDoc (BioRad, USA) and were 
further normalized (Stain-free blots as housekeeping proteins) and analysed with ImageLab 
5.0 (ImageLab software, USA). All primary antibodies were diluted in TBS-Tween in a 1:1000 
ratio while the secondary antibody was diluted in TBS-Tween in a 1:4000 ratio. All data points 
are from independent biological repeats (n=4-5).  
Statistical Analysis 
GraphPad Prism™ software (GraphPad™ Software, Version 8.1.2(332), San Diego, CA, USA) 
was used for statistical analysis. Normal data distribution was measured using the Shapiro-
Wilk, Anderson-Darling, Kolmogorov-Smirnov and D'Agostino & Pearson, normality tests. 
When data passed all normality tests, a one-way ANOVA of variance with a Tukey’s Post-hoc 
Test were performed. Where data was not evenly distributed, a Kruskal-Wallis test and a 
Dunns Post-hoc Test were carried out. A probability level of p< 0.05 was considered 






Basic Biological Parameters  
After 8 weeks of treatment, STZ60 animals lost a significant amount of body weight compared 
to both control and STZ30 (p<0.0001) [Table 1]. Additionally, STZ60 animals presented with a 
significant increase in blood glucose levels compared to both control and STZ30 (p<0.0001) 
(n=8) [Table 1 and Figure 1]. 
 
 
Table 1: Basic biological parameters 
*p<0.05 vs. control; $ p<0.0001 vs. control; & p<0.0001 vs. STZ30. Blood glucose levels is the 
mean of consecutive measurements from induction to termination. 
  
Parameters Control STZ30 STZ60 Global p-value 
Start body weight 
(g) 
272.1±7.076 277.2±4.599 283.0±3.692 0.3 
End body weight 
(g) 
340.7±10.09 377.9±8.777* 252.3±11.80$& <0.0001 
Difference in body 
weight (g) 
86.4±19.32 100.8±7.95 -27.6±11.39*& <0.0001 
Glucose level 
(mml/L) 






Figure 1: Non-fasting blood glucose levels of experimental animals as monitored during the 






























STZ60 animals displayed a significant decrease in the percentages of motile and progressively 
motile spermatozoa compared to the control group (p<0.05) (n=8) [Figure 2 A-B; 
supplementary figure (SF) 1]. Although there was a decrease in the progressive motility as 
well as total motility of STZ30 animals compared to control, the reduction was not statistically 
significant. Additionally, there was a substantial, but non-significant decrease in the sperm kinematic 
parameters [Table 2] of STZ60 animals compared to both the control and STZ30 groups respectively, 
(Curvilinear velocity (VCL): -30%, -30%; Straight-line velocity (VSL): -21%, -17%; Average path velocity 
(VAP): -18%, -9%). The kinematic parameters of STZ30 animals, despite all six being lower, remained 









Figure 2: The effect of STZ induction on sperm motility. A. percentage of total motility; B. 
percentage of progressive motility. *p<0.05 vs control. Global p for progressive motility is 





















Control 179.0±54.19 83.29±26.02 50.69±18.29 57.37±5.192 28.65±5.113 46.62±6.127 
STZ30 178.2±86.85 79.73±31.36 45.56±18.83 52.46±10.23 25.09±7.736 44.58±10.15 
STZ60 124.6±49.91 65.81±12.74 41.53±9.435 56.30±7.103 28.24±5.816 45.59±5.362 
Curvilinear speed (VCL), Average path velocity (VAP), Straight Line velocity (VSL), Straight 
line index (STR), Linearity index (LIN), and Oscillation index (WOB). 
 
 
Oxidative Stress Parameters 
STZ60 animals presented with a non-significant decrease (-65%) of catalase activity compared 
to the control group, while STZ30 animals displayed a 57.7% reduction of catalase activity 
compared to control (p=0.14) (n=8). This was accompanied by a 96.6% increase in MDA levels 
in the STZ60 animals and 10% increase in the STZ30 group compared to controls (p=0.18) 

















Figure 3: The effect of STZ induction on oxidative stress parameters. A. the effect of STZ 
induction on catalase activity; B. the effect of STZ induction on MDA levels. The global p for 
catalase activity p=0.13, global p for MDA p=0.18. 
 
AGE Accumulation and RAGE Expression 
Four different isoforms of AGE proteins were observed, with STZ60 animals showing a non-significant 
increase in accumulation of each AGE isoform except for the 70kDa protein compared to control 
[Figure 4 A-F; SF3]. Additionally, STZ60 animals displayed a non-significant increase in the total 
accumulation of AGE isoforms (6.4%) compared to control and STZ30 presented a 2.2% increase 




































Figure 4: The effect of STZ induction on advanced glycation end products accumulation. 
Four different isoforms of AGE proteins were observed A=70kDa, B=43kDa, C=25kDa, 
D=17kDa, E=Radar plot showing relative distribution of total and individual AGE isomers as a 





























In the same vein, four different isoforms of RAGE proteins were observed. The testicular 
tissue of STZ60 animals showed a 21.7% (p=0.054) increase in the expression of RAGE (65kDa) 
compared to control and a significant increase compared to STZ30 (p<0.05). The total 
combined expression of the four RAGE isoforms was 11.7% higher than that of the control 
group, while STZ30 animals presented with 1.2% non-significant increase compared to the 




























Figure 5: The effect of STZ induction on receptor for advanced glycation end products 
accumulation. Four different isoforms of RAGE proteins were observed A=65kDa, B=50kDa, 
C=43kDa, D=37kDa, E= Radar plot showing relative distribution of total and individual RAGE 
isomers as a ratio of their respective controls; F=Blot (probed). *p<0.05 vs. STZ30. The global 


























STZ60 animals exhibited a highly significant increase in the expression of cleaved caspase 3 
compared to both control (p<0.001) and STZ30 (p<0.001). Additionally, there was a 30% 
increase in the total expression of caspase 7 of STZ60 animals compared to control and a 20% 
increase in STZ30 group compared to the control group (p=0.056). Although not significant, 
both of the STZ groups showed increased PARP cleavage compared to the control (p=0.059) 
[Figure 6 A-F; SF5].  
Also observed was a non-significant gradual increase in p38MAPK expression relative to the 
increase in STZ concentration administered (p=0.2). STZ60 animals further presented with a 
significant increase in the expression of JNK 46kDa (p<0.05) compared to the control group. 
A non-significant increase in JNK55kDa was also observed compared to control (25.6%) and 



































Figure 6: The effect of STZ induction on apoptosis activation. A=Cleaved Caspase 3; B=Caspase 
7; C= PARP D=Blot for caspase 3 (probed); E= Blot for caspase 7 (probed) F=Blot for PARP 
(probed). @p<0.001 vs. control; #p<0.001 vs. STZ30. The global p for cleaved caspase 3 





































Figure 7: The effect of STZ induction on and the MAPKs signalling. A=p38MAPK; B=JNK46kDa; 
C=JNK55kDa; D=Blot for p38MAPK; E=Blot for JNK, F=Radar plot for all measured apoptotic 


























Figure 8. The proposed mechanisms through which diabetes may affect male reproductive 
function. 
↓=decrease, ↑=increase. In DM, there is altered antioxidant enzyme activity (↓Catalase) 
which may result in OS. The development of OS can on one arm instigate the breakdown of 
poly unsaturated fatty acids (MDA) and also indirectly increase AGE formation. The 
peroxidation of PUFA attracts more ROS formation which can activate apoptotic induction, 
resulting in impaired sperm function. Due to the presence of RAGE ligand, AGE, binding 
occurs. The AGE-RAGE complex initiates the activation of the MAPKs which may induce 
apoptosis by increasing the cleavage of PARP, hence resulting in nDNA damage. All these 






Diabetes has been shown to affect male reproductive function by altering hormone regulation 
and increasing OS, thereby causing testicular dysfunction and altering spermatogenesis 
(10,27,28). These effects subsequently result in decreased total and progressively motile 
spermatozoa and reduced normal sperm morphology (11,17,29). However, the pathway(s) 
through which the effects are exerted is little understood. Hence, the current study was 
performed, in order to investigate the possibility of alternative pathways through which DM 
could affect sperm function.  
In the current study, STZ60 animals presented with significantly elevated blood glucose levels 
to far above the normal reference range, accompanied by a substantial loss in body weight. 
These are typical features of type 1 DM. STZ30 animals, on the other hand, presented with 
only a 6.4% non-significant increase in blood glucose, which remained within the normal 
physiological range. Interestingly, these animals furthermore displayed a significant increase 
in body weight. The increase in glucose levels and decreased body weight observed in STZ60 
animals might be explained by the inability to utilize the glucose derived from the food as a 
consequence of the ablated pancreatic β-cells and subsequent lack of insulin signalling. 
Hence, the STZ60 group could be regarded as a typical type 1 DM model (Singh et al., 2009; 
Vikram et al., 2008). 
Diabetic animals from the current study presented with a decrease in the percentage of total 
and progressively motile spermatozoa. This concurs with Bhattacharya et al. who reported 
decreased sperm motility parameters in diabetic men (Bhattacharya et al., 2014) and as well 
supported by Singh et al. who showed impaired sperm motility in STZ induced diabetic rats 




MDA levels. This is in agreement with the findings of Adaramoye and Lawal, who similarly 
reported increased lipid peroxidation and decrease in the activities of catalase, SOD and GPx 
in diabetic rats (33). Hyperglycaemia has been reported to cause increased OS in various 
tissues (34), including testicular tissue (35) and spermatozoa (36). This is evidenced by 
another study that reported elevated MDA levels, lipid hydroperoxides and lipid peroxides in 
the plasma of type 1 diabetic patients (37). In the diabetic state, lipid peroxidation can be 
induced by protein glycation and glucose auto-oxidation that can further lead to the 
formation of free radicals (38). The damage that these free radicals impose on cells may be 
quantitatively determined by measuring MDA levels which is a product of lipid peroxidation 
(39). The increase in lipid peroxidation may be as a result of the imbalance between the 
oxidant and antioxidant activities. This is supported by Buttke and Sandstrom who reported 
that under an elevated OS status, ROS cause cellular injury via several mechanisms including 
lipid peroxidation and oxidative damage of proteins and DNA (40). These findings are backed 
up by other studies which also reported a relationship between ROS and DNA damage (41,42)  
Furthermore, an increase in the production of ROS has been shown to cause the non-
enzymatic and progressive glycation of proteins with the consequently increased formation 
of glucose-derived AGEs. The modified proteins further cause an increase in ROS formation 
and aggravation of OS (43,44) after binding to the ligand-receptor, RAGE. 
AGE-RAGE activation has been implicated in the development and progression of several 
diseases, both metabolic and non-metabolic. This is evidenced by Chen et al. who showed 
that the excessive production of oxidants in the endothelial progenitor cells (EPCs) resulted 
in RAGE-mediated AGE accumulation with resultant inhibition of cell proliferation, migration 




of RAGE aided the protective effect of glucagon-like peptide-1 on AGE-induced apoptotic 
neuronal cells (45). Observed in the current study is an increase in the expression of RAGE in 
the testis of diabetic animals. This result concurs with Mallidis et al. who reported increased 
RAGE, not only in the testis but also in the epididymis, sperm and seminal plasma of diabetic 
men. This study further reported that the increased RAGE expression contributed to the 
elevated levels of damaged nDNA observed in the spermatozoa (46). 
An association has been reported between AGE-RAGE activation and MAPKs signalling (47–
49). MAPKs are activated in response to external stimuli. Upon external stimulation, mitogen-
activated protein kinase kinase kinase (MAPKKK) is phosphorylated thereby activating two 
different subgroups of mitogen-activated protein kinase kinase (MAPKK) (MKK3/MKK6 and 
MKK4). These dual kinases phosphorylate and activate p38MAPK and JNK (50). P38MAPK and 
JNK have been implicated in the development and progression of human diseases. Adhikary 
et al. described the accumulation of p38MAPK in the interstitial macrophages and 
myofibroblasts in the kidneys of both diabetic male mice and human. It is associated with 
increased HbA1c levels, albuminuria and ultimately lead to interstitial fibrosis (51). 
Additionally, p38MAPK and JNK accumulation have been associated with apoptosis (52,53). 
Another study reported the activation of p38MAPK followed by stimulation of cytochrome C 
release, Caspase 8 and 3 activation, PARP cleavage and DNA fragmentation in induced 
apoptosis of human promyelocytic leukaemia HL‐60 cells. The apoptotic events were 
repressed when p38 was blocked, which suggest that p38 phosphorylation occurred prior to 
caspase activation (54). It was also showed that p38MAPk is an instigator of Bcl2-x (Bax) 
activation and mitochondrial apoptosis in primary keratinocytes (55). In the current study, we 
investigated if diabetes can affect male reproductive function through the p38MAPK-




and Caspase 3 and an increasing trend in p38MAPK, Caspase 7 and PARP cleavage in the testis 
of diabetic rats. The activation of p38 has been described to phosphorylate, activate and 
translocate Bcl2, Bax and Bcl-xl. The translocation causes a change in the mitochondrial 
membrane potential and thus lead to cytochrome C release which further activates the 
cleavage of pro-apoptotic caspases. Additionally, JNK has been shown to induce apoptosis 
through FASL signalling. Increase in JNK expression stimulates FAS/FASL and subsequent 
phosphorylation of Bid (a Bcl-2 family) and the release of cytochrome C or it recruits caspase 
8 through adaptor protein FAAD and thus cleaves caspase 3. Jiang et al. reported activation 
of the apoptotic pathway, as evidenced by increased expression of cleaved caspase 3 and 
caspase 8 and subsequently altered spermatogenesis (14). Additionally, Metzler et al 
reported that spermatocyte loss in AZFc-deleted patients occurs through apoptotic pathway 
activation (56). Furthermore, a significant association was found between caspase 3 
activation and increased sperm DNA fragmentation (57). In corroboration with previous 
studies, the current study suggests a possible pathway and association between DM and male 
infertility, as explained in Figure 8. 
The current study highlighted the possible inter-connected mechanism through which 
diabetes may confer its impact on the male reproductive function, which may further 
contribute to male infertility (Figure 8). We, therefore, conclude that there is an association 
between AGE-RAGE activation and MAPKs signalling. The increase in the expression of JNK 
and Caspase 3 and the non-significant increase in the expression of p38MAPK, Caspase 7 and 
PARP cleavage in the testis of diabetic rats reveals a deadly liaison, which can result in altered 
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The current study was designed to investigate whether treatment with rooibos, honeybush 
and sutherlandia will impact sperm functional parameters positively or otherwise, in 
healthy rats. 
Fourteen week old pathogen-free adult male Wistar rats (25-300g) were randomly divided 
into four groups of ten, including a control group (receiving tap water), rooibos group (RF, 
receiving 2% fermented rooibos), honeybush (HB, receiving 4% fermented honeybush) and 
a sutherlandia group (SL, receiving 0.2% unfemented sutherlandia). Animals were 
sacrificed, the testes and the epididymides were harvested and weighed. Spermatozoa 
were retrieved from the cauda epididymis for motility, morphology and concentration 
analysis and the testis was used for all biochemical assays. 
The infusion treated animals (RF, HB, and SL) presented with a non-significant decrease of 
(-14.3%, -18.2%, -17.2%) (-24.8%, -20.7%, -27.3%) in total motility and progressive motility 
when compared to the control group respectively. There was a significant increase in the 
number of spermatozoa with slow speed (P=0.03), especially SL treated group compared 
to the control (P=0.03). There was a percentage reduction in the sperm kinematic 
parameters of the infusion treated animals. However, they (RF, HB, SL) showed an increase 
of 2.3%, 14.3%, 19.7% in sperm concentration compared to the control. Additionally, there 
was an increase of 28.8%, 31.7%, 23% in SOD activity of RF, HB and SL compared to control. 
This was accompanied with a percentage decrease of -21.1%, -23.7%, 45.9% in MDA levels 
compared to the control group.  
Animals treated with the respective infusions presented with a percentage increase in SOD 




they presented with increased sperm concentration. Hence, it is concluded that rooibos, 
honeybush and sutherlandia may enhance sperm concentration which represent the 
sperm quantity, but, they may impair sperm motility and morphology (sperm quality) when 
consumed by healthy animals. 
 






The use of medicinal plants in treating diseases have been used over many decades in 
traditional medicine. It is interesting to know that the world is becoming more intrigued in 
exploring the benefits of phytochemicals and to also investigate their importance in health. 
Rooibos, honeybush and sutherlandia are indigenous Southern Africa plants, and they 
are caffeine-free beverages. Rooibos originate from the Cederberg Mountains of the 
Western Cape region of South Africa (Joubert et al., 2008; McGaw et al., 2007). The leaves 
and stems are used for the commercially available rooibos tea. Rooibos is generally 
available either as the unfermented (green rooibos) or the fermented (reddish-brown 
rooibos) form. The fermented tea is achieved by oxidation that result in the unique 
reddish-brown leaf colour with woody-fynbos-floral honey flavour (Koch et al., 2012). 
Whether unfermented or fermented rooibos, studies have shown the presence of 
numerous bioactive chemical compounds, which include nothofagin, aspalathin, C-5-
hexosyl derivative of aspalathin, aspalalinin, phenypyruvic acid-2-0-glucoside, orientin, 
isoorientin, vitexin, isovitexin, luteolin, luteolin-7-0-glucoside, chyrysoerio, and many more 
(Beelders et al., 2012). Due to the presence of aspalathin and other phytochemical 
contents, hot water extracts prepared from green and fermented rooibos are used as food 
and/or cosmetic ingredients. Although the aspalathin content of unfermented rooibos is 
greater (8%) than the fermented (2%), the latter is still more preferable in food because of 
the flavour, and it is considered more economical as there is greater demand for it (de Beer 
et al., 2017; Joubert and de Beer, 2012). Studies have elucidated the role of rooibos in 
protecting against disease development (Lawal et al., 2019) and also the ameliorative 




al. suggested that the long-term continuous consumption of fermented rooibos tea confer 
a mild neuroprotection against ischaemic brain injury in rats. This was evidenced by the 
decrease in brain oedema, neuronal apoptosis, decreased lipid peroxidation and increase 
total antioxidant capacity, which cumulatively improved neuro-behavioural outcomes in 
rats (Akinrinmade et al., 2017). Nash et al. reported that osteoblast (Saos2 cells) treated 
with luteolin and orientin (from rooibos) displayed elevated alkaline phosphatase and 
mitochondrial activities. This was associated with reduced toxicity and decreased 
expression of anti-inflammatory cytokines, which collectively suggest that these rooibos 
metabolites improved osteoblast mineral content (Nash et al., 2015). Other studies have 
reported its antioxidant (Hong et al., 2014), anti-diabetic (Dludla et al., 2018; Layman et 
al., 2019; Orlando et al., 2019; Son et al., 2013) and anti-inflammatory (Pyrzanowska et al., 
2019) properties.  
Honeybush is native to the Southeast and Southwest coastal areas of South Africa and 
it forms a part of the fynbos biome with the family name Fabaceae. It has been shown to 
be used as a traditional tea since the 19th century (Joubert et al., 2011; Schloms and Swart, 
2014). Honeybush tea does not only have a pleasant taste and scent, it also contains 
phytochemicals and volatile organic compounds that are beneficial to health (Joubert et 
al., 2008). The known health benefits of honeybush are ascribed to its rich bioactive 
compounds such as Eriodictyol, Hesperetin, Isokuranetin, Naringenin, Chrysoeriol, 
Luteolin, Kaempferol, Afrormosin, Calycosin, Formononetin, Fujikinetin, Pseudobaptigen, 
Wistin, Flemichapparin, Medicagol, Sophoracoumestan, Pinitol, Isomangiferin and 
Mangiferin (Diane L. McKay and Jeffrey B. Blumberg, 2007; Kamara et al., 2007).  




in patients with crow’s feet wrinkles after daily supplementation during their randomized 
double-blinded controlled trial (Choi et al., 2018). The anti-wrinkle effect of honeybush has 
been reported in animals (Im et al., 2014) and in vitro studies (Magcwebeba et al., 2016). 
Furthermore, studies have also shown its antioxidant (Marnewick et al., 2003; Sánchez et 
al., 2000), anti-mutagenic (Kokotkiewicz and Luczkiewicz, 2009) and mucosa immune 
therapy (Murakami et al., 2018) effects in both in vivo and in vitro studies. 
Sutherlandia has been used in traditional medicine since the 1800s. Sutherlandia has 
a variety of health benefits which are associated to its bioactive phytochemicals. The 
chemical compounds include, asparagine, proline and arginine (Moshe et al., 1998; van 
Wyk and Albrecht, 2008), ƴ-aminobutyric acid (GABA), L-carvanine, (Ortega, 2003), 
sutherlandin A, sutherlandin B, sutherlandin C, and sutherlandin D) (Avula et al., 2010), 
sutherlandioside A, sutherlandioside B, sutherlandioside C, sutherlandioside D (Avula et 
al., 2010) and cycloartane-type triterpene glycoside (van Wyk and Albrecht, 2008). Based 
on the array of pharmacological products present in sutherlandia, studies have highlighted 
its role in cancer (Grandi et al., 2005; Tai et al., 2004), Human immunodeficiency 
virus/acquired immunodeficiency syndrome (HIV/AIDS) (Harnett et al., 2005; Mills et al., 
2005; Wilson et al., 2015), diabetes (Chadwick et al., 2007; J. et al., 2012; Sia, 2004), 
inflammation (Lei et al., 2015; Vasaikar et al., 2018) stress (Chuang et al., 2015; Sergeant 
et al., 2017) and oxidative stress (Fernandes et al., 2004; Tobwala et al., 2014).  
With regards to the effects of these infusions on male reproduction, very few studies 
are available. This include a study that reported improvement in sperm motility, sperm 
concentration and sperm viability after treatment with rooibos in rats (Opuwari and 




semen with rooibos protected the sperm acrosome structure, which was accompanied by 
improved sperm velocity (Ros-Santaella and Pintus, 2017). Additionally, Awoniyi et al. 
suggested that rooibos may provide a measure of protection against induced oxidative 
damage by elevating antioxidant activities and thus improve sperm function (Awoniyi et 
al., 2012).  
However, to the best of our knowledge, there are no studies reporting the effect of 
honeybush or sutherlandia on male reproduction. Despite the numerous health benefits 
of these infusions, there are concerns as to their safety in long-term use (Fantoukh et al., 
2019). Opuwari and Monsees reported that lengthened exposure to rooibos induced 
acrosome reaction in rats, which can subsequently lead to impaired reproduction (Opuwari 
and Monsees, 2014). Additionally, the toxicity of canavanine (from sutherlandia) has been 
implicated in lupus erythematosus syndrome. Long-term exposure to sutherlandia have 
likewise been reported to cause protein cross-links and it can as well result in 
autoimmunity and teratogenicity. Ngcobo et al. showed that the in vitro chronic treatment 
of normal T-lymphocyte cells with sutherlandia was toxic (Ngcobo et al., 2012), which 
means too much of sutherlandia may be bad. Therefore, the current study was designed 
to investigate whether treatment with rooibos, honeybush and sutherlandia will impact 





Materials and methods 
Animal care 
Fourteen week old healthy pathogen-free adult male Wistar rats (250-300g) were 
housed at the Stellenbosch University’s Faculty of Medicine and Health Sciences’ Animal 
Unit at room temperature (18-23°C), under a normal 12:12 light/dark cycle. Animals were 
caged individually, had free access to food (standard raw chow) and water/infusions and 
were treated according to the recommendations of the Laboratory Animal Care of the 
National Society of Medical Research and the National Institutes of Health Guide for the 
Care and Use of Laboratory Animals (Committee for the Update of the Guide for the Care 
and Use of Laboratory Animals; National Research Council, 2010). Ethics approval was 
obtained from the Stellenbosch University Animal Ethics Committee (SU-ACUD17-00016). 
 
Infusion preparation  
Fermented rooibos (2%, Carmien SA PTY LTD, South Africa), fermented honeybush 
(4%, Afrinaturals, South Africa) and unfermented sutherlandia (0.2%, Afrinaturals, South 
Africa) were prepared according to standard protocols. Preparation procedure conformed to 
the experimental established protocols for rooibos (Marnewick et al., 2011), honeybush (Toit 
And Joubert, 1999) and sutherlandia (Tobwala et al., 2014). In brief, 2% rooibos was prepared 
by adding 20g of dried fermented rooibos in 1litre of boiling water and allowed to steep/rest 
for 30-45 minutes. The mixture was filtered three times using a cheesecloth, number 4 filter 
paper and number 1 filter paper (WhatmanTM, Buckinghamshire, UK) respectively. Filtered 




(4%; 40g in 1L) was prepared following the similar steps as used for making rooibos tea. 
However, due to the bitter taste of sutherlandia, the concentration was reduced to 0.2%. 
Briefly, 40g of unfermented sutherlandia was prepared as described for rooibos, from the 
initial 4% solution, 2.5ml was diluted in 50ml of water to give the working concentration of 
0.2%. 
All infusions (rooibos, honeybush and sutherlandia) were prepared every other day 
(48 hours). The herbal teas serve as the only drinking fluid for these infusion groups. The fluid 
intake of the animals was measured three times a week. 
Experimental design 
Forty animals were randomly divided into four groups of ten. The groups include a 
control group, which received tap water, rooibos group (RF) (2% fermented), honeybush 
(HB) (4% fermented) and a sutherlandia group (SL) (0.2% unfermented). Animals were 
sacrificed after 7 weeks of treatment. Blood, testes and epididymides were harvested. 
Blood was collected into a heparized tube, placed on ice for 30 minutes and afterwards 
centrifuged (3000rpm at 4°C for 30 minutes). Plasma was stored at -80°C until further 
analysis. The testis was used for all biochemical analysis, while the caudal area of the 
epididymis was dissected for sperm retrieval. Relative testicular/epididymal weight were 





Sperm functional parameters  
Motility  
Sperm retrieval and motility analysis were carried out as described by (Omolaoye et 
al., 2018). Briefly, the left epididymis was rinsed in a petri dish containing 2ml Hams F-12 
nutrient media (Sigma Chemicals, St Louis, MO, USA) at 37°C. The caudal area of the rinsed 
epididymis was dissected and spermatozoa were retrieved into a separate 2ml Hams, at 
37°C. After 30 seconds of retrieval, 2µl of the sperm solution was infused into a 20µl depth 
chamber slide (Leja, Netherlands) and placed on a Nikon Eclipse E200 microscope with an 
in-built heating stage (37°C). Sperm motility was measured via computer-aided sperm 
analysis (CASA) using the Sperm Class Analyser (SCA 6.3, Microptic, Barcelona, Spain). Total 
motility, progressive motility and the sperm kinematic parameters (curvilinear velocity 
(VCL), average path velocity (VAP), straight-line velocity (VSL), straight-line index (STR), 
linearity index (LIN), sperm oscillation index (WOB), amplitude lateral head (ALH) and beat 
frequency (BCF) were analysed. After analysing sperm motility at 30 sec, sperm 
concentration was measured by dissecting the caudal epididymis into smaller pieces and 
was left for a further 5 minutes allowing a maximum number of spermatozoa to swim out. 
The pieces were removed after 5 minutes and the sperm solution was mixed 
homogenously. Of the 2ml solution, 10µl was diluted in 50µl of Hams and sperm 
concentration was analysed through CASA.  
 
Morphology  
From the sperm solution used for sperm concentration analysis, 10µl was smeared on 




and stain (Microptic SL, Barcelona, Spain) for 3 minutes, rinsed for 3 seconds to remove 
excessive stain, air dried and then mounted (DPX, HiMedia Laboratories Pvt.Ltd., Mumbai, 
India). Sperm morphology was analysed through computer-aided sperm morphometry 
analysis (CASMA) using the SCA® (Maree et al., 2010) 
 
Testosterone and Estradiol 
The plasma concentration of testosterone (E-EL-0072) and estradiol (E-EL-0065) were 
measured using a commercially available ELISA kit (Elabscience Biotechnology, Hubei) as 
per manufacturer’s instructions.  
 
Biochemical analysis 
Superoxide dismutase activity 
Testicular tissue samples were homogenized in lysis buffer (Na3PO4, 0.5% Triton X-
100) and centrifuged at 15000rpm for 20 minutes at 4°C. Tissue homogenates were diluted 
to 10x in deionized water. From the diluted standards and samples, 10μl were dispensed 
into the microplate wells in triplicate, followed by adding 170μl of 
diethylenetriaminepentaacetic acid (DETAPAC) and 5µl of SOD assay buffer (50mM Na/K 
Phosphate buffer at PH 7.4). SOD activity was measured on a plate reader (Multiskan 
spectrum) at 490nm, 25°C for 5minutes at 1 minute interval using SkanIt RE for MSS 2.2 
(ThermoScientific™ Inc.immediately after adding 15μl of freshly prepared 6-






Tissue homogenates were obtained as described for SOD. From the diluted samples 
and standards, 5μl were loaded in triplicate into UV microplate wells. Catalase assay buffer 
(170μl) were added into each well and lastly, 50μL of H2O2 was added into the wells and 
analysis was performed immediately on a plate reader (Multiskan spectrum) at 240nm 




Testicular tissue samples were homogenized in lysis buffer (0.1M KPi, 1.15% KCl) by 
bullet blending at speed 9 for 3 minutes with a 1-minute interval in-between. MDA levels 
in the testis was determined by pipetting 100µl of standards and samples into 
corresponding 10ml glass tubes, followed by adding 1ml of SDS and 2ml of 10%TCA-BHT 
buffer solution. Samples were vortexed, and after resting for 10 minutes, 2ml of TBA was 
added and vortexed again. The standards and samples were covered with marbles and 
incubated in a water bath (1 hour at 100⁰C), where after it was cooled on ice for 15 
minutes. The standards and samples were centrifuged (3000rpm, 15 minutes 4°C) and the 
supernatants retrieved. From the supernatants, 250μl of each standard and sample were 
loaded in triplicate into microplate wells and analysed on a plate reader (Multiskan 






GraphPad Prism™ software (GraphPad™ Software, Version 8.2, CA, USA) was used. 
Normal data distribution was measured using the Anderson-Darling and Kolmogorov-
Smirnov normality tests. When data passed all normality tests, a one-way ANOVA of 
variance with a Tukey’s Post-hoc Test were performed. Where data were not evenly 
distributed, a Kruskal-Wallis test and a Dunns Post-hoc Test were carried out. A 
probability level of P< 0.05 was considered statistically significant and results are 







After 7 weeks of treatment, no significant differences were observed in the body, 
testicular and epididymal weights between any of the groups [Table 1]. However, the SL 
group presented with a higher (7%) percentage epididymal weight mean compared to the 
RF group (P=0.07). The RF treated animals displayed a significantly lower (-7.5%) relative 
testicular weight compared to the HB group (P=0.04), while there was no significant 
difference in relative epididymal weight between the groups (P=0.3) (Table 1). 
 






































































Sperm functional parameters 
The infusion treated animals (RF, HB, and SL) presented with a non-significant 
decrease (-14.3%, -18.2%, -17.2%) (-24.8%, -20.7%, -27.3%) in total motility and 
progressive motility when compared to the control group respectively [Figure 1A-B]. 
Although not significant, the rapid progressive motility of RF, HB and SL animals reduced 
by 23%, 28% and 37% respectively (Table 2), and there was a significant increase in the 
number of spermatozoa with slow speed (P=0.03), especially the SL treated group 
compared to the control (P=0.03) (Table 2). All sperm kinematic parameters of the infusion 
treated animals were non-significantly reduced compared to the control (Table 3). RF, HB 
and SL treated animals displayed a decrease in VCL (-14.3%, -18.8%, -23.7%); VAP (-16.5%, 
-22%, -27.6%); VSL (-20%, -25.5%, -33.2%); STR (-11.1%, -8.5%, -14.9%); LIN (-15.8%, -
14.6%, -22.6%) WOB (-8%, -9%, -10%); ALH (-14.8%, -15.9%, -20.5%) and BCF (-16.3%, -
18.7%, -26.3%), compared to the control group respectively (Table 3). Interestingly, 
infusion treated groups displayed a non-significant increase in sperm concentration 
compared to the control group [Figure 2]. However, there was no significant differences in 
the percentage of morphologically normal spermatozoa between the groups, but RF and 



















Figure 1: Sperm total and progressive motilities at 30 seconds. A. total motility, B. 
progressive motility, RF=rooibos, HB=honeybush, SL=sutherlandia, values in brackets () 
denotes the percentage change from control, n=10 
 
 














































































aP<0.05 vs. control, values in brackets () denotes the percentage change from control, n=10 
 
 











191,1±48,70 163,7±40,97 155,1±35,23 145,8±30,83 0,0799 
VAP 
(µm/s) 
87,85±25,67 73,29±28,39 68,47±20,24 63,52±21,67 0,2031 
VSL 
(µm/s) 
53,55±18,42 42,75±15,01 39,87±12,19 35,77±13,33 0,1217 
STR 
(%) 
58,55±5,960 52,03±6,885 53,56±7,608 49,80±7,788 0,0577 
LIN 
(%) 
28,53±3,798 24,00±7,050 24,36±6,019 22,08±6,994 0,1348 
WOB 
(%) 
45,99±3,302 42,29±9,588 41,84±6,011 41,25±8,967 0,4825 
ALH 
(µm) 
7,360±1,363 6,269±1,688 6,186±1,451 5,846±1,063 0,1088 
BCF 
(Hz) 
16,65±3,116 13,92±3,311 13,53±2,933 12,26±4,292a 0,0504 








Figure 2: Sperm concentration measured after 5 minutes of retrieval. RF=rooibos, 






















































Hormones and biochemical assays 
There were no statistical difference in the concentration of testosterone and estradiol 
between the groups [Figure 3A-B]. However, there was an increase of 28.8%, 31.7%, and 
23% in SOD activity, decrease of -11.3%, -16.6%, 23.7% in catalase activity and a decrease 
of -21.1%, -23.7%, 45.9% in MDA levels of RF, HB and SL groups when compared to the 










Figure 3: Testosterone and estradiol concentration. A. testosterone, B. estradiol, 













Figure 4: Oxidative stress parameters. A. SOD activity, B. catalase activity, C. MDA levels, 
RF=rooibos, HB=honeybush, SL=sutherlandia, values in brackets () denotes the percentage 








The use of natural products in the prevention and treatment of diverse diseases is 
increasing. This is due to the availability of phytochemical bioactive compounds in these 
plants, which are able to mimic the pharmacokinetics of synthetic drugs with fewer 
resultant adverse effects (Diane L. McKay and Jeffrey B. Blumberg, 2007; Mills et al., 2005; 
van Wyk and Albrecht, 2008). Rooibos, honeybush and sutherladia are plants with 
bioactive compounds and they have been shown to have numerous health benefits (van 
Wyk and Albrecht, 2008). However, only a few studies have been performed regarding 
their effects on male reproductive function. From these few studies, concerns regarding 
long term use have already been highlighted. Opuwari and Monsees reported that long-
term consumption of rooibos resulted in spontaneous acrosome reaction, which may 
impair male reproduction (Opuwari and Monsees, 2014). The current study investigated 
the effects of rooibos, honeybush and sutherlandia on male reproductive functional 
parameters in rats. 
After 7 weeks of treatment, there was no significant difference in body and organ 
(testes and epididymides) weights. This is similar to the report of Opuwari and Monsees, 
who also showed no significant difference in the body and tissue weight gain after 52 days 
of rooibos consumption in rat (Opuwari and Monsees, 2014). Many natural products of 
plant origin contains flavonoids, and flavonoids are considered endocrine disruptors 
(Patisaul and Jefferson, 2010). Chandra et al. reported that green tea administered in 
relatively high dose inhibited the activities of testicular 3β and 17β-hydoxy-steriod 
dehydrogenase, decreased serum testosterone and reduced testicular weight, which 




tea may impair the morphological and normal function of the testis (Das and Karmakar, 
2015). Regarding rooibos, an in vitro study reported decrease in the production of 
testosterone by the Leydig cells after treatment with rooibos (Opuwari and Monsees, 
2015). However, In the current, although RF animals presented with a decrease in relative 
testicular weight, there was no significant difference in the serum concentration of 
testosterone, but the estradiol levels decreased by 5%. The observed result of testosterone 
in the current study is supported by a study that reported no significant difference in serum 
testosterone after administration of both fermented and unfermented forms of rooibos in 
rats (Opuwari and Monsees, 2014). The role of rooibos as endocrine disruptor still remains 
inconclusive, because, recently, Noh reported that MR-10, a novel complex of dandelion 
and rooibos increases testosterone levels and also improved sperm production in older 
(>45) men (Noh, 2018). Hence, more studies are required to ascertain the role of rooibos 
on the endocrine regulation of male reproduction. Honeybush has been shown to have 
mild oestrogenic activity as it was reported to induce proliferation of oestrogen-insentive 
MDA-MD-231 cells (Verhoog et al., 2007). As previously stated, studies are lacking on its 
role in male reproduction, thus more studies are required to investigate the role on male 
reproduction. 
In the current study, the effects of rooibos, honeybush and sutherlandia on the sperm 
motility, concentration and morphology represent an ilicit/confusing situation. Animals 
treated with the respective infusion (RF, HB, SL) presented with a decrease in all sperm 
kinematic parameters. This is in contrast to the report of Ros-Santaella and Pintus. They 
showed that after treating boar semen with rooibos, there was an increase in sperm 
kinematic parameters (Ros-Santaella and Pintus, 2017). The contrasting result may be due 




-18%, -17%), progressive motility (-24%, -20%, -27%) and normal sperm morphology (-
1.5%, 0.3% and -9%) of animals treated with RF, HB and SL, with SL animals showing a 
significant increase in the percentage of spermatozoa with slow speed. The results of the 
total and progressive motilities of the current study are in contrast with the reports of 
Awoniyi et al. and Ayeleso et al.(Awoniyi et al., 2012; A. O. Ayeleso et al., 2014). The 
difference may be due to the health status of animals analysed. Awoniyi et al. reported an 
increase in the total and progressive motilities of diabetic animals treated with rooibos and 
Ayelso et al. showed an improvement in the total and progressive motilities of animals that 
were induced with OS. Additionally, from data obtained in our laboratory (SURRG 
Stellenbosch University Reproductive Research Group), we observed that diabetic animals 
treated with fermented rooibos displayed an increase that was up to 5% in total and 
progressive motilities when compared to non-diabetic animals (un-published work). This 
suggest that rooibos consumption may be beneficial in a diseased state, especially, DM-
related male reproductive function impairment in rats. However, when consumed by 
healthy rats, it may reduce sperm motility. Since studies on honeybush and sutherlandia 
are lacking, little can be said about them. We can speculate that when administered to 
healthy animals, there is a possibility of sperm function impairment since they follow the 
same trend as rooibos.  
Interestingly, animals treated with these infusions displayed a non-significant increase 
in sperm concentration. This is partly supported by Opuwari and Monsees. They reported 
that unfermented rooibos supplementation significantly enhanced sperm concentration in 
rats (Opuwari and Monsees, 2014). Several studies have shown the antioxidant potential 
of rooibos, honeybush and sutherlandia on diverse diseases (A. Ayeleso et al., 2014; 




presented with an increase in SOD activity accompanied with reduced MDA levels in RF 
and HB groups, with SL group showing higher MDA levels. The former is supported by 
several studies that have shown increased testicular antioxidant enzyme activity after 
treatment with rooibos either in disease or health (Awoniyi et al., 2012; A. O. Ayeleso et 
al., 2014; Opuwari and Monsees, 2014). Although, SOD activity was increased in the 
infusion treated groups of the current study, the sperm motility and morphology were 
adversely affected. The mechanisms behind these outcomes were not investigated, but it 
can be speculated that, the increased SOD and reduced catalase activities observed are 
compensatory responses. As SL that displayed higher SOD and catalase activities, 
resultantly showed a non-significant 45% increase in MDA levels. 
 
Conclusion  
The present study have evaluated the role of rooibos, honeybush and sutherlandia on 
sperm functional parameters in healthy rats. Animals treated with the respective infusions 
presented with percentage increase in antioxidant enzyme activity but have reduced 
sperm motility and decreased normal morphology. Paradoxically, they presented with 
increased sperm concentration. Hence, it is concluded that rooibos, honeybush and 
sutherlandia may enhance sperm concentration, which represent sperm quantity, but they 
may impair sperm motility and morphology (sperm quality) when consumed by healthy 
animals.  
Thus, caution should be taken regarding the amount of teas’ consumed when healthy, 
as it can affect the antioxidant shift (antioxidant paradox). That is, too much of antioxidants 
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This study aimed to investigate the testicular oxidative stress and apoptosis status in 
streptozotocin (STZ) induced diabetic rats following treatment with rooibos, honeybush and 
sutherlandia infusions. Diabetes was induced by injecting fourteen week old adult male 
Wistar rats (250-300g) with a single intraperitoneal injection of STZ (45mg/kg). Fifty rats were 
randomly divided into five groups. The groups included a vehicle (Veh) (citrate buffer), a 
diabetic control (DC) (STZ45mg/kg), a diabetic + rooibos (DRF) (STZ45mg/kg + 2% rooibos), a 
diabetic + honeybush (DHB) (STZ45mg/kg + 4% honeybush) and a diabetic + sutherlandia (DSL) 
(STZ45mg/kg + 0.2% sutherlandia) group. Animals in the infusion treatment groups started 
receiving the respective infusion one week before diabetes induction for acclimatization. 
Animals were sacrificed after 7 weeks of DM induction. The testes and the epididymides were 
harvested and weighed. Spermatozoa was retrieved from the cauda epididymis for motility, 
morphology and concentration analysis and the testis was used for all biochemical assays. 
After diabetes induction, DC, DRF, DHB and DSL animals presented with a significantly 
elevated blood glucose levels compared to the Vehicle group (p<0.0001). DC animals 
presented with a reduction in sperm progressive motility (-15.17%), while DRF and DSL 
animals displayed a respective increase (26.2%, 15%) in progressive motility compared to DC. 
DHB, on the other hand, showed a decrease (-17%) in progressive motility. Additionally, the 
percentage of morphologically normal spermatozoa was increased by 13%, 16%, and 15% 
after treatment with rooibos, honeybush and sutherlandia respectively. DRF, DHB and DSL 
animals displayed an increase (37.4%, 53.7%, and 48%) in SOD activity compared to DC 
respectively, which was accompanied by a reduction in lipid peroxidation, as measured by 
malondialdehyde (MDA) levels. However, they (DRF, DHB and DSL) showed an increase in the 




apoptosis protein (XIAP). The results of the current study suggests that rooibos, honeybush 
and sutherlandia infusions may partly play a role in alleviating DM-induced sperm function 
impairment through the suppression of OS, but their role in apoptosis is still unclear, hence 
further investigations are required. 
 





1.0  Introduction  
Diabetes mellitus (DM) is a metabolic disorder which results either from a lack of insulin 
secretion or the insensitivity of the target tissue to the effect of insulin (Expert Committee on 
the Diagnosis and Classification of Diabetes Mellitus, 2003). DM is one of the non-
communicable diseases that poses threat to the general health, including male reproductive 
health (Agbaje et al., 2007; Bhattacharya et al., 2014; Delfino et al., 2007; Giacco and 
Brownlee, 2010; Li et al., 2004; Mallidis et al., 2009; Roessner et al., 2012). Studies have 
highlighted some of the negative impacts of DM on male fertility, this include endocrine 
function deregulation, testicular dysfunction, spermatogenesis disruption, reduced sperm 
motility and decreased normal sperm morphology (Amaral et al., 2006; Chen et al., 2016; 
Khaki et al., 2010). One of the pathways through which DM exert its effect on male fertility is 
through the development of oxidative stress (OS) and the subsequent induction of apoptosis 
(Allan et al., 1992; Reiter et al., 2000). Kanter et al. showed that after DM induction in rats, 
there was an increase in testicular malondialdehyde (MDA) levels with reduced antioxidant 
enzyme activities in glutathione peroxidase (GPx) and superoxide dismutase (SOD). This 
subsequently resulted in severe testicular damage as evidenced by disrupted seminiferous 
tubule structure. Also observed was the increased number of spermatozoa with fragmented 
DNA following apoptosis activation (Kanter et al., 2012). Additionally, Chen et al. reported a 
significant decrease in the testicular antioxidant activities (SOD, catalase (CAT)) and increase 
in MDA and ROS levels in DM rats. This was followed by an elevated Bax/Bcl-2 ratio, which is 
indicative of apoptosis (Chen et al., 2016). This phenomenon has been described by several 
other authors (Guneli et al., 2008; Jiang et al., 2013; Roessner et al., 2012). Hence, it is evident 
that DM negatively impact male fertility. Since it has been reported that DM affects 422 




(Nijpels, 2016), it is therefore essential to explore every possible strategy to combat DM and 
its associated male reproductive complications.  
Rooibos (Aspalathus linearis), honeybush (Cyclopia intermedia) and sutherlandia (Lessertia 
frutescens) are plants endemic to Southern Africa (Joubert et al., 2011, 2008; McGaw et al., 
2007; Morton, 1983; Schloms and Swart, 2014; van Wyk and Albrecht, 2008). They are 
caffeine-free beverages derived from the leaves and stems of their respective plants.  
The infusion derived from rooibos contain diverse bioactive compounds, including 
dihydrochalcones, cyclic dihydrochalcone, phenylpropenoids, flavones, flavonols, and the 
flavanones (Beelders et al., 2012). Honeybush contains compounds such as flavanones, 
flavones, isoflavonols, phenolic acid, Inositols and Xanthones (Diane L. McKay and Jeffrey B. 
Blumberg, 2007; Kamara et al., 2007), while, sutherlandia has phytochemicals such as 
flavonoids, non-protein amino acids, free amino acids and cycloartanol glycosides (Avula et 
al., 2010; Ortega, 2003).  
Due to the presence of rich bioactive compounds in these teas, studies have explored their 
role in different systems and cells as antioxidants (Awoniyi et al., 2012; Hong et al., 2014; 
Marnewick et al., 2003; Pheiffer et al., 2013), anti-inflammatory agents (Marnewick et al., 
2009), anti-carcinogens (Skerman et al., 2011; Tai et al., 2004; Van Der Walt et al., 2016), and 
anti-diabetic agents (Bates et al., 2000; Ojewole, 2004). Although there are several known 
health benefits of these infusions, only a few studies have investigated the role of rooibos on 
DM-impaired male reproductive function. To the best of our knowledge, no studies have 
reported the effect of honeybush and sutherlandia on male fertility or DM related male 
reproductive complications. Awoniyi et al. reported that rooibos increases SOD and 
glutathione activities in rat sperm and subsequently improved sperm function in OS–induced 




concentration were reportedly improved in diabetic rats treated with rooibos. However, long-
term treatment and excessive consumption induced the acrosome reaction, which 
subsequently may lead to impaired reproduction (Opuwari and Monsees, 2014). Seeing that 
the reports on the effect of these infusions are still elusive, this study aimed to determine 
both the testicular oxidative stress status and apoptosis status in diabetic rats following 





2.0  Materials and Methods 
2.1  Animal care  
Healthy adult male Wistar rats (fourteen weeks old) weighing 250-300g were housed at the 
Animal Unit of the Faculty of Medicine and Health Sciences, Stellenbosch University (18-23°C, 
12:12 light/dark cycle). Animals were individually caged, had free access to food and 
water/infusions and were treated according to the recommendations of the Laboratory 
Animal Care of the National Society of Medical Research and the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals (Committee for the Update of the Guide 
for the Care and Use of Laboratory Animals; National Research Council, 2010). Ethics approval 
was obtained from the Stellenbosch University Animal Ethics Committee (SU-ACUD17-
00016). 
2.2  Infusion preparation  
Fermented rooibos (2%; Carmien SA PTY LTD, South Africa), fermented honeybush (4 
%; Afrinaturals, South Africa) and unfermented sutherlandia (0.2%; Afrinaturals, South Africa) 
were prepared according to standard protocols. Preparation methods conformed to the 
experimental established protocols for rooibos (Marnewick et al., 2011), honeybush (Du Toit 
and Joubert, 1999) and sutherlandia (Tobwala et al., 2014). Briefly, 2% rooibos was prepared 
by adding 20g of dried rooibos in 1litre of boiling water and allowed to rest for 30 minutes. 
The mixture was filtered three times using a cheesecloth initially, whereafter it was 
respectively filtered through a number 4 and number 1 Whatman filter paper (WhatmanTM, 
Buckinghamshire, UK). Filtered infusions were transferred to a dark plastic containers and 




the same protocol. All infusions (rooibos, honeybush and sutherlandia) were prepared every 
other day (48 hours). The herbal teas serve as the only drinking fluid for these infusion groups. 
The fluid intake of the animals was measured three times a week. 
 
2.3  Experimental design 
Diabetes was induced with streptozotocin (STZ, S0130-IG, Sigma, South Africa) and a stock 
solution (30mg/ml) was prepared by dissolving it in freshly prepared sodium citrate buffer 
(pH 4.5). From the stock solution, rats were administered single intraperitoneal injection of 
STZ (45mg/kg body weight). Fifty rats were randomly divided into five groups (n=10). The 
groups included a vehicle group (Veh) (received citrate buffer), a diabetic control group (DC) 
(received STZ45mg/kg), a diabetic + rooibos (DRF) (received STZ45mg/kg +2 % rooibos), a 
diabetic + honeybush (DHB) (received STZ45mg/kg + 4% honeybush) and a diabetic + 
sutherlandia (DSL) (received STZ45mg/kg +4 % sutherlandia) (Table 1). Animals in the infusion 
treatment groups started receiving the respective infusions one week before diabetes 
induction occurred for accclimatization. Body weights were measured three times a week and 
blood glucose was measured weekly (for diabetic status confirmation). Animals were 
sacrificed 7 weeks after DM induction. The testes and the epididymides were harvested and 
weighed. The testis was used for all biochemical assays and spermatozoa was retrieved from 
the epididymis for motility, morphology and concentration analysis. The relative testicular 
weight was measured by dividing the testicular weight by end bodyweight and multiplied by 






Table 1: The experimental design. 
 




2.4  Experimental procedures 
2.4.1  Sperm functional parameters 
At 30 seconds, sperm motility was analysed using computer-aided sperm analysis (CASA) (SCA 
version 6.3, Microptic, Barcelona, Spain) in accordance with the protocol previously described 
by Omolaoye et al. (Omolaoye et al., 2018). Sperm morphology was analysed using computer-
aided sperm morphology analysis (CASMA) (SCA 5.4) and it conformed with the formerly 
established methods by van der Horst et al. (van der Horst et al., 2018). Sperm concentration 
was also measured using CASA. In brief, spermatozoa were retrieved from the epididymis by 
dissecting the caudal part into small pieces in a 2ml Dulbecco’s modified eagle’s medium-low 
glucose (DMEM) and allowing sperm to swim out during a 5 minute period. The tissue pieces 
were removed after 5 minutes and the sperm solution was mixed homogenously. Of the 2ml 
solution, 10µl was removed and diluted in 50µl of DMEM, where after the sperm 
concentration was measured via CASA. 
Abbreviation Intervention Treatment 
Veh Citrate buffer vehicle Tap water 
DC 45mg/kg STZ Tap water 
DRF 45mg/kg STZ 2% fermented rooibos 
DHB 45mg/kg STZ 4% fermented honeybush 




2.4.2  Oxidative stress parameters 
2.4.2.1  Catalase  
Frozen testicular tissue samples were homogenized in cold lysis buffer (Na3PO4, 0.5% Triton 
X-100) and centrifuged at 15000rpm for 20 minutes at 4°C. Tissue homogenates were diluted 
10x in deionized water. From the diluted samples and standards, 5μl were loaded in triplicate 
into UV microplate wells. Catalase assay buffer (170μl) were added into each well and lastly, 
50μL of H2O2 was added into the wells and analysis was performed immediately on a plate 
reader (Multiskan spectrum) at 240nm every 60 seconds over a 5 minute period using SkanIt 
RE for MSS 2.2 (ThermoScientific™ Inc.) software. 
2.4.2.2  Superoxide dismutase (SOD) 
Tissue homogenates were prepared as described for catalase. From the diluted standards and 
samples, 10μl were dispensed into the microplate wells in triplicate, followed by adding 170μl 
of diethylenetriaminepentaacetic acid (DETAPAC) and 5µl of SOD assay buffer (50mM Na/K 
Phosphate buffer at PH 7.4). Immediately before reading, SOD activity was activated by 
adding 15μl of freshly prepared 6-hydroxydopamine (6-OHD) into the wells and instantly 
analysed on a plate reader (Multiskan spectrum) at 490nm, 25°C for 5minutes at 1 minute 
interval using SkanIt RE for MSS 2.2 (ThermoScientific™ Inc.) software. 
2.4.2.3  TBARS assay 
Frozen testicular tissue samples were homogenized in lysis buffer (0.1M KPi, 1.15% KCl) by 
bullet blending at speed 9 for 3 minutes with a 1-minute interval in-between. To measure the 
levels of MDA in testicular tissue, 100µl of standards and samples were pipetted into 
corresponding 10ml glass tubes, followed by adding 1ml of SDS and 2ml of 10%TCA-BHT 




added and vortexed again. The standards and samples were covered with marbles (to prevent 
contamination from the boiling medium) and incubated in a water bath (1 hour at 100⁰C), 
where after it was cooled on ice for 15 minutes. The standards and samples were centrifuged 
(3000rpm, 15 minutes 4°C) and the supernatants retrieved. From the supernatants, 250μl of 
each standard and sample were loaded in triplicate into microplate wells and analysed on a 
plate reader (Multiskan spectrum) at a 532nm wavelength within 30 minutes after 
centrifugation. 
2.4.3  Apoptotic markers 
Apoptotic markers were measured using Western blot procedures. Tissue homogenates and 
protein determination were obtained as described by (Bradford, 1976; Marais et al., 2001). 
Tissue lysates were prepared by diluting sample in Laemmli sample buffer and lysis buffer, 
boiled for 5 minutes and 50ug protein/µl was separated by electrophoresis on a 12% SDS-
PAGE mini-proteon gel. The running protocol consisted of an initial 10 minutes 
electrophoresis at 100V and 200mA followed by 30-40 minutes at 200V and 200mA. Gels were 
activated using ChemiDoc (BioRad). Thereafter, the proteins were transferred onto a milipore 
Immobilon-P transfer membrane (0.45µm) (Immobilon®-P, Merck Millipore Ltd, Germany). 
Non-specific sites were blocked with 5% fat free milk in TBS-tween. Primary antibodies were 
diluted in TBS-Tween in a 1:1000 ratio while the secondary antibody was diluted in TBS-Tween 
in a 1:4000 ratio. All data points are from independent biological repeats (n=4-5). Measured 
apoptotic biomarkers are Caspase 3 (Sigma-Aldrich), Caspase 7 (Abcam, SA), PARP (Cell 
Signalling Technology), p38MAPK (Cell Signalling Technology), C-Jun-N-terminal kinase (JNK) 
(Cell Signalling Technology) and X-linked inhibitory apoptotic protein (XIAP). A goat anti-





2.5  Statistics  
GraphPad Prism™ software (GraphPad™ Software, Version 8.2, San Diego, CA, USA) was used 
for the statistical analysis. Normal data distribution was measured using the Shapiro-Wilk, 
Anderson-Darling, Kolmogorov-Smirnov and D'Agostino & Pearson, normality tests. When 
data passed all normality tests, a one-way ANOVA of variance with a Tukey’s Post-hoc Test 
was performed. Where data were not evenly distributed, a Kruskal-Wallis test and a Dunns 
Post-hoc Test were carried out. Additionally, a Pearson’s two-tailed correlation matrix was 
performed. A probability level of p< 0.05 was considered statistically significant and results 





3.0  Results  
3.1  Anthropometric data 
Although, DC and DHB animals gained less body weight, while DRF and DSL animals loss a 
significant amount of body weight compared to Vehicle (p<0.0001; p<0.0001; p<0.05; 
p<0.0001) respectively. DHB animals showed an increase in the change in body weight 
compared to DC (23,65±62,52 vs. 2,510±21,58). DRF and DSL animals showed a significant 
increase in relative testicular weight compared to the Vehicle group (p<0.05). After one week 
of diabetes induction, DC, DRF, DHB and DSL animals presented with significantly elevated 
blood glucose levels compared to Vehicle (p<0.0001) (Table 2). 
 
Table 2: Basic anthropometric data 




273,5±18,23 278,3±13,11 282,9±15,80 264,7±80,32 274,2±14,20 0.9516 
End body weight 
(g) 
















*p<0.05 vs. vehicle; @p<0.001 vs. vehicle; &p<0.05 vs. DHB 
 DC=diabetes control, DRF=diabetes+rooibos, DHB=diabetes+honeybush, DSL=diabetes+sutherlandia 
 
 
3.2  Sperm functional parameters 
Although not significant, DC animals had a nearly 7% decrease in total motility compared to 
the Vehicle. DRF animals displayed a 4.3% increase in total motility compared to the Vehicle 
group and a 12% increase compared the DC group (Figure 1A). Additionally, there was a 
15.17% decrease in the percentage of progressively motile spermatozoa of DC animals 
compared to the Vehicle group, while DRF displayed a 7% increase compared to the Vehicle 
and 26.2% compared to the DC group. DHB animals displayed the largest decrease (-17%) in 
the progressive motility compared to Vehicle and a mild reduction compared to the DC group. 
DSL animals on the other hand, presented with a 15% increase in progressive motility 
compared to DC (Figure 1B), and a significant decrease in sperm concentration compared to 
the Vehicle (p<0.05) (Figure 1C). There were no significant differences in sperm kinematic and 
speed parameters between the groups (Table 3, 4). The DRF group showed a 25% increase in 
sperm concentration compared to DC, while DHB animals presented with a 30% increase in 
sperm concentration compared to the DC animals (Figure 1C). Although not significant, DC 
Blood glucose 
levels (average 
of 7 weeks) 
(mmol/L) 









animals showed a decrease (-26%) in the percentage of normal sperm morphology compared 
to Vehicle. DRF, DHB and DSL animals also presented with a decrease in normal sperm 
morphology compared to the Vehicle group (-8%, -14%, -13%) respectively. However, when 
compared to the DC animals they showed a mild improvement in the percentage of morphologically 
























Figure 1: The effects of DM and infusions on sperm functional parameters. A. Total sperm motility 
(%), B. Progressive motility (%), C. Sperm concentration (M/ml), D. Normal sperm morphology (%). 
*p<0.05 vs. veh; Gp value for total motility=0.5, progressive motility=0.3, sperm concentration=0.018, 










Table 3: Sperm kinematic parameters at 30 seconds. 
Parameters Vehicle DC DRF DHB DSL 
Global p 
Value 
VCL (µm/s) 161,6±66,59 163,3±42,49 170,0±27,87 155,7±35,00 152,2±50,79 0.9247 
VAP (µm/s) 70,48±34,04 71,00±20,83 78,12±14,57 70,25±15,30 67,90±26,78 0.6862 
VSL (µm/s) 41,89±22,31 42,54±15,69 48,13±10,46 42,79±9,328 44,26±19,43 0.7741 
STR (%) 54,65±7,99 54,30±9,63 58,49±6,48 56,64±3,40 60,32±9,33 0.3033 
LIN (%) 23,81±8,83 24,75±7,48 28,11±5,52 26,91±3,52 27,71±7,90 0.3113 
WOB (%) 40,81±10,88 42,31±5,13 45,19±7,48 44,36±5,08 42,91±7,55 0.7609 
ALH (µm) 6,430±2,21 6,471±1,41 6,539±0,96 5,898±1,16 5,713±1,53 0.4925 
BCF (Hz) 13,58±5,53 14,29±3,42 16,35±3,29 16,35±2,39 16,06±6,60 0.3577 
Curvilinear speed (VCL), Average path velocity (VAP), Straight Line velocity (VSL), Straight line index (STR), 
Linearity index (LIN), and Oscillation index (WOB), Amplitude Lateral Head (ALH), Sperm Beat Frequency (BCF). 
DC=diabetes control, DRF=diabetes+rooibos, DHB=diabetes+honeybush, DSL=diabetes+sutherlandia. 
 
 
Table 4: Sperm speed and progressive motilities.  





42,87±30,40 45,78±22,76 51,75±18,66 41,93±20,40 42,56±24,97 0.8110 
Medium 
speed (%) 
12,74±8,17 11,71±5,15 14,80±10,75 16,06±6,09 11,16±9,56 0.6361 
Slow speed 
(%) 















21,89±9,16 24,34±7,40 18,80±7,82 24,24±7,83 19,54±7,38 0.3931 
 
DC=diabetes control, DRF=diabetes+rooibos, DHB=diabetes+honeybush, DSL=diabetes+sutherlandia 
 
 
3.3  Oxidative stress parameters 
There was a significant difference in SOD activity as measured in the testicular tissue between 
the groups (p<0.05). The DC group presented with a decrease of 13.5% in SOD activity 
compared to the Vehicle group. While DRF animals displayed an increase (18.8%) in SOD 
activity compared to Vehicle and 37.4% compared to the DC group. DHB animals displayed an 
increase of 32.9%, 53.7% in SOD activity compared to Vehicle and DC respectively (p=0.06). 
DSL animals also presented with 28.3%, 48% increase in SOD activity compared to the Vehicle 
and DC groups respectively (Figure 2A). Additionally, DHB animals presented with a significant 
increase in catalase activity compared Vehicle (133.4±42.81µl/µg vs. 20.64±16.38µl/µg, 
p=0.005) and 170% increase compared to the DC group (133.4±42.81µl/µg vs. 
49.24±21.59µl/µg, p=0.3) (Figure 2B). Although not significant, DC group displayed more than 
a doubling increase (119%) in the MDA levels compared to Vehicle (p=0.2), while it was 
reduced by 41%, 60%, and 27% respectively in the DRF, DHB and DSL groups compared to the 
DC group (Figure 2C). 
 
3.4  Apoptotic markers 
The expression of caspase 7 in the testicular tissues of DC animals increased by 75.7% 




caspase 7 compared to DC (Figure 3A). DC animals displayed an increase (28%, 34%, 29%, 
27.5%) in the expression of cleaved PARP, pP38, JNK55kDa and JNK44kDa respectively (Figure 
3B-F). The testicular tissues of DRF, DHB and DSL animals showed an increase in cleaved PARP 
(19%, 41%, and 15%) compared to DC. DHB animals displayed a significant increase in the 
phosphorylation of p38 compared to Vehicle (3.630±2.576 vs. 0.459±0.3749, p<0.05). In addition, DRF, 
DHB, DSL animals showed a -25%, -53.5%, -41.5% decrease in the expression of JNK55kDa compared 
to the DC group, with DHB showing significance (p<0.05). To further evaluate apoptotic activity, the 
total expression of XIAP was measured. DC animals presented with nearly 20% decrease in the total 
expression of XIAP compared to Vehicle, while DRF showed a significant decrease compared to Vehicle 
(0.5789±0.427, 0.2939±0.2266 vs. 0.6903±0.2108, p<0.05) respectively. DRF, DHB and DSL animals 
displayed a further decrease in the expression of total XIAP (-52.6%, -33.9%, -50.6%) compared to the 










Figure 2: The effect of DM and infusions on testicular oxidative stress. A. SOD activity, B. Catalase 
activity, C. MDA levels. @p<0.001 vs. veh. Global p value for SOD=0.04, catalase=0.008, MDA 
levels=0.07. Veh=vehicle, DC=diabetes control, DRF=diabetes+rooibos, DHB=diabetes+honeybush, 
DSL=diabetes+sutherlandia 
  






















Figure 3: The effects of DM and infusions on testicular apoptotic biomarkers. A. caspase 7, B. cleaved 
PARP, C. pP38MAPK, D. JNK55kDa, E. JNK46kDa, F. JNK (grouped data), G. total XIAP (XIAP1+XIAP2), 
and H. Blots (probed). *p<0.05 vs. veh, @p<0.001 vs. veh. Global p value for caspase 7=0.054, cleaved 
PARP=0.08, pP38MAPK=0.02, JNK55kDa=0.1, JNK46kDa=0.4, XIAP=0.02. Veh=vehicle, DC=diabetes 











4.0  Discussion  
The use of phytochemicals containing natural products has been a crucial part of traditional 
medicine. The presence of the diverse bioactive compounds in these products have initiated 
new insights on how they can be beneficial to humanity, either by extracting the bioactive 
compounds (Dludla et al., 2018; Kokotkiewicz et al., 2013; Son et al., 2013) or by using the 
whole plant (Hong et al., 2014; Marnewick et al., 2011; Schloms and Swart, 2014). Rooibos, 
honeybush and sutherlandia are plants containing diverse bioactive compounds, with 
associated health benefits (Awoniyi et al., 2012; Harnett et al., 2005; Hong et al., 2014; 
Marnewick et al., 2003; Mills et al., 2005; Pheiffer et al., 2013). Several studies have 
highlighted their role in preventing the development of cell toxicity (Tandeka U. Magcwebeba 
et al., 2016; Tandeka Unathi Magcwebeba et al., 2016), alleviating OS in different organ 
systems including the brain (Hong et al., 2014), liver (Layman et al., 2019), skin (Tiedtke et al., 
2002), and many more. However, little is known about the effects of these infusions in DM-
induced male reproductive function impairment. Hence, the current study investigated the 
plausible ameliorative role of rooibos, honeybush and sutherlandia on DM-induced sperm 
function impairment and also set out to determine testicular OS and apoptosis status after 
treating diabetic rats with these infusions.  
As expected, following DM induction, animals in the DC, DRF, DHB and DSL groups presented 
with elevated blood glucose levels and they gained less body weight/loss weight over the 
treatment period. These are known characteristic of type 1 DM as shown by several studies 
(Singh et al., 2009; Vikram et al., 2008). Hence, animals became diabetic. The DC animals of 
the current study presented with a non-significant decrease in the percentage of total and 
progressive motilities. This is in agreement with several studies that showed reduced sperm 




2009). Additionally, DC animals presented with a decrease in the percentage of sperm with 
normal morphology. This concur with other studies who reported reduction in the number of 
spermatozoa with normal morphology after inducing diabetes in rodents (Mangoli et al., 
2013; Maresch et al., 2017). Interestingly, in the current study, DRF animals presented with 
an increase in progressive motility when compared to DC. However, what is more interesting 
is that DRF animals had a mild increase in progressive motility than the non-diabetic group. 
The former result is supported by findings from Awoniyi et al. who reported a significant 
increase in sperm motility after treating OS-induced rats with both fermented and green 
rooibos (Awoniyi et al., 2012). Regarding the effect of honeybush and sutherlandia on sperm 
functional parameters of diabetic rats, the result of the current study showed that DHB 
animals presented with a decrease in sperm motility. However, there was a mild increase in 
sperm motility of DSL animals and this represent the first study reporting the effect of 
honeybush and sutherlandia on sperm motility. Although not significant, and not as normal 
as the vehicle rats, DRF, DHB and DSL animals had increased number of spermatozoa with 
normal sperm morphology. 
Studies have shown that DM induce subtle molecular changes that are essential for sperm 
quality and function through the development of OS, caused by the imbalance in the ratio of 
ROS production and the antioxidant activities (Agarwal et al., 2014; Bhattacharya et al., 2014). 
Observed in the DC animals of the current study, is a decrease in the activity of SOD, 
accompanied by an increased level of MDA, which were negatively correlated (Supplementary 
figure 1). This is supported by studies that reported a significant increase in the plasma level 
of TBARS in diabetic rats (Ayeleso et al., 2014). This also concur with the findings of Uličná et 
al. who showed increased levels of MDA in the plasma, liver, kidney and lens of diabetic rats 




activity. Interestingly, not only did their SOD activity surpasses the DC group, there was an 
increase in SOD activity compared to the healthy group. Additionally, DHB group presented 
with increased catalase activity. The increase in SOD and catalase activities were accompanied 
by a reduction in the MDA levels. Studies have reported the ameliorative effects of these 
infusions and how they can act as antioxidants in diverse pathologies (Bramati et al., 2003; 
Tobwala et al., 2014) . In OS, sperm motility is affected because of the increased ROS 
production (Lanzafame et al., 2009). The sperm plasma membrane has a very high percentage 
of polyunsaturated fatty acids (PUFA) (Lenzi, 2000; Lenzi et al., 1996) which are essential for 
sperm motility. These PUFAs are vulnerable to ROS, hence, the invasion of the sperm plasma 
membrane leads to lipid peroxidation (Liu et al., 2015). Lipid peroxidation occurs when ROS 
react with fatty acid chains to form the lipid peroxyl radical. Peroxyl radicals in turn react with 
fatty acids to produce more ROS. The reaction between the free radicals produced results in 
lipid breakdown. However, studies have shown that to protect against OS-induced damage, 
it is necessary to treat the underlying cause (Agarwal et al., 2014) and then supress pro-
oxidants by antioxidants (Tremellen, 2008). 
Hence, based on the results of the current study, it is suggested that the improved sperm 
motility observed in diabetic animals treated with rooibos and sutherlandia may in part be 
due to the boost in antioxidant enzyme activity of these animals which subsequently protect 
against/alleviate the stress imposed by DM on sperm motility. Although DHB animals 
presented with improved antioxidant enzyme activities, the sperm motilities were not 
improved. This shows the involvement of other plausible factors in the process of impaired 
sperm function observed in DM. 
The induction of apoptosis as a result of OS has been shown in several pathologies, including 




(Simon et al., 2000) which result in mitochondria DNA (mtDNA) damage and subsequently 
affects sperm functions negatively. In the current study, DC animals displayed increased 
caspase 7, cleaved PARP, JNK46kDa and p38MAPK, which are all biomarkers of apoptosis. This 
is partly in agreement with Roessner et al. who reported increase in the cleavage of caspase 
3, elevated ROS production and disrupted mitochondrial potential in diabetic men (Roessner 
et al., 2012). They further showed that these parameters were negatively correlated with the 
sperm fertilizing capacity in diabetic men. From the current study, after treating diabetic 
animals with rooibos, honeybush or sutherlandia, there were no improvement observed. To 
better understand the presented apoptotic status, XIAP was measured. For the control of 
apoptosis, mammals developed some regulatory proteins which are classified as members of 
the inhibitor of apoptosis (IAP) family. The pro-type member of the family is XIAP. XIAP has 
three baculovirus IAP repeat (BIR) domains and a C-terminal RING finger. It is known to inhibit 
caspases at the initiation (caspase-9) and execution phases (caspase 3 and 7) of apoptosis 
(Scott et al., 2005). In lieu of this, XIAP was quantified. The expression of XIAP in the testicular 
tissue of DC animals was decreased, while diabetic animals treated with rooibos, honeybush 
or sutherlandia showed further decrease in the expression of this protein. From the result of 
the current study, the reduction of XIAP in DC animals may indicate that caspases were not 
inhibited and thus apoptosis ensue. However, since the same trend was observed in the 
infusion treated groups, it can be said that rooibos, honeybush and sutherlandia did not 
alleviate testicular apoptosis seen in diabetic rats. 
5.0 Conclusion  
The current study have highlighted the negative impact of DM on sperm functional 




in the infusion treatment groups was increased antioxidant enzyme activity, which may be 
partly responsible for the observed improvement in sperm motility and morphology in the 
DRF and DSL groups. Additionally, the current study have showed the increased expression of 
apoptotic biomarkers in DM, which were not alleviated by the infusions. This suggest that 
these infusions play a role in alleviating DM-induced sperm function impairment through 
suppression of OS, but their role in apoptosis is still unclear. Therefore, based on the results 
of the current study, it can be speculated that in disease related male reproductive 
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The current study was designed to investigate the role of rooibos, honeybush and 
sutherlandia on insulin signalling in the testicular tissue of diabetic rats. 
Animals (n=60) were randomly divided into six groups. The groups include a control group (no 
treatment + water) and vehicle group (STZ control, injected intraperitoneally with citrate 
buffer and treated with water). Diabetes was induced in the remainder of animals via a single 
intraperitoneal injection of STZ at 45mg/kg. The remaining four groups are, a diabetic control 
group (DC, received water), a diabetic + rooibos (DRF, received 2% fermented rooibos), a 
diabetic + honeybush (DHB, received 4% fermented honeybush) and a diabetic + sutherlandia 
group (DSL, received 0.2% unfermented sutherlandia). Animals in the infusion treatment 
groups were pre-treated for one week before diabetes induction and all animals were 
sacrificed after seven weeks of DM induction. Blood and testes were collected.  
All diabetic groups (DC, DRF, DHB, DSL) presented with a significant increase in blood glucose 
levels after diabetes induction compared to the control and vehicle (p<0.001). However, the 
infusion treated animals displayed a mild decrease in fasting blood glucose compared to the 
DC group at sacrifice. The DC animals showed a decrease in testis protein expression of IRS-
1, PkB/Akt and GLUT4 compared to control. DRF and DHB animals displayed an acute 
upregulation in IRS-1, while DSL group showed improvement in IRS-2 compared to DC. 
Although, DRF animals presented with a decrease in PkB/Akt, DHB and DSL animals displayed 
upregulation (22.3%, 48%) compared to control respectively. All diabetic animals showed 
significantly increased phosphorylated ERK1/2 and reduced total ERK1/2 when compared to 
control (p<0.001) and vehicle (p<0.001). Additionally, DC animals presented with a non-




and DSL showed significant decrease (p=0.01) and DHB showed mild upregulation compared 
to DC. In conclusion, it can be suggested that these infusions may enhance insulin signalling 
through diverse pathways, but further investigations are required to elucidate the specific 
upstream and downstream proteins that are plausibly activated during this process. 
 







Diabetes mellitus (DM) is a non-communicable disease that brings about complications in 
various systems including the male reproductive system. Both experimental and human 
studies have highlighted diverse adverse effects of DM on male fertility (Hassan et al., 1993; 
Sanguinetti et al., 1995; López-Alvarenga et al., 2002; Dhindsa et al., 2004; Maneesh et al., 
2006; Bondarenko et al., 2011). In experimental diabetic animals, studies have reported 
altered spermatogenesis, diminished epididymal sperm reserve (Amaral et al., 2009), 
abnormal Sertoli-Sertoli cells junction complexes, reduction in the testicular weight, sperm 
concentration, testicular morphology index and decreased fertility potential (Cameron et al., 
1990). Lopez-Alvarenga et al. reported the suppression of both endogenous pulsatile and 
exogenous gonadotropin releasing hormone (GnRH) stimulated the secretion of luteinizing 
hormone (LH) in men with type I DM, which resulted in hypogonadotropism (López-Alvarenga 
et al., 2002). Studies have also shown that there is reduced levels of testosterone, LH and 
follicle stimulating hormone (FSH) in the sera of diabetic men (Maneesh et al., 2006; Hussein 
and Jawad Al-Qaisi, 2012; Rezvani et al., 2012). Also reported is an increase in spermatozoa 
with nuclear and mitochondrial DNA fragmentation (Agbaje et al., 2007, 2008), reduced 
sperm motility (La Vignera et al., 2009) and decreased sperm with normal morphology 
(Delfino et al., 2007). In the course of unravelling the mechanism(s) through which DM exert 
these detrimental effects, studies have shown the importance of insulin regulation in glucose 
homeostasis, insulin signalling and how lack in insulin secretion indirectly led to reduced male 
fertility (Ballester et al., 2004; Gómez et al., 2009; Schoeller et al., 2012). Gomez et al. 
reported a decrease in both systemic and testicular insulin concentration in diabetic rats with 
resultant disrupted spermatogenesis. It was suggested that, although, the testis produces 




al., 2009). Since findings have shown that, although the Sertoli cells secretes its own insulin, 
lack in pancreatic β-cell insulin production still affected male reproduction adversely. 
Schoeller et al., investigated the role of both systemic and testicular insulin signalling in male 
fertility using the Akita mouse diabetic model. They validated the presence of insulin in the 
testes and further reported that insulin affects male fertility through its indirect regulatory 
effect on the hypothalamic-pituitary-gonadal axis (HPGA). It was hypothesized that in DM, 
due to hypoinsulinemia/hyperglycaemia, insulin signalling is altered and the function of HPGA 
is disrupted, which cumulatively resulted in altered spermatogenesis and reduced sperm 
function. This was evidenced by the decrease in the levels of serum GnRH, LH, FSH and 
testosterone as well as testicular LH, FSH and testosterone in the diabetic animals. However, 
when insulin was administered the levels of these hormones were increased and normal 
spermatogenesis was restored. They concluded that insulin rescue fertility by restoring 
function to the HPGA, thus normalizing the hormone levels of LH and testosterone (Schoeller 
et al., 2012). However, other studies have further shown the importance of normal insulin 
signalling in normal male reproduction (Yagci and Zik, 2006; Griffeth, Carretero and Burks, 
2013). 
Since the importance of maintaining normal insulin signalling have been highlighted, it is 
essential to explore natural and artificial agents that has health benefits, and that can possibly 
enhance this process. Rooibos (Aspalathus linearis), honeybush (Cyclopia intermedia) and 
sutherlandia (Lessertia frutescens) are teas native to Southern Africa (Morton, 1983; van Wyk 
and Albrecht, 2008). Studies have highlighted some of their health benefits (Marnewick et al., 
2003, 2009; Awoniyi et al., 2012; Pheiffer et al., 2013; Hong, Lee and Kim, 2014), including 
antidiabetic properties (Bates, Jones and Bailey, 2000; Ojewole, 2004). Kawano et al. reported 




mice at 30, 60, 90 and 120 minutes (Kawano et al., 2009). They further added that rooibos, in 
a dose-dependent manner, enhanced glucose uptake in cultured L6 myotubes and also 
increased the secretion of insulin by RIN-5F cells. The results of Kawano et al. is supported by 
several other authors (Muller et al., 2012; Mazibuko et al., 2013, 2015; Son et al., 2013; 
Kamakura et al., 2015; Mikami et al., 2015; Dludla et al., 2018), with the inclusion that 
aspalathin promoted activated protein kinase (AMPK) phosphorylation, enhanced GLUT4 
translocation and also improved protein kinase B activation. This suggest that rooibos may 
improve glucose metabolism by enhancing glucose uptake through restoring normal insulin 
signalling. Studies have also highlighted the anti-diabetic potential of honeybush (Jung et al., 
2004; Akiyama et al., 2010; Muller et al., 2011; Saleh et al., 2014; Wang et al., 2014) and 
sutherlandia (Chadwick et al., 2007; J. et al., 2012; Williams et al., 2013) in both in vitro and 
in vivo experiments. All these studies showcasing the hypoglycaemic effects of rooibos, 
honeybush and sutherlandia were carried out in cardiovascular and other systemic diseases. 
Only few studies have investigated the role of these teas/infusions (rooibos only) on DM-
related male reproductive disorder. Hence, this study was designed to investigate the role of 
rooibos, honeybush and sutherlandia on testicular insulin signalling in diabetic rats. 
Materials and methods  
Infusion preparation  
Rooibos (Aspalathus linearis, 2% fermented), was obtained from Carmien SA PTY LTD, 
South Africa, while honeybush (Cyclopia intermedia, 4% fermented) and sutherlandia 
(Lessertia frutescens, 0.2% unfermented) was obtained from Afrinaturals, South Africa. They 




according to the method described by Marnewick et al. (Marnewick et al., 2011), honeybush 
by Du Toit and Joubert (Du Toit and Joubert, 1999) and sutherlandia by Tobwala et al. 
(Tobwala et al., 2014). In summary, 2% fermented rooibos was prepared by adding 20g of 
dried rooibos in 1litre of boiling water and allowed to draw for 30 minutes. The mixture was 
filtered using a cheesecloth, a number 4 and finally a number 1 Whatman filter paper 
(WhatmanTM, Buckinghamshire, UK). Filtered teas/infusions were transferred to a dark plastic 
containers and stored at 4°C. Infusions were stored in dark plastics and as well prepared 
freshly every other day, to prevent the degrading of the polyphenols that have short half-life 
and are light sensitive. Fermented honeybush (4%; 40g in 1L) and unfermented Sutherlandia 
(0.2%) were prepared following the same procedures. All infusions (rooibos, honeybush and 
sutherlandia) were prepared every other day (48 hours). The herbal teas serve as the only 
drinking fluid for these infusion groups. The fluid intake of the animals was measured three 
times a week. 
 
Animal care and study design 
Fourteen-week-old adult male Wistar rats weighing 250-300g were housed in the Animal Unit 
of the Faculty of Medicine and Health Sciences, Stellenbosch University (18-23°C, 12:12 
light/dark cycle). Animals were caged individually, had free access to food and 
water/infusions and were treated according to the recommendations of the Laboratory 
Animal Care of the National Society of Medical Research and the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals (Committee for the Update of the Guide 




was obtained from the Stellenbosch University Animal Ethics Committee (SU-ACUD17-
00016). 
Diabetes was induced with streptozotocin (STZ, S0130-IG, Sigma, South Africa) and a stock 
solution (30mg/ml) was prepared by dissolving it in freshly prepared sodium citrate buffer 
(pH 4.5). From the stock solution, rats were administered single intraperitoneal injection of 
STZ (45mg/kg body weight). Animals in the vehicle group were injected with citrate buffer. 
Sixty rats were randomly divided into six groups (n=10). The groups include a control group 
(water), vehicle group (citrate buffer), a diabetic control group (DC, STZ45mg/kg + water), a 
diabetic + rooibos (DRF, STZ45mg/kg + 2% fermented rooibos), a diabetic + honeybush (DHB, 
STZ45mg/kg + 4% fermented honeybush) and a diabetic + sutherlandia group (DSL, 
STZ45mg/kg + 0.2% unfermented sutherlandia). Animals in the infusion treatment groups 
were pre-treated with the tea for one week before diabetes induction. Food intake, fluid 
intake and body weights were measured three times a week and blood glucose levels were 
measured once weekly. Animals were sacrificed after 7 weeks of DM induction. Blood samples 
were collected immediately after sacrifice, and the testes was harvested and weighed. Plasma 
was used for hormonal assays, while the testis was used for Western blotting. The relative 
testicular weight was expressed as a percentage of body weight. The reported average blood 
glucose levels were the mean of blood glucose measured over seven weeks and the fasting 
blood glucose levels were recorded immediately before sacrifice. 
Intraperitoneal glucose tolerance test 
Intraperitoneal glucose tolerance test (IPGTT) was performed 2-3 days before sacrifice. 
Animals were fasted overnight but allowed free access to water/infusion as appropriate. After 




a dose of 2g/kg body weight (10µl/g). Blood glucose levels were then measured at 12 different 
time points (0, 3, 5, 10, 15, 20, 25, 30, 45, 60, 90 and 120 minutes). 
Western Blot analysis 
Tissue homogenates and protein determination were obtained as described by (Bradford, 
1976; Marais et al., 2001). Tissue lysates were prepared by diluting sample in Laemmli sample 
buffer and lysis buffer, boiled for 5 minutes and 50ug protein/µl was separated by 
electrophoresis on either a 12% SDS-PAGE mini-proteon gel or a 4-20% stain-free precast gel 
(Criterion TGX, Biorad, USA). The running protocol consisted of an initial 10 minutes 
electrophoresis at 100V and 200mA followed by 30-40 minutes at 200V and 200mA for the 
mini-proteon gels, while the running protocol for the precast gel consist of an initial 10 
minutes electrophoresis at 100V and 200mA followed by 25-30 minutes at 140V and 140mA. 
Gels were activated using ChemiDoc (BioRad) and thereafter, proteins were transferred onto 
a milipore Immobilon-P transfer membrane (0.45µm) (Immobilon®-P, Merck Millipore Ltd, 
Germany). Non-specific sites were blocked with 5% fat free milk in TBS-tween. Primary 
antibodies were diluted in TBS-Tween in a 1:1000 ratio while the secondary antibody was 
diluted in TBS-Tween in a 1:4000 ratio. All data points are from independent biological repeats 
(n=4-5). Measured biomarkers are GLUT 4, tPkB/Akt, p/tERK1/2 and p/tIRS 1/2. All primary 
antibodies were obtained from Cell Signalling Technology. A goat anti-mouse/rabbit-






The plasma concentration of testosterone (E-EL-0072), estradiol (E-EL-0065) and insulin (E-EL-
R2466) were measured using a commercially available ELISA kit (Elabscience Biotechnology, 
Hubei) as per manufacturer’s instructions. 
 
Statistical analysis  
GraphPad Prism™ software (GraphPad™ Software, Version 8.2, San Diego, CA, USA) was used 
for the statistical analysis. Normal data distribution was measured using the Shapiro-Wilk, 
Anderson-Darling, Kolmogorov-Smirnov and D'Agostino & Pearson, normality tests. When 
data passed all normality tests, a one-way ANOVA of variance with a Tukey’s Post-hoc Test 
was performed. Where data were not evenly distributed, a Kruskal-Wallis test and a Dunns 
Post-hoc Test were carried out. To investigate the plausible mixed effect of the phospho to 
total ratios, a mixed effect or ordinary two-tailed, two-way ANOVA was performed. Where 
appropriate, a Pearson’s correlation matrix was carried out. Significance was accepted at p< 
0.05. Results are expressed as mean ± SD. 
Results  
Diabetic control (DC) animals consumed more food and drank more water compared to the 
control (p<0.001) and vehicle (p<0.001) groups. Diabetic animals receiving rooibos (DRF), 
honeybush (DHB) and sutherlandia (DSL) followed the same trend as DC when compared to 
the control (p<0.001) and vehicle (p<0.001). However, the DM animals treated with the 
infusions (DRF, DHB, and DSL) displayed a significant decrease in food intake when compared 




animals presented with elevated fasting blood glucose levels when compared to the control 
(19.62±7.49mmol/L vs. 6.150±0.7246mmol/L, p<0.001) and vehicle (19.62±7.49 mmol/L vs. 
5.660±1.02mmol/L, p<0.001) groups. Although the diabetic infusion treatment groups (DRF, 
DHB and DSL) presented with a significant increase in fasting blood glucose levels when 
compared to the control and vehicle groups (p<0.001), their (DRF, DHB and DSL) respective 
fasting blood glucose levels mildly decreased when compared to the DC group (Table 1). DC 
animals showed a significant reduction in body weight when compared to control (p<0.05). 
The respective infusion treatment groups (DRF, DHB and DSL) also presented with a decrease 
in body weight when compared to the control (p<0.001) and vehicle (p<0.001) (Table 2).  
Regarding glucose tolerance, there was a significant difference in the measured glucose levels 
between 0 and 120 minutes, in the DC, DRF, DHB and DSL groups (p=0.001). Although there 
was a non-significant improvement in the glucose tolerance of DHB animals (Figure 1A). 
Additionally, there was a significant positive correlation (r=0.7631) between fasting blood 
glucose levels and the fluid intake per day (p<0.0001) (Figure 1B). All diabetic animals (DC, 
DRF, DHB and DSL) presented with increased phosphorylated ERK1/2 (pERK1/2) when 
compared to the vehicle (0.988±0.252, 1.226±0.368, 1.028±0.369, 1.408±0.682 vs. 
0.766±0.138, p<0.05). They (DC, DRF, DHB and DSL) also displayed a reduction in the total 
ERK1/2 (tERK1/2) when compared to the control and vehicle (0.6438±0.5, 0.51±0.398, 
0.316±0.323, 0.56±0.537 vs. 0.847±0.281 and 0.7407±0.094, p<0.001) (Figure 2A-C). 
Furthermore, DHB animals presented with a significant difference in the ratio of phospho to 
total ERK1/2 compared to control (p=0.02). DSL on the other hand showed an increase in the 
ratio when compared to vehicle (p=0.02).  
Diabetic control animals presented with a decrease (-48%, -32%) in tIRS-1 when compared to 




DHB, DSL) displayed a non-significant decrease in trend in tIRS-1 when compared to the 
control and vehicle groups, but DRF and DHB were acutely upregulated when compared to 
DC (0.515±0.56, 0.5±0.453 vs. 0.48±0.246) (Figure 3). Despite the reduced tIRS-1 displayed by 
DSL animals when compared to the DC, they showed a nearly 50% upregulation in tIRS-2 when 
compared to the DC (Figure 3A-B). 
Additionally, DC animals presented with a decrease (-41.7%, -34%) in the expression of 
PkB/Akt when compared to the control and vehicle groups respectively. The diabetic infusion 
treatment groups (DRF, DHB, DSL) also displayed a percentage decrease in PkB/Akt when 
compared to the control and vehicle groups, but DRF animals presented with a further 
decrease in the total PkB/Akt compared to DC group. While, the DHB and DSL animals 
displayed an upregulation in total PkB/Akt (22.3%, 48%) when compared to DC respectively 
(Figure 4A-B).  
DC animals showed a reduction in tGLUT4 (-30%, -4%) when compared to the control and 
vehicle respectively. DRF and DHB groups also displayed a decrease in GLUT4 expression when 
compared to the DC and control groups. However, DSL animals presented with an increase in 
GLUT4 (70.9%) when compared to the DC group (p=0.08) (Figure 5A-B). 
Although, not significant, DC animals presented with a mild decrease in the level of plasma 
testosterone concentration (-16.5%) when compared to the vehicle, while DRF and DSL 
groups displayed a significant decrease compared to vehicle (811.2±126.5nmol/L vs. 
1085±95.66nmol/L, p=0.01) (793.1±192.9nmol/L vs. 1085±95.66nmol/L, p=0.02) respectively. 
However, DHB animals showed a mild increase in testosterone concentration compared to 
DC (Figure 6A). There were no significant differences in the level of plasma 17β-estradiol 





The potential hypoglycaemic effects of rooibos, honeybush and sutherlandia extracts have 
been widely investigated in both in vivo (Chadwick et al., 2007; Kawano et al., 2009; Muller et 
al., 2011) and in vitro studies (Williams et al., 2013; Chellan et al., 2014; Mazibuko et al., 2015; 
Mazibuko-Mbeje, Dludla, Roux, et al., 2019). The mechanisms through which this occur have 
been mostly determined in in vitro studies using cells lines, such as adipocytes, 
cardiomyocytes, fibroblast, myotubes/myoblast, etcetera. However, extremely few to no 
studies have reported the effects of rooibos, honeybush and sutherlandia on testicular insulin 
signalling, hence, the current study was designed. 
As expected, the diabetic control animals of the current study displayed polyphagia, 
polydipsia, excessive weight loss, sustained increased blood glucose and impaired glucose 
tolerance. These are features typical of type I DM. This is in agreement with several studies 
reporting the symptomatic characteristics of DM (Szkudelski, 2001). However, the diabetic 
animals treated with rooibos (DRF), honeybush (DHB) and sutherlandia (DSL) showed a 
significant decrease in food intake, and polydipsia was suppressed, as evidenced by the 
percentage reduction in fluid intake and by the significant positive correlation seen between 
fluid intake and the fasting blood glucose (FBG) ( r=0.7631, p<0.0001). This was accompanied 
with a reduction of 23.6% and 15% in the FBG levels of DHB and DSL animals respectively. This 
means that increased FBG can lead to osmotic diuresis thereby stimulating osmoreceptors to 
increase fluid intake. Although, the glucose tolerance of DRF and DHB animals improved, it 
did not reach significance and the glucose tolerance of DSL animals remained unchanged. The 
slight/mild decrease in FBG levels observed in the DRF animals of the current study, is party 
supported by a study that showed a significant reduction in the FBG levels of obese diabetic 




accompanied with improved glucose intolerance. This is also in agreement with the findings 
of Muller et al., who showed that rooibos offer a glucose lowering effect on diabetic rats by 
improving the glucose tolerance (Muller et al., 2012). The decrease in the FBG of up 23.6% 
observed in the DHB animals of the current study concur with Muller et al., who reported 
reduced FBG levels in obese insulin resistant rats after administration of honeybush extract 
(Muller et al., 2011). Additionally, the decrease in FBG levels of DSL animals in the current 
study is supported by Wayne et al. who showed diabetic rats receiving sutherlandia displayed 
lower blood glucose as evidenced by normoinsulinaemic levels and increased glucose uptake 
(Chadwick et al., 2007).  
In normal insulin signalling, IRS 1/2 are the most important insulin receptor substrate for 
glucose homeostasis (Withers et al., 1999), as they act as binding sites for Src-homology-2 
domain containing molecules such as PI3K. Binding of these molecules to IRS1/2 activates 
series of cascade signalling which eventually activates PkB. Activation of PkB/Akt in turn 
stimulate the translocation of GLUT4 from the intracellular pools to the plasma membrane.  
However, the absence of GLUT4 in the testis has been reported by several authors (Burant 
and Davidson, 1994; Schürmann et al., 2002; Kokk et al., 2004). Gomez et al. showed that 
GLUT8 is the dominant glucose transporter in the testis and that both insulin depletion and 
hyperglycaemia do not regulate its expression (Gómez et al., 2009). A year after this report, 
Lampioa and du Plessis reported that insulin stimulates GLUT8 expression in human 
spermatozoa and they further speculated that GLUT8 translocation is aided through the 
PkB/Akt pathway (Lampiao and du Plessis, 2010). In the current study, GLUT4 was measured 
in the testis and all groups showed GLUT4 expression. Briefly, both the control and vehicle 




GLUT4. In addition to the stimulation of GLUT8 during testicular glucose metabolism, these 
results suggest the involvement of GLUT4 in testicular insulin signalling. 
Additionally, the testicular tissue of diabetic control animals of the current study showed a 
decrease in IRS1/2, PkB/Akt and GLUT4. This is in agreement with the group of authors that 
reported impaired insulin signalling in C3A liver cells induced with insulin resistance, as these 
cells displayed decreased PtdIns (3, 4, 5)P2 and subsequent reduction in PkB (Mazibuko-
Mbeje, Dludla, Johnson, et al., 2019). In addition to the impaired insulin synthesis and 
secretion observed in DM, studies have shown that this disorder in part develop because of 
disruption in IRS 1/2 (Araki et al., 1994; Withers et al., 1998). Araki et al. reported impaired 
glucose tolerance, decreased insulin/insulin-like growth factor-1 (IGF-1) stimulated glucose 
uptake, and reduced intrauterine growth, in targeted gene mutated IRS-1 deficient mice 
(Araki et al., 1994). Withers et al. additionally showed that disruption of IRS-2 impaired both 
pancreatic β cell function and peripheral insulin signalling in IRS-2 deficient mice. They further 
reported that these mice displayed dysfunctional glucose homeostasis, and hence concluded 
that disruption of IRS-2 may contribute to the pathophysiology of human type II DM (Withers 
et al., 1998). Pertainng to male reproduction, Griffeth et al. reported that deletion of IRS-2 in 
mice resulted in a 45% reduction in testicular weight with consequent decreases in Sertoli 
cells, spermatogonia, spermatocytes, spermatids and the epididymal sperm reserve. 
However, there was normal cellular association (Griffeth, Carretero and Burks, 2013). Yagci 
and Zik also reported that IGF-1 play a significant role in testicular function and germ cell 
development. As the receptor for IGF-1 was distributed in the pachytene primary 
spermatocyte and Leydig cells of aged rats (Yagci and Zik, 2006). This suggest the importance 
of maintaining normal testicular insulin signalling, as disruption in signalling molecules, 




diabetic control animals of this study had lower plasma testosterone levels. This is in 
agreement with several studies that reported reduced serum testosterone following diabetes 
induction (Ballester et al., 2004; Vikram et al., 2008). 
Regarding the effects of rooibos on testicular insulin signalling, the diabetic animals receiving 
rooibos (DRF) presented with an increase in testicular protein expression of IRS ½. 
Interestingly, there was also a reduction in the expression of PkB/Akt and GLUT4. The 
decrease in PkB/Akt and GLUT4 observed in the testicular tissue of DRF rats of the current 
study is in contrast with the findings of Mazibuko et al., which showed the reversal of insulin 
resistance in 3T3-L1 adipocytes treated with rooibos through the suppression of 
phosphorylated IRS-1, nuclear factor kappa beta (Nf-kB), and AMPK and increased GLUT4 
expression (Mazibuko et al., 2015). In another manuscript, the same group of authors 
reported the ameliorative effects of rooibos on insulin resistant C2C12 muscle cells. This was 
evidenced by the enhanced glucose uptake, mitochondrial activity and ATP production after 
treating the muscle cells with rooibos. Mechanistically, it was shown that rooibos increased 
the activation of Akt, AMPK and GLUT4, suggesting that rooibos can exert its ameliorative 
effects through the PkB/Akt/GLUT4 pathway in these cells (Mazibuko et al., 2013). The 
difference between the results of the current study and the reports of Mazibuko et al., may 
be due to (i) different models of investigation (in vivo/in vitro), (ii) different tissues 
(testis/adipocytes and muscle cells) and (iii) the plausibility that rooibos does not enhance 
testicular insulin signalling through the PkB/Akt/GLUT4 pathway.  
Studies have shown that insulin can also activate the mitogen activated protein kinases 
(MAPK), especially the ERKs through the binding of growth factor receptor-bound protein-2 
(GRB-2) and Son-of-sevenless proteins (SOS) to IRS1/2. GRB-2 and SOS can bind IRS1/2 




activates membrane bound Ras. The phosphorylation of Ras stimulates a stepwise activation 
of kinase signalling of Raf, MEK and ERK. ERK is then translocated into the nucleus where its 
stimulate the phosphorylation of transcription factors to initiate gene expression needed for 
cell proliferation and differentiation (Alan and Kahn, 2001). Interestingly, the DRF animals of 
the current study presented with an upregulation (13.2%) in phosphorylated ERK 1/2. 
Although, the upstream signalling molecules (GRB-2 and SOS) were not measured, it may be 
suggested that rooibos may rather exert its effect on diabetic testicular insulin signalling 
through the IRS/ERK pathway. Regarding testosterone levels, diabetic animals receiving 
rooibos displayed a non-significant decrease in plasma testosterone levels. This partly concur 
with Opuwari and Monsees who reported that both fermented and unfermented rooibos 
reduces testosterone production in TM3 Leydig cells (Opuwari and Monsees, 2015). This 
suggest that although rooibos may play a role in insulin signalling, it does not have an effect 
on testosterone levels. 
While studies have shown the hypoglycaemic effects of honeybush (ICHIKI et al., 1998; 
Muruganandan et al., 2002), little to nothing is known about the mechanism/pathway at 
which these effects are exerted. In the current study, diabetic animals receiving honeybush 
(DHB) displayed a mild increase in testis protein expression of IRS 1/2 and PkB/Akt while 
GLUT4 remained unchanged. Since GLUT8 was not measured in the current study, little can 
be said about it. However, extrapolating from previous reports, it can be speculated that 
honeybush may enhance insulin signalling through the stimulation of IRS1/2, PkB/GLUT8 
pathway. Additionally, the DHB animals presented with a mild increase (7%) in the level of 
plasma testosterone. Since, this is the first study demonstrating this property, it can be 
suggested that honeybush may have a positive effect on testosterone production, although 




Diabetic animals receiving sutherlandia presented with increased tIRS-2, tPkB and tGLUT4. 
The increase in GLUT4 observed in the current study concur with Dang et al. who reported 
that pinitol (a sutherlandia component) enhanced GLUT4 translocation from the cytosol 
(intracellular vesicles) to the plasma membrane in skeletal muscle of C57BL/6 mice (Dang et 
al., 2010). Bates et al. also showed that pinitol exert a mild but sustained hypoglycaemic 
insulin-like effect in the murine model of type 1 DM (Bates, Jones and Bailey, 2000). 
Additionally, Williams et al. reported that sutherlandia prevents changes in DM related gene 
expression in insulin resistant cell model and that it upregulates GLUT4 translocation to the 
cell surface (Williams et al., 2013). Hence, it can be suggested that the decrease in the blood 
glucose levels of diabetic animals receiving sutherlandia observed in the current study may 
be through the stimulation of the IRS1/2, PkB/Akt, GLUT4 pathway. 
In conclusion, the result of the present study have shown the presence of GLUT4 in the testis 
and its plausible role in insulin signalling as seen in a typical cell. We have also demonstrated 
the role of rooibos, honeybush and sutherlandia in insulin signalling. Therefore, it can be 
suggested that these infusions may enhance insulin signalling through diverse pathways, but 
further investigations are required to elucidate the specific upstream and downstream 
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Table 1: Biometric data 
 
*p<0.05 vs. control; &p<0.001 vs. control; $p<0.05 vs. vehicle; @p<0.001 vs. vehicle; #p<0.001 
vs. DC. DC=diabetic control, DRF=diabetic+rooibos, DHB=diabetic+honeybush, DSL=diabetic 
+suthelandia 
  
Parameters Control Vehicle DC DRF DHB DSL 
Global 
p Value 
Food intake per 
day (g) 
22,40±2,48 21,48±1,61 40,43±2,87&@ 35,38±4,94&@# 32,22±5,44&@# 34,92±4,14&@# <0,0001 
Fluid intake per 
day (ml) 













Table 2: Body, organ and tissue weights 
 
*p<0.05 vs. control; &p<0.001 vs. control; $p<0.05 vs. vehicle; @p<0.001 vs. vehicle; #p<0.001 
vs. DC. DC=diabetic control, DRF=diabetic+rooibos, DHB=diabetic+honeybush, DSL=diabetic 
+suthelandia 
  





344,6±19,04 332,4±30,19 280,8±20,89* 266,7±32,95&@ 288,3±37,86* 247,4±30,60&@ <0,0001 
Testicular 
weight (g) 
1,414±0,12 1,351±0,09 1,380±0,11 1,357±0,14& 1,342±0,15 1,213±0,22 0,2510 
Visceral fat 
weight (g) 









































Figure 1: Glucose blood test. A. Glucose tolerance test (graph showing mean±SD) B. Glucose 
tolerance test (graph showing mean only) C. Correlation between fasting blood glucose 
levels and fluid intake per day. DC=diabetic control, DRF=diabetic+rooibos, 













Figure 2: Protein expression of phospho and total ERK1/2. A. individual phospho:total 
ERK1/2, B. p/tERK1/2 at a glance, C. Probed blot. *p<0.05 vs. control. Veh=vehicle, 























Figure 3: Protein expression of total IRS-1 and IRS-2. A. Ratio of IRS1 to IRS 2, B. Probed blot. 
Veh=vehicle, DC=diabetic control, DRF=diabetic+rooibos, DHB=diabetic+honeybush, 



















Figure 4: Total protein expression of PkB/Akt. A. Graph of PkB/Akt, B. Probed blot of 
PkB/Akt. Values in bracket () denotes percentage change versus DC. Veh=vehicle, 


















Figure 5: Total protein expression of GLUT4. A. Graph showing tGLUT4, B. Probed blot. 
Values in bracket () denotes percentage change versus DC. Veh=vehicle, DC=diabetic 




















Figure 6: Plasma levels of testosterone and estradiol. A. Tetosterone, B. Estradiol. Values in 
bracket () denotes percentage change versus DC. Veh= vehicle, DC=diabetic control, 
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The aim of the current study was to evaluate the testis and the cauda epididymis after treating 
both healthy and diabetic rats with rooibos, honeybush and sutherlandia.  
Materials and methods  
Ninety animals were divided into nine groups without bias (n=10 per group). The groups 
included five control groups, (control, vehicle, rooibos (RF, 2% fermented rooibos), 
honeybush (HB, 4% fermented honeybush) and sutherlandia (SL, 0.2% unfermented 
sutherlandia)) and four diabetic groups. Diabetes was induced via a single intraperitoneal 
injection of STZ at 45mg/kg. The groups are a diabetic control group (DC, received water), a 
diabetic + rooibos (DRF, received 2% fermented rooibos), a diabetic + honeybush (DHB, 
received 4% fermented honeybush) and a diabetic + sutherlandia group (DSL, received 0.2% 
unfermented sutherlandia). Animals were sacrificed after seven weeks of DM induction. 
Blood and testes were collected. 
Results  
Animals in the DC group presented with a significant increase in fasting blood glucose (FBG) 
levels compared to the control (p=0.02) and vehicle (p=0.0006) groups. DRF and DSL animals 
presented with a non-significant increase in FBG compared to the control (p=0.07, p=0.1) but 
was significantly increased compared to the vehicle (p=0.002, p=0.004) groups respectively. 
However, there was no statistically significant difference between the FBG of DHB compared 





DC animals presented with a significant decrease in the percentage of histologically normal 
seminiferous tubules compared to the control (49±13.85% vs. 68±7.54%, p=0.049). While 
DRF, DHB and DSL animals displayed an upregulation (21%, 14%, 5.4%) in the percentage of 
normal seminiferous tubules compared to the DC group.  
Conclusion  
The infusion control groups (RF, HB and SL) showed normal seminiferous tubule cellular 
association, presence of an epididymal lumen filled with spermatozoa and have normal 
overall architecture. Both the testicular and epididymal morphology were altered in DM, but 
these disruptions were mildly ameliorated by rooibos, honeybush and sutherlandia 
 






The testis is the male reproductive gonad and its function is to produce spermatozoa through 
a process called spermatogenesis. The produced spermatozoa are transited into the 
epididymis where maturation occurs. Spermatogenesis is a complex biological process that 
involves proliferation and differentiation of spermatogonia into spermatids within the 
seminiferous tubules of the testis. Studies have shown the importance of controlled glucose 
metabolism and other intermediate metabolites in spermatogenesis [1]. It is known that 
spermatogenesis takes approximately 74 days in humans [2–4], while it takes 35-52 days in 
rodents [5]. However, a recent study conducted in a group of normal men concluded that the 
total time to produce sperm may vary between 42-76 days [6]. The seminiferous tubules are 
the functional units of the testis. They consist of a basal membrane (the tubular epithelium), 
Sertoli cells (which are surrounded by the spermatogenic cells on the inside of the epithelium 
and stem cells exteriorly) , blood-testis barrier (which regulates the passage of substances 
between rete testis fluid and the lymph or plasma), germ cells at different developmental 
stages and the lumen that housed early and late spermatids [7]. After spermatozoa 
production in the seminiferous tubules of the testis, they are transferred into epididymis and 
move through the caput, and corpus part and are finally stored in the caudal epididymis until 
ejaculation. The individual sections of the epididymis contributes specifically to the luminal 
microenvironment stability, which is important for sperm maturation by the time they reach 
the caudal segment. Due to the array of cellular structures present in the testis and 
epididymis, diverse biochemical and physiological processes occur. Hence, these organs are 
easily influenced either positively or otherwise by several factors. Studies have shown the 
association between an altered cellular organization in the seminiferous tubule, the loss of 




diverse pathologies including diabetes mellitus (DM). DM is a chronic disease marked by 
hyperglycaemia. It occurs because of lack in insulin synthesis and secretion and/or due to the 
insensitivity of the specific tissue to the effect of insulin. DM has been shown to inflict damage 
on several organs, including the testis [8]. It is estimated that between 35-51% of diabetic 
men has testicular and or erectile dysfunction [9]. Keyhanmanesh et al. reported a significant 
decrease in the seminiferous tubule diameter, epithelium height, reduction in the number of 
Sertoli and Leydig cells, spermatogonia and spermatocytes in diabetic rats [10]. Soudamani et 
al. on the other hand reported reduction in the size of all the epididymis segments (caput, 
corpus and cauda) and an increase in the interstitial stroma of diabetic rats. It was further 
stated that due to the reduction in the epididymal segments, the tubules were shrinked, the 
epididymal principal cells were tightly packed having clumped nuclei and that the lumen was 
devoid of spermatozoa [11]. Several other authors have also reported abnormalities in the 
testis and epididymis of diabetic rats [12,13]. Interestingly, Ayuob et al. reported that after 
treating diabetic rats with antidiabetic drugs (metformin, pioglitazone and sitagliptin), 
although the symptoms of DM were improved, these drugs induced histopathological 
changes on the testicular structures (testis, epididymis, and seminal vesicle) [14]. It was stated 
that the testis of diabetic rats treated with metformin showed deformed primary 
spermatocytes, has few spermatozoa in the lumen and also showed cellular vacuolation, 
while the diabetic animals treated with pioglitazone showed atrophy. The testis of sitagliptin 
treated rats displayed a reduced mean cross sectional area of the epithelium and the tubular 
capillaries were congested.  
Since the Western/synthetic antidiabetic drugs seem to pose a great danger to the process of 
sperm production, sperm quality and quantity, it is important to develop different therapeutic 




undertaken to explore the phytotherapeutic effects of rooibos, honeybush and sutherlandia 
in diverse pathologies, including DM. 
Rooibos, honeybush and sutherlandia are indigenous Southern African plants. Rooibos 
originates from the Cederberg Mountains of the Western Cape region of South Africa [15,16]. 
It is generally available in either the unfermented (green rooibos) or the fermented (reddish-
brown rooibos) form. The fermented tea is obtained by oxidation and results in the unique 
reddish-brown leaf colour and woody-fynbos-floral honey flavour [17]. Honeybush is native 
to the Southeast and Southwest coastal areas of South Africa. It forms a part of the fynbos 
biome with the family name Fabaceae. It is used as a traditional tea since the 19th century 
[18,19]. Sutherlandia is a plant with diverse species that are widely spread across specific 
geographic regions of Southern Africa. It is indigenous to the Northern, Eastern and Western 
Cape areas of South Africa, southern areas of Namibia and south eastern regions of Botswana 
and Lesotho [20]. The infusions from these plants contains assorted phytochemicals that are 
beneficial to health.  
Several authors have reported the suppression of steatosis, liver cirrhosis, reduced 
inflammation and hepatocellular injury, inhibition of triacylglycerol and reduced plasma levels 
of aminotransferases in rats treated with either fermented or unfermented rooibos [21,22]. 
Honeybush has been shown to offer photo protection against UVB-induced skin damage in 
SKH-1 mice. This was evidenced by the reduction in erythema, peeling and hardening of the 
skin. It was suggested that honeybush enhanced cell proliferation, hence the observation 
[23]. Sutherlandia have also been reported to have a neuroprotective effect in C57BL/6J mice. 
As these mice showed a significant decrease in neuronal cell death with increased activation 




Regarding testicular tissues, Opuwari and Monsees reported that there were no crucial 
changes in the histomorphology of the testis and epididymis of healthy rats treated with 
rooibos. As testis showed complete spermatogenic phases with abundant spermatozoa in the 
lumen [25]. These authors in another manuscript also reported decreased testosterone 
production by Leydig cells treated with rooibos in vitro. This suggest that rooibos may have 
anti-androgenic activities [26]. Hence, the role of rooibos on male reproductive 
histomorphology remains controversial. Additionally, to the best of our knowledge, till date 
there are no studies reporting the effects of honeybush and sutherlandia on the 
histomorphology of the testis and epididymis in experimental animals, in both healthy and 
diseased states. 
Hence, the aim of the current study was to evaluate the testis and the cauda epididymis after 
treating both healthy and diabetic rats with rooibos, honeybush and sutherlandia.  
Materials and methods  
Infusion preparation  
Fermented rooibos (Aspalathus linearis) was procured from Carmien SA PTY LTD, 
South Africa. Fermented honeybush (Cyclopia intermedia) and unfermented sutherlandia 
(Lessertia frutescens) were obtained from Afrinaturals, South Africa. Infusions were prepared 
according to previously established methods [27]. Briefly, 2% fermented rooibos was 
prepared by adding 20g of dried rooibos in 1litre of boiled water and allowed to soak for 30 
minutes. After 30 minutes, the mixture was initially filtered using a cheesecloth and then 
filtered with a number 4 and a number 1 Whatman filter paper respectively (WhatmanTM, 




prevent the degradation of the light sensitive polyphenols and were stored at 4°C. Infusions 
were prepared freshly every 48 hours. Fermented honeybush (4%) and unfermented 
sutherlandia (0.2%) were prepared following the same method as described for rooibos. All 
infusions (rooibos, honeybush and sutherlandia) were prepared every other day (48 hours). 
The herbal teas serve as the only drinking fluid for these infusion groups. The fluid intake of 
the animals was measured three times a week. 
Experimental design 
Ninety adult male Wistar rats of weight range 250-300g were housed at the Stellenbosch 
University’s Faculty of Medicine and Health Sciences Animal Unit (18-23°C, 12:12 light/dark 
cycle). Animals were randomly divided into nine groups of ten. They were treated according 
to the recommendations of the Laboratory Animal Care of the National Society of Medical 
Research and the National Institutes of Health Guide for the Care and Use of Laboratory 
Animals [28]. Rats were individually caged and had free access to both food and 
water/infusions. The Stellenbosch University Animal Ethics Committee approved the study 
under (SU-ACUD17-00016). 
Diabetes was induced by administering a single intraperitoneal injection of streptozotocin 
(STZ) at 45mg/kg body weight from a stock solution of 30mg/ml (dissolved in sodium citrate 
buffer pH 4.5) (STZ S0130-IG, Sigma, South Africa). DM was confirmed after one week if the 
blood glucose level was ≥14mmol/L. 
The groups examined in this study include a control group, vehicle group (Veh), rooibos 
control (RF), honeybush control (HB), sutherlandia control (SL), a diabetic control group (DC), 
a diabetic + rooibos (DRF), a diabetic + honeybush (DHB) and a diabetic + sutherlandia group 




before diabetes induction. Food intake, fluid intake and body weights were measured thrice 
a week and blood glucose levels were measured once weekly. After 7 weeks of DM induction, 
animals were sacrificed and blood samples immediately collected. The testes and epididymis 
were also harvested and weighed. The relative testicular and relative epididymal weights 
were expressed as a percentage of body weight. The reported fasting blood glucose levels 
were recorded immediately before sacrifice and the average blood glucose measured over 
the treatment period was also reported  
Experimental procedures  
Testosterone  
The plasma concentration of testosterone (E-EL-0072) was measured using a commercially 
available ELISA kit (Elabscience Biotechnology, Hubei), and analysis was performed as per 
manufacturer’s instructions. Briefly, 100µl of standards and samples were added to each 
appropriate wells and were incubated for 90 minutes at 37°C. The liquid were removed after 
incubation and 100µl of Biotinylated detection Ab/Ag was added and incubated for another 
60 minutes at 37°C. After incubation, the liquid were aspirated and washed 3 times at 5 
minutes interval. Thereafter, 100µl of HRP testosterone conjugate was added, incubated for 
30 minutes at 37°C. The liquid were aspirated and the washing steps were repeated 5 times. 
Hereafter, 90µl of substrate reagent was added and incubated for 15 minutes at 37°C and 






The right testis and the epididymis were fixed in a 10% formalin solution. The tissues were 
kept in the solution for a minimum of 48 hours to allow for complete fixation. The fixed tissues 
were processed according to previously reported protocol [29]. Tissues were stained with 
haematoxylin and eosin (AUCL/E, Kimix Chemical and Lab. Supplies, South Africa) using an 
autostainer (Leica Auto stainer XL). Additionally, for proper visualization of the tissues 
towards qualitative analysis, testicular tissues (testis and epididymis) were stained with alcian 
blue-periodic acid schiff (AB/PAS). In brief, sectioned tissues were deparaffinised and 
hydrated in distilled water. Sections were stained with Alcian Blue (AB/PAS powder, Sigma 
South Africa) for 15 minutes, rinsed thoroughly in tap water for 2 minutes and further rinsed 
in distilled water for another 2 minutes. Sections were oxidized in 1% periodic acid (Sigma, 
South Africa) solution for 10 minutes and then rinsed in distilled water. Rinsed sections were 
placed in Schiff’s reagent (CLECA/E, Kimix Chemical and Lab. Supplies, South Africa) for 15 
minutes and then wash in lukewarm tap water for 7 minutes 30 second. At this point, sections 
turned dark pink. Sections were counter stained with haematoxylin solution for 30 seconds, 
washed in tap water for 3 minutes, then dehydrated, and cleared with xylene. Sections were 
mounted and allowed to air dry. 
Descriptive histomorphology 
To properly analyse the morphology of the testis and cauda epididymis, an initial blinded 
overview of the sections stained with H&E was performed (Figure 1). Thereafter, using 
AB/PAS stained tissues, tubules were further analysed blindly and categorized as previously 
described [29]. Briefly, one hundred seminiferous tubules per animal were randomly counted 




tubules were classified as normal when it showed complete spermatogenic phases, regular 
cellular organization, normal cellular association and regular interstitial spaces. Tubules were 
classified as undergoing atrophy when it showed epithelium shrinkage, few or absence of 
germ cells and cellular disorganization. Tubules undergoing sloughing are characterized by 
having excessive numbers of immature cells in their lumen and there are absence of some or 
all of the spermatogenic phases (Figure 2). 
The cauda epididymis was considered normal/intact if the following are absent (Figure 3): 
(i) Cribriform changes (this represent a hyperplastic modification of the epithelium, 
e.g infolding of the epithelium) 
(ii) Inflammatory infiltrate (excessive accumulation of cells in the interstitium, 
appearing as a vesicle filled with cells or scattered) 
(iii) Debris in the lumen (presence of cytoplasmic shedding in the lumen instead of 
spermatozoa) 
(iv) Clear cells / tubules (clear cells occurs as a consequence of debris in the lumen) 
(v) Sperm compaction (this occurs as a result of excessive fluid resorption due to lack 
in sperm production) 
(vi) Epithelial vacuolation (it represents the presence of small and/or large intra and 
inter cytoplasmic vacuoles, which leads to the alteration of the epithelial 
organization). 
After the blinded overview phase of the cauda epididymis, forty tubules were analysed per 
animal. Analysis occurred randomly across the whole section at field area ranging between 
234.16mm2-348.97mm2. The epididymal tubules were then categorized as normal or 




was obtained by dividing the exact number of normal/intact tubules by the total tubules 
counted multiplied by 100. 
Statistical analysis 
GraphPad Prism™ software (GraphPad™ Software, Version 8.2, San Diego, CA, USA) was used 
for the statistics. Normal data distribution was measured using the Anderson-Darling, 
Kolmogorov-Smirnov, Shapiro-Wilk and D'Agostino & Pearson, normality tests. When data 
passed all normality tests, a one-way ANOVA of variance with a Tukey’s Post-hoc Test was 
performed. Where data were not evenly distributed, a Kruskal-Wallis test and a Dunns Post-







Anthropometric parameters  
Animals in the DC group presented with a significant increase in fasting blood glucose (FBG) 
levels compared to the control (p=0.02) and vehicle (p=0.0006), RF (p=0.0015), HB (p=0.005) 
and SL (p=0.0004) groups. After seven weeks of infusion treatment, diabetic animals receiving 
rooibos (DRF) presented with a non-significant increase in FBG compared to the control 
(p=0.07) but was significantly increased compared to the vehicle (p=0.002). However, there 
was no statistically significant difference between the FBG of diabetic animals receiving 
honeybush (DHB) compared to the control (p=0.8) and vehicle (p=0.06) groups. The diabetic 
animals receiving sutherlandia (DSL) followed the same trend as DRF as there was no 
significant increase in the FBG compared to the control (p=0.1) group, while it was 
significantly higher compared to the vehicle (p=0.004) (Table 1) 
The DC and DHB animals gained less body weight, while animals in the DRF and DSL groups 
were significantly lighter compared to the control (p<0.0001), vehicle (p<0.001), RF (p<0.001), 
HB (p<0.0001) and SL (p<0.0001) groups. The bodyweight of DHB groups significantly 
increased compared to DSL (p=0.02).  
There was no statistically significant difference in testicular weights between the groups. 
However, the epididymal weight of the DC animals was 10% less compared to the control 
animals. DRF animals presented with a significant reduction in epididymal weight compared 
to the control (p=0.03). DHB epididymal weight was more than 10% less than the control, 
while DSL displayed a significant decrease compared to the control (p=0.001) group. All 
diabetic groups presented with a significant reduction in visceral fat weight compared to the 




Although not significant, DC animals presented with an increase of just more than 20% in the 
relative testicular weight (RTW) compared to control and vehicle respectively, but, there was 
a significant increase compared to RF (p=0.014) and SL (p=0.045). DRF animals displayed a 
significant increase in RTW compared to control (p=0.02), vehicle (p=0.014), RF (p=0.0002) 
and SL (p=0.09). There was no statistical significant difference in relative epididymal weight 
(REW) between the groups except between the RF and DRF groups (p=0.006) (Table 1). 
Testosterone  
Although not significant, the DC animals presented with a percentage decrease in plasma 
testosterone concentration (-9.78%, -16.5%) when compared to the control and vehicle 
groups respectively. While the DRF animals displayed a significant decrease in plasma 
testosterone concentration compared to the vehicle group (811.2±126.5nmol/L vs. 
1085±95.66nmol/L, p=0.04). The DHB group presented with a non-significant difference in 
testosterone compared to the DC group. The DSL animals showed a significant reduction in 
testosterone concentration compared to the RF (793.1±192.9nmol/L vs. 1114±104.5nmol/L, 
p=0.01) and SL (793.1±192.9nmol/L vs. 1102±165.6nmol/L, p=0.03) (Figure 4). 
Histology  
DC animals presented with a significant decrease in the percentage of histologically normal 
seminiferous tubules compared to the control (49±13.85% vs. 68±7.54%, p=0.049). While 
DRF, DHB and DSL animals displayed an upregulation (21%, 14%, 5.4%) in the percentage of 
normal seminiferous tubule compared to the DC group (Figure 5). Furthermore, there was a 
significant difference in the percentage of histomorphologically normal epididymis between 
groups (p=0.01). There was a significant decrease in the percentage of normal epididymal 
tubules of the DC group when compared to the SL group (68±12.17% vs. 89.5±10.95%, 




vehicle respectively. Although not significant, the percentage of normal epididymal tubules 
was higher in the DRF, DHB and DSL groups when compared to the DC group (23%, 20%, and 
10%) respectively (Figure 6).  
Discussion  
Studies have reported alteration in the cellular arrangement and ultimately disruption of the 
seminiferous tubule in DM [11]. The absence of spermatozoa in the luminal epididymis has 
likewise been shown after DM induction or when toxins were administered to rodents [30]. 
Regarding the effects of drugs used in the treatment of DM, a set of authors investigated the 
role of some antidiabetic drugs (metformin, pioglitazone and sitagliptin) on the histological 
organization of the testis and epididymis. Interestingly, they concluded that these drugs 
confer histopathological changes in the testis and epididymis of these rats [14]. 
Seeing that synthetic drugs negatively affects male reproductive organs, it is pertinent to 
develop natural strategies in treating DM and its male reproductive complications. Hence, the 
current study evaluated the testis and cauda epididymis in both healthy and DM-induced rats 
after treating with rooibos, honeybush and sutherlandia.  
The infusion control groups (RF, HB and SL) of the current study presented with normal FBG 
relative to the control group. The DC animals showed elevated FBG, reduced visceral fat and 
body weight. Although there was no statistically significant difference in the testicular weight 
of the DC animals, they presented with a decrease in epididymal weight. This is in agreement 
with Soudamani et al. and several other authors who reported the association between 
hyperglycaemia and reduction in testicular and epididymal weight [10,11,31]. After treating 
diabetic animals with the respective infusions for seven weeks, DRF animals presented with a 




the vehicle. However, they showed a very mild decrease in FBG compared to DC. The 
extremely mild decrease in the FBG of the DRF animals of the current study is partly supported 
by studies that reported the hypoglycaemic effect of rooibos, both in in vivo and in vitro 
experiments [32,33]. Opuwari and Monsees reported that rooibos had no significant effect 
on the testicular and epididymal weight of control animals treated for fifty-two days [25]. 
Another study indicated that after treating rats with rooibos for ten weeks with oxidative 
stress induction during the last two weeks, there were no changes in the testicular and 
epididymal weights of these animals [34]. The DRF animals of the current study showed 
reduction in the testicular, epididymal and visceral fat weights. The DHB animals on the other 
hand showed no significant difference in the FBG levels when compared to both control and 
vehicle. When compared to the DC group, they showed a decrease of -23.6%. This concurs 
with previous studies that have reported the hypoglycaemic effect of honeybush, both in in 
vivo and in vitro studies [35,36]. Despite the moderate improvement seen in FBG, they still 
presented with a decrease in body and epididymal weights. Regarding sutherlandia, DSL 
animals showed improved FBG, but their tissue weight remained on the lower side. Several 
studies have highlighted the hypoglycaemic potential of sutherlandia [37,38], as Chadwick et 
al. reported that diabetic rats treated with sutherlandia showed normal serum insulin levels 
and that it enhanced glucose uptake into the muscle and adipose tissues [38]. Cumulatively, 
these infusions displayed a very mild hypoglycaemic potential but the animals (DRF, DHB and 
DSL) showed reduction in the testicular, epididymal and visceral fat weights. It can be 
speculated that (i) there is increased usage of fat for energy and for the formation of 
cholesterol (ii) there is a breakdown of the body’s protein and amino acid oxidation. Since 
alteration in the testicular and epididymal morphology observed in DM have been associated 




concentration to testicular, epididymal and visceral fat weights. A significant positive 
correlation was seen between the plasma testosterone concentration and testicular weight 
(r=0.2482, p=0.02), epididymal weight (r=0.4188, p=0.0001) and visceral fat weight (r=0.4719, 
p=<0.0001) (Supplementary figure 1). These findings further shows that these animals had 
less fat and plausibly had less cholesterol and thus leading to altered steroidogenesis.  
The DC animals of the current study presented with a decrease in plasma testosterone levels 
and had altered histomorphology of the testis and epididymis. They showed an increase in 
the number of disrupted seminiferous tubules, elevated atrophic and sloughy tubules. The 
epididymis of the DC animals showed an increase in the number of lumen with no 
spermatozoa, presented with debris in the lumen, vacuoles in the epithelium and moderate 
inflammatory infiltrates. This cumulatively means that the DC animals showed a reduced 
percentage of normal/intact epididymides (Figure 6). The histopathological changes observed 
in both the testis and epididymis of the DC animals of the current study is in agreement with 
Arikawe et al. who reported altered seminiferous tubule morphology in diabetic rats [42]. 
Additionally, Soudamani et al. showed the reduction in tubular size (tubular diameter, volume 
and surface density) of all epididymal segments (caput, corpus and cauda) in diabetic rats. 
They further reported that due to the shrinkage of tubules, principal cells were packed tightly 
with clumping of nuclei [11].  
Coming to the infusion treated groups, the DRF and DSL animals of the current study 
presented with a decrease in plasma testosterone concentration, but they showed 
improvement in the histo-architecture of the seminiferous tubules and epididymis. This is 
evidenced by the reduced number of seminiferous tubules with accumulation of immature 




epididymal epithelium showed lesser vacuolization, and debris in the lumen was reduced. 
Interestingly, the DHB animals presented with a mild increase (6%) in plasma testosterone 
concentration with improved histo-morphology of the seminiferous tubules and epididymis. 
It is worth noting that this is the first study reporting the role of rooibos, honeybush and 
sutherlandia on the histo-architecture of the testis and epididymis. Although, mechanisms 
through which these mild changes are exerted is unknown, it can be speculated that 
honeybush probably enhanced the function of the hypothalamic-pituitary gonadal axis as 
testosterone was increased.  
Conclusion  
The current study was designed to evaluate the histomorphology of the testis and epididymis 
after treating with rooibos, honeybush and sutherlandia, in both healthy and diabetic rats. 
The infusion control groups (RF, HB and SL) showed normal seminiferous tubule cellular 
association, presence of an epididymal lumen filled with spermatozoa and have normal 
overall architecture. Both the testistular and epididymal morphology were altered in DM, but 
these disruptions were mildly ameliorated by rooibos, honeybush and sutherlandia. Hence, it 
can be concluded that (i) DM does have detrimental effects on the histomorphological 
architecture of the testis and epididymis (ii) the individual infusions have no obvious adverse 
effect on the architecture of the testis and epididymis and (iii) the infusions mildly improve 
the histomorphology of the testis and epididymis in diabetes. Since, this represent the first 
study reporting these effects, further investigations are required regarding the mechanisms 
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Table and figure legends 
Table 1: Anthropometric data. ap<0.0001 vs. control, bp<0.0001 vs. vehicle, cp<0.0001 vs. 
rooibos, dp<0.0001 vs. honeybush, ep<0.001 vs. sutherlandia, fp<0.05 vs. DHB, gp<0.05 vs. 
control, hp<0.05 vs. vehicle, ip<0.05 vs. rooibos, jp<0.05 vs. honeybush, kp<0.05 vs. 
sutherlandia. RF=rooibos, HB=honeybush, SL=sutherlandia, DC=diabetic control, 
DRF=diabetic+rooibos, DHB=diabetic+honeybush, DSL=diabetic+sutherlandia. Average blood 
glucose = mean of blood glucose measured over 7 weeks. 
 
Figure 1: Histological overview of the seminiferous tubules using H&E. Veh=vehicle, 
RF=rooibos, HB=honeybush, SL=sutherlandia, DC=diabetic control, DRF=diabetic+rooibos, 
DHB=diabetic+honeybush, DSL=diabetic+sutherlandia, Scale bar=100µm. 
 
Figure 2: Classification for the seminiferous tubules (AB/PAS). A. Normal (complete 
spermatogenic phases, regular cellular organization, normal cellular association and regular 
interstitial spaces), B. Atrophic (epithelium shrinkage, few or absence of germ cells and 
cellular disorganization), C and D. Sloughy (presence of immature accumulation of cells in the 
lumen and absence of some or all of the spermatogenic phases). SG=spermatogonia, 
PS=primary spermatocytes, S=spermatids. The scale bar for micrographs A, B, C= 20µm and 
micrograph D= 50µm 
 
Figure 3: Illustration of the cauda epididymal abnormalities (AB/PAS). A. Cribiform changes 




Inflammatory infiltrate (excessive accumulation of cells in the interstitium), D and E. Debris 
in the lumen (presence of cytoplasmic shedding in the lumen instead of spermatozoa), F. Clear 
lumen (no spermatozoa in the lumen), G. Epithelium disruption (altered epithelium 
organization), H. Cellular accumulation in the lumen. The scale bar for micrographs A, B, D, E, 
F, G, H = 50µm and C= 100µm. 
 
Figure 4: Plasma testosterone concentration. ap<0.05 vs. veh, bp<0.05 vs. RF, cp<0.05 vs. SL. 
Veh=vehicle, RF=rooibos, HB=honeybush, SL=sutherlandia, DC=diabetic control, 
DRF=diabetic+rooibos, DHB=diabetic+honeybush, DSL=diabetic+sutherlandia. 
 
Figure 5: Histomorphological overview of the testis (AB/PAS). A. Micrographs scale 
bar=100µm (the DC seminiferous tubules were frequently disorganized, having few 
spermatozoa), B. Micrographs scale bar=50µm (these abnormalities were shown at a higher 
magnification), C. Showing the percentage of normal seminiferous tubule. ap<0.05 vs. control. 
Veh=vehicle, RF=rooibos, HB=honeybush, SL=sutherlandia, DC=diabetic control, 
DRF=diabetic+rooibos, DHB=diabetic+honeybush, DSL=diabetic+sutherlandia. CL=clear 
lumen, DT=disorganized tubule, FS=few spermatozoa. 
 
Figure 6: Histomorphological overview of cauda epididymis (AB/PAS). A. Micrographs scale 
bar=200µm (the epididymal tubule of the DC animals was frequently void of sperm or have 
few spermatozoa. Although, the tubule of DSL have spermazoa, there was an in folding of the 
epithelium), B. Micrographs scale bar=100µm, C. Showing the percentage of normal/intact 




DC=diabetic control, DRF=diabetic+rooibos, DHB=diabetic+honeybush, 





Table 1: Anthropometric data 





344,6±19,04 332,4±30,19 349,4±21,41 345,3±25,55 352,6±19,37 275,1±11,38a,b,c,d,e 266,7±32,95a,b,c,d,e 288,3±37,86a,b,c,d,e 247,4±30,60a,b,c,d,e,f <0,0001 
Visceral fat 
(g) 
13,22±2,942 12,40±3,022 12,25±2,867 12,78±3,784 12,58±3,338 3,073±1,363a,b,e,I,j 2,476±1,539a,b,c,d,e 4,208±2,514g,h,j,k 2,378±1,200a,b,c,d,k <0,0001 
Testicular 
weight (g) 




0,4107±0,032 0,4090±0,043 0,3858±0,025 0,4174±0,034 0,4034±0,018 0,4937±0,052c,k 0,5165±0,081g,h,I,k 0,4679±0,036i 0,4921±0,080c <0,0001 
Epididymal 
weight (g) 























Figure 1: Histological overview of the seminiferous tubules using H&E. Veh=vehicle, 
RF=rooibos, HB=honeybush, SL=sutherlandia, DC=diabetic control, DRF=diabetic+rooibos, 








Figure 2: Classification for the seminiferous tubules (AB/PAS). A. Normal (complete 
spermatogenic phases, regular cellular organization, normal cellular association and regular 
interstitial spaces), B. Atrophic (epithelium shrinkage, few or absence of germ cells and 
cellular disorganization), C and D. Sloughy (presence of immature accumulation of cells in the 
lumen and absence of some or all of the spermatogenic phases). SG=spermatogonia, 
PS=primary spermatocytes, S=spermatids. The scale bar for micrographs A, B, C= 20µm and 






Figure 3: Illustration of the cauda epididymal abnormalities (AB/PAS). A. Cribiform changes 
(hyperplastic modification of the epithelium, e.g infolding of the epithelium), B and C. 
Inflammatory infiltrate (excessive accumulation of cells in the interstitium), D and E. Debris 
in the lumen (presence of cytoplasmic shedding in the lumen instead of spermatozoa), F. Clear 
lumen (no spermatozoa in the lumen), G. Epithelium disruption (altered epithelium 
organization), H. Cellular accumulation in the lumen. The scale bar for micrographs A, B, D, E, 







Figure 4: Plasma testosterone concentration. ap<0.05 vs. veh, bp<0.05 vs. RF, cp<0.05 vs. SL. 
Veh=vehicle, RF=rooibos, HB=honeybush, SL=sutherlandia, DC=diabetic control, 






















Figure 5: Histomorphological overview of the testis (AB/PAS). A. Micrographs scale 
bar=100µm (the DC seminiferous tubules were frequently disorganized, having few 
spermatozoa), B. Micrographs scale bar=50µm (these abnormalities were shown at a higher 
magnification), C. Showing the percentage of normal seminiferous tubule, atrophic and 
sloughing tubules. ap<0.05 vs. control. Veh=vehicle, RF=rooibos, HB=honeybush, 

























Figure 6: Histomorphological overview of cauda epididymis (AB/PAS). A. Micrographs scale 
bar=200µm (the epididymal tubule of the DC animals was frequently void of sperm or have 
few spermatozoa. Although, the tubule of DSL have spermazoa, there was an in folding of the 
epithelium), B. Micrographs scale bar=100µm, C. Showing the percentage of normal/intact 
epididymis. ap<0.05 vs. SL. Veh=vehicle, RF=rooibos, HB=honeybush, SL=sutherlandia, 
DC=diabetic control, DRF=diabetic+rooibos, DHB=diabetic+honeybush, 
















SF1: Correlations between plasma testosterone concentration and (A) testicular weight (B) 














……..“Too much of everything is bad, but too much of rooibos, 










Conclusion and Recommendation 
Conclusion  
Diabetes, characterized by hyperglycaemia does not only affect cardiovascular health, it 
affects and complicate general health, including male reproductive health. Systematic studies 
conducted amongst normozospermic men revealed that male fertility is on the decline as 
sperm quality reduced by 50-60% between 1973 and 2011 (Levine et al., 2017). Given that, 
DM affects approximately 422 million people globally as of 2014, and it was reported that 
there is a rise in the number of childhood, adolescent and adulthood diabetic males. This 
means that as the prevalence of DM increases, there is a plausibility that male 
subfertility/infertility will increase, because men are mostly affected during their 
reproductive years (Silink, 2002; Agbaje et al., 2007). Studies have shown that in both diabetic 
men and animals, there is reduced sperm motility (Singh et al., 2009; Bhattacharya, Ghosh 
and Nandi, 2014), decreased normal sperm morphology (Maresch et al., 2017) and increased 
sperm with fragmented nuclear and mitochondria DNA (Agbaje et al., 2007; Shrilatha and 
Muralidhara, 2007). Although there are significant data available on the effects of DM on 
sperm function, the mechanism through which the effects are exerted is less clearly 
understood. Hence, the first part of this study briefly investigated, in corroboration with 
previously established independent pathways, the possibility of activation and involvement 
of the AGE-RAGE pathway in DM related sperm function impairment. 
The use of medicinal plants in treating diseases have been used for many centuries in 




exploring the benefits of phytochemicals and to as well investigate their importance in health, 
as studies have shown that they have fewer negative side effects. Rooibos, honeybush and 
sutherlandia are plants containing various bioactive chemicals with supposed health benefits. 
The effects of the infusions/teas from these plants have been widely investigated in diverse 
disease states, however, very few studies have investigated the role of rooibos in male 
reproduction and no studies are available regarding honeybush and sutherlandia. Hence, this 
study investigated the role of rooibos, honeybush and sutherlandia in healthy and diabetes-
induced rats, and on the consequent male reproductive function impairment. 
Aim 1: Section 1.3.1 
Diabetes induction and male reproductive parameters 
From the results of this part of the study, it was evident that diabetic animals showed a 
reduction in sperm motility and normal morphology while the sperm deformity index was 
increased. Additionally, diabetic animals presented with increased seminiferous tubular 
diameter, decrease in the number of normal seminiferous tubules and increased number of 
atrophic tubules. They also presented with severe absence of spermatogenic phases as well 
as persistent cellular degeneration. The tubules were disorganized and germ cells were 
severely dissociated.  
Ricci et al., who showed the abnormal localization or absence of Occludin in the tight junction 
between Sertoli-Sertoli cells, which prevents the formation of the blood-testis barrier in DM, 
also reported the absence of some spermatogenic phases (Ricci et al., 2009) in DM. Hess and 
Nakai also concluded that the presence of seminiferous tubules with persistent atrophy is 




Considering this, the observations from this part of the study suggest that the absence of 
phases II and III of spermatogenesis and the presence of atrophic and sloughing tubules in 
diabetic animals may position testicular morphological structures to abnormalities, which 
ultimately may result in reduced fertility. 
Diabetes on sperm function: A closer look at AGEs, RAGEs, MAPKs and activation of the 
apoptotic pathway 
Hyperglycaemia has been reported to cause increased OS in various tissues (Giacco and 
Brownlee, 2010), including testicular tissue (Ricci et al., 2009) and spermatozoa (Khaki et al., 
2010). Another study reported elevated MDA levels, lipid hydroperoxides and lipid peroxides 
in the plasma of type 1 diabetic patients (Martín-Gallán et al., 2003). In the diabetic state, 
lipid peroxidation can be induced by protein glycation and glucose auto-oxidation that can 
further lead to the formation of ROS (Mullarkey, Edelstein and Brownlee, 1990). 
Furthermore, an increase in the production of ROS has been shown to cause the non-
enzymatic and progressive glycation of proteins with the consequently increased formation 
of glucose-derived AGEs. The modified proteins further cause an increase in ROS formation 
and aggravation of OS (Nicholl and Bucala, 1998; Valencia et al., 2004) after binding to the 
ligand-receptor, RAGE. 
AGE-RAGE activation has been implicated in the development and progression of several 
diseases, both metabolic and non-metabolic. Chen et al. reported that the excessive 
production of oxidants in the endothelial progenitor cells resulted in RAGE-mediated AGE 
accumulation with resultant inhibition of cell proliferation, migration and adhesion which 
were all attenuated after RAGE blockage (Chen et al., 2010). In the same vein, inhibition of 
RAGE aided the protective effect of glucagon-like peptide-1 on AGE-induced apoptotic 




From the results of this study, diabetic animals presented with an increase in testicular MDA 
levels, reduction in catalase enzymatic activities, increase in the expression RAGE, p38MAPK, 
JNK, caspase 3/7 and PARP. This suggest that the association between AGE-RAGE activation 
and MAPKs signalling may contribute to the reproductive function impairment seen in DM.  
Aim 2: Section 1.3.2 
The effect of rooibos, honeybush and sutherlandia on sperm functional parameters 
Rooibos, honeybush and sutherlandia are plants with numerous health benefits. However, 
studies have reported that lengthened exposure to rooibos induced acrosome reaction in 
rats, which may subsequently lead to impaired reproduction (Opuwari and Monsees, 2014). 
Additionally, long-term exposure to sutherlandia was reported to cause protein cross-links 
and that it can as well result in autoimmunity and teratogenicity. Ngcobo et al. showed that 
the in vitro chronic treatment of normal T-lymphocyte cells with sutherlandia was toxic 
(Ngcobo et al., 2012). Studying the available evidence regarding the excessive consumption 
and the long-term intake of these infusions, it is pertinent to further investigate their role in 
health status. Hence, sperm functional parameters of healthy animals were examined after 
administration of the respective infusions.  
From the results obtained from this study, it was evident that rooibos, honeybush and 
sutherlandia enhanced testicular antioxidant enzyme activities and reduced MDA levels. 
However, their role on sperm parameters was confusing. As there was a decrease in sperm 
kinematic parameters, sperm motility and sperm with normal morphology, however, sperm 
concentration was increased. This is a novel finding and further investigations are 
encouraged. We conclude that care should be taken when consuming these teas as a healthy 




Testicular oxidative stress and apoptosis status after treating diabetic rats with rooibos, 
honeybush and sutherlandia 
Several studies have highlighted the antioxidant ameliorative potential of these infusions in 
both human and animal studies (Marnewick et al., 2003; Hong, Lee and Kim, 2014). 
Diabetic animals treated with rooibos (DRF), honeybush (DHB) and sutherlandia (DSL) showed 
an elevation in the antioxidant enzyme activities. It was interesting to see that DRF animals 
showed increased sperm motility even when compared to the vehicle. DHB animals however 
displayed a decrease in sperm motility and DSL animals showed an increase in sperm motility 
compared to the diabetic control. Additionally, these animals (DRF, DHB and DSL) showed an 
improvement in the number of spermatozoa with normal morphology. It is suggested that 
the improved sperm motility observed in the DRF and DSL animals may in part be due to the 
boost in antioxidant enzyme activity, which subsequently protected against/alleviate the 
stress imposed by DM on sperm motility. Although DHB animals presented with improved 
antioxidant enzyme activities, the sperm motilities were not improved.  
The effects of rooibos, honeybush and sutherlandia on testicular insulin signalling of 
diabetic rats 
The antidiabetic potential of rooibos, honeybush and sutherlandia has been reported. Studies 
have shown that these infusions may exert their hypoglycaemic effects by improving glucose 
tolerance and enhancing glucose uptake (Kawano et al., 2009). Some studies showed that 
rooibos improved glucose metabolism by promoting the activation of PkB and GLUT4 (Mikami 
et al., 2015; Muller et al., 2018), which suggest its role in insulin signalling. Additionally, the 
importance of controlled insulin signalling for normal male reproduction have been 
highlighted (Yagci and Zik, 2006; Griffeth, Bianda and Nef, 2014). Since insulin signalling is 




The diabetic control group of this study showed impaired testicular insulin signalling. This was 
evidenced by the decrease in IRS1/2, PkB/Akt and GLUT4 protein expression. Following 
infusion treatment, DRF animals presented with improved IRS1/2, but PkB/Akt and GLUT4 
remained unchanged. DHB animals displayed upregulation in IRS1/2 and PkB/Akt protein 
expression, but GLUT4 remained unchanged. DSL group showed an increased IRS-2, PkB/Akt 
and GLUT4. Since there was a very mild decrease in the fasting blood glucose of the DRF, DHB 
and DSL groups, the following were suggested:  
(i) Rooibos may have exerted this mild hypoglycaemic effect through a pathway 
involving IRS1/2 activation 
(ii) Since GLUT8 is believed to be a dominant glucose transporter in the testis, it was 
suggested that honeybush may have exerted its effect through the 
IRS1/2,PkB/Akt, GLUT8 pathway 
(iii) DSL may improve testicular insulin signalling through the IRS1/2,PkB/Akt, GLUT4 
pathway. 
These are novel findings, which requires further investigations, to ascertain the specific 
activated upstream and downstream signalling proteins. 
Descriptive histomorphology evaluation of the testis and epididymis following 
administration of rooibos, honeybush and sutherlandia 
The control animals receiving rooibos, honeybush and sutherlandia displayed normal 
seminiferous tubule cellular association, cauda epididymal lumen were filled with matured 
spermatozoa and there was normal overall seminiferous tubule and epididymal tubule 
architecture. Both the testistular and epididymal morphology were altered in DM, but these 




sutherlandia. Since, this represent the first study reporting these effects, further 
investigations are required regarding the mechanisms. 
In conclusion, the results of this study have showed that DM impairs male reproductive 
parameters and the histo-architecture of the testis and cauda epididymis. The impairment 
may be exerted through the ROS/OS/AGE-RAGE/MAPKs and apoptosis activation.  
Additionally, rooibos, honeybush and sutherlandia may suppress testicular OS in DM by 
promoting antioxidant enzyme activities but their role in apoptosis needs further 
investigation. These infusions may also exert mild hypoglycaemic effects by improving insulin 
signalling and they may enhance the histomorphology of the testis and cauda epididymis. 
However, when healthy, consumption of these infusions should be proceeded with caution 
as too much may reduce sperm quality. 
In closing, extrapolating from these results, it can be suggested that rooibos, honeybush and 
sutherlandia are potentially beneficial to general health. Moreover, healthy young men 
should be careful of how frequent these teas are consumed. In diabetes, rooibos, honeybush 
and sutherlandia displayed mild hypoglycaemic effect, hence these teas can be used in the 
management of diabetes. Regarding male reproduction, rooibos seem to have the most 
beneficial effect on sperm motility, followed by sutherlandia with honeybush showing no 
positive effect. Hence, rooibos and sutherlandia are recommended for young diabetic men 






(i) Although a recent study has indicated that the period of spermatogenesis can vary 
between 42 and 76 days, and the duration of treatment for this study fell within 
the range, it would have been nice to investigate what happens in a much longer 
study.  
(ii) Infusions were prepared every 48 hours. While some studies have shown that 
aspalathin, the main component of rooibos have a half-life of 8 hours, others have 
described the beneficial effects of several bioactive components of rooibos, 
honeybush and sutherlandia, which have extended half-lives. It is therefore 
suggested that future studies should prepare the infusions every day. Additionally, 
since there are wide variations in the phenolic contents of the infusions (rooibos, 
honeybush and sutherlandia), the determination of the various phytochemical 
componenets of the herbal teas should be carried out in future studies. 
(iii) Since people tend to consume diverse teas simultaneously, a group mimicking this 






(i) In order to properly understand the insulin-signalling pathway in the testis and 
spermatozoa, future studies can investigate the importance of the activation of 
the CbI-Proto-oncogene pathway in spermatogenesis. 
(ii) In the study of male infertility, the conventional seminal analysis in categorizing 
fertility is becoming inadequate. It is evident that AGE negatively affect male 
reproductive function and subsequently male fertility through ROS and/or 
activation of other mechanistic pathways, which at this time is largely unknown. 
Therefore, it is essential to investigate the fundamental/basic molecular protein 
interaction, which may provide more information about infertility as a whole. We 
recommend that future studies investigating idiopathic infertility and disease 
induced infertility should further elucidate the impact of protein modification and 
glycation. Additionally, studies investigating its mechanistic role in infertility are 
required as this will aid the therapeutic approach 
(iii) Since this is the first study reporting the role of rooibos, honeybush and 
sutherlandia on male reproduction, we were unable to delve deep into the 
mechanisms through which the effects were exerted. Hence, future studies can 
investigate the role of these infusions on the upstream and downstream insulin 
signalling activation. 
(iv) Further histological, and immunohistological analysis should be performed, in 
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Probed Blots for CHAPTER 7: Testicular Oxidative Stress and Apoptosis Status in Streptozotocin-induced Diabetic Rats after Treatment with 














































Appendix A: G1=gel 1, G2=gel 2. (G1 and G2 of A-F are 4-20% stain free precast gels (26 lanes)), while G1, G2 and G3 of G are 12% stain free gel (15 lanes). 






Probed Blots for CHAPTER 8: The effect of rooibos (Aspalathus linearis), honeybush (Cyclopia intermedia) and sutherlandia (Sutherlandia 












































Appendix B: G1=gel 1, G2=gel 2. (G1 and G2 of A-F are 4-20% stain free precast gels (26 lanes)), while G1, G2, G3 and G4 of C and D are 12% stain free gel 
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